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Cellular heterogeneity and lineage dynamics of the developing, adult, and 
diseased murine pancreas 
Lauren Byrnes 
 
Abstract 
Organogenesis requires the complex interactions of multiple cell lineages that coordinate 
their expansion, differentiation, and maturation over time. In Chapters 2 and 3, we utilize a 
combination of single-cell RNA-sequencing, immunofluorescence, in situ hybridization, and 
genetic lineage tracing, to profile the cell types within the epithelial and mesenchymal 
compartments of the murine pancreas across developmental time. We find a previously 
undescribed endocrine progenitor population, as well as an analogous population in both human 
fetal tissue and human embryonic stem cells differentiating towards a pancreatic beta cell fate. 
Further, we identify candidate transcriptional regulators along the differentiation trajectory of 
this population towards the alpha or beta cell lineages. Within the mesenchyme, we identify 
previously underappreciated cellular heterogeneity and reconstruct potential lineage relationships 
among the pancreatic mesothelium and mesenchymal cell types. In Chapter 4, we further 
characterize the pancreatic mesothelium, identifying novel markers and secreted factors 
expressed within this population. Knockout of the secreted factor specifically expressed by the 
mesothelium, Fgf9, reveals a hypoplastic pancreas by late gestation. We find a disrupted ratio of 
epithelial and mesenchymal cells that suggests Fgf9 regulates the epithelial-mesenchymal 
interactions critical for pancreatic development. In Chapter 5, we extend our single-cell RNA-
sequencing approach to adult pancreatic homeostasis and disease, describing multiple subtypes 
of mesenchymal and mesothelial populations in both conditions. Comparison of diseased and 
 vii 
healthy pancreata reveal shifts in mesenchymal cell types, highlighting populations and 
transcriptional targets that may regulate the development of disease. In summary, this work 
reveals transcriptional and cellular heterogeneity of the developing, adult, and diseased pancreas, 
and identifies lineage relationships among novel populations within both the epithelial and 
mesenchymal compartments.  
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Chapter 1 
Introduction 
  
 2 
Diabetes mellitus  
Diabetes mellitus is a disease caused by deficient insulin production, resulting in 
abnormally high blood glucose levels. Currently, 425 million people across the globe are 
diagnosed with diabetes and that number is projected to rise to 642 million by 2040, highlighting 
the urgent need to understand, treat, and prevent this disease. (International Diabetes Federation: 
http://www.diabetesatlas.org/). Within the pancreas, groups of aggregated endocrine cells termed 
the islets of Langerhans secrete hormones in response to fluctuations in blood glucose levels. 
One of these endocrine cells within the islet, the beta cell, secretes insulin, the hormone 
responsible for initiating the uptake of glucose from the blood into cells throughout the body. 
The insulin-secreting function of beta cells is disrupted in individuals with both type 1 and type 2 
diabetes. In type 1 diabetes, auto-immune destruction of beta cells results in their absence within 
the pancreas, leading to inadequate insulin secretion to regulate blood glucose. In type 2 
diabetes, peripheral tissue resistance to uptake glucose requires increased production of insulin 
from beta cells. Over time, the beta cells are not able to increase the production of insulin and 
become dysfunctional, leading to dysregulated blood glucose levels. Therefore, the beta cells are 
a critical cell type for the maintenance of the body’s blood glucose levels.  
For individuals with Type 1 diabetes, who lack beta cells, restoring insulin to the body in 
order to regulate blood glucose levels has been a major focus of the last century. The isolation of 
insulin from pancreata of dogs, and later synthesis of human insulin, allowed for delivery of 
exogenous insulin to individuals with type 1 diabetes. Although insulin injections greatly 
reduced mortality associated with diabetes mellitus, secondary complications arising from the 
reduced glycemic control, such as diabetic nephropathy, neuropathy, and retinopathy, continue to 
affect individuals with the disease. Transplantation approaches, using either the whole pancreas 
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or only the pancreatic islet fraction, have continued to improve and can provide long-term tight 
regulation of blood glucose levels and slowed progression of secondary complications in 
individuals with diabetes (A. C. Gruessner & Gruessner, 2016; Posselt et al., 2010; Shapiro et al., 
2000; Shapiro, Pokrywczynska, & Ricordi, 2016). Transplantation approaches demonstrate the 
success of restoring insulin production to cure type 1 diabetes. However, a severe lack of supply 
for transplantation makes this treatment unavailable for the large majority of individuals with 
diabetes mellitus.  
 There exists a great need for a renewable source of transplantation material to provide 
relief for individuals suffering from diabetes mellitus and its secondary complications. Stem cell 
differentiation platforms are a promising approach to produce a nearly unlimited supply of 
transplantation material (Pagliuca & Melton, 2013; Sneddon et al., 2018). These approaches take 
advantage of the ability of human embryonic stem cells (hESCs) to develop into any cell type of 
the body by guiding these pluripotent cells through a directed differentiation protocol to a 
particular cellular fate in vitro.  Transplantation of hESC-derived oligodendrocyte precursors, for 
instance, has restored locomotion after spinal cord injury in an adult rat model (Keirstead et al., 
2005). Similarly, hESC-derived cardiomyocytes have improved heart regeneration after 
infarction in guinea pigs (Shiba et al., 2012).  Given the lack or dysfunction of one particular cell 
type in diabetes, the beta cell, directed differentiation of hESCs to a beta cell fate in vitro can 
produce theoretically limitless transplantation material for individuals with diabetes. A 
challenge, therefore, is developing differentiation protocols that can produce a beta cell in vitro 
with the same functionality as beta cells in vivo. Mouse studies of in vivo pancreatic development 
have facilitated significant progress in the development of differentiation protocols for hESC-
derived beta cells. 
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Pancreatic epithelial development 
Development of the pancreas results in a highly-branched, mature organ composed of 
multiple cell types that are organized into two separate compartments with distinct functions. 
The exocrine compartment, consisting of acinar and ductal cells, forms the network that shuttles 
acinar cell-produced digestive enzymes to the duodenum to aid in food digestion. The endocrine 
compartment, consisting of the islets of Langerhans, secrete multiple hormones to regulate blood 
glucose levels. The islets of Langerhans are composed of four different endocrine cell types that 
each secrete a different hormone, including beta (insulin), alpha (glucagon), gamma (pancreatic 
polypeptide), and delta (somatostatin) cells. During development, a fifth endocrine cell, the 
ghrelin-producing epsilon cell, is also present. Decades of work have sought to understand the 
developmental steps that produce the mature pancreatic organ, with a specific emphasis on the 
development of the beta cell. 
Pancreas development begins with the specification of the endoderm and endoderm-
derived gut tube, which is facilitated and marked by expression of the transcription factors Sox17 
and FoxA2 (Ang & Rossant, 1994; Kanai-Azuma et al., 2002; Weinstein et al., 1994). The 
regulation of endoderm differentiation by Nodal signaling is conserved across multiple 
vertebrates, including mice (Tremblay, 2010). Within the endoderm, pancreas specification is 
marked by expression of the transcription factor Pdx1 in two groups of cells along the dorsal and 
ventral primitive foregut by embryonic day 8.5 (E8.5) (Ohlsson, Karlsson, & Edlund, 1993). All 
epithelial cells in the pancreas are derived from this pool of Pdx1+ progenitors (G. Gu, 
Dubauskaite, & Melton, 2002). Expression of Pdx1 requires the inhibition of hedgehog signaling 
and activation of retinoic acid signaling by secretion of signals from the notochord (Hebrok, 
Kim, & Melton, 1998) and mesenchymal cells (Martín et al., 2005; Molotkov, Molotkova, & 
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Duester, 2005), respectively. Around E9, the Pdx1+ cells evaginate into a cap of surrounding 
mesenchymal cells, proliferate to form a stratified epithelium, and begin to undergo branching 
morphogenesis (Fig. 1a). The proliferation and branching of Pdx1+ progenitors is supported by 
the secretion of FGF10 from the surrounding mesenchymal cap (Bhushan et al., 2001). 
Coinciding with branching morphogenesis, subtypes of Pdx1+ progenitors form tip and trunk 
domains by E12.5. Cross-antagonistic interaction between two transcription factors, Ptf1a and 
Nkx6-1, delineate the tip and trunk regions (Schaffer, Freude, Nelson, & Sander, 2010). Tip cells, 
characterized by expression of Ptf1a, Cpa1, and c-Myc, act as multipotent progenitors for the 
three major cell types of the pancreas up until E13.5, when their cellular fate becomes restricted 
to the acinar cell (Q. Zhou et al., 2007). The trunk cells, marked by Sox9, Hnf1b, Hnf6, Glis3, 
and Nkx6-1, are restricted to either a ductal cell or endocrine cell fate (Kang et al., 2009; Y.-S. 
Kim et al., 2012; Schaffer et al., 2010; Seymour et al., 2008; Solar et al., 2009). The fate of a 
trunk cell toward the ductal or endocrine lineage is regulated by differential levels of Notch 
signaling (Apelqvist et al., 1999; Jensen et al., 2000; Shih et al., 2012). High levels of Notch 
result in a ductal fate, while lower levels lead to an endocrine cell fate (Shih et al., 2012). 
The endocrine lineage begins with the expression of a transcription factor, Neurogenin3 
(Ngn3) in trunk cells with low levels of Notch (Fig. 1a). Ngn3 expression defines the endocrine 
progenitor cells that will differentiate into the main endocrine lineages of the pancreas: alpha, 
beta, delta, and gamma cells (Gradwohl, Dierich, LeMeur, & Guillemot, 2000; G. Gu et al., 
2002). Epsilon cells are partially derived from Ngn3+ progenitors, although an Ngn3-
independent differentiation trajectory has also been described for this endocrine cell type (Arnes, 
Hill, Gross, Magnuson, & Sussel, 2012). In the mouse, Ngn3 is expressed in two waves during 
development (Villasenor, Chong, & Cleaver, 2008). The first wave, termed the primary 
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transition, occurs from E9.5 – E12.5 and generates mostly alpha cells (Herrera, 2000; Pan & 
Wright, 2011). Only a minority of primary transition alpha cells are maintained in the adult 
pancreatic islet (G. Gu et al., 2002; Herrera, 2000). The second transition occurs from E12.5 to 
birth and generates the large majority of endocrine cells in the mature pancreas (Pan & Wright, 
2011). In a divergence from mice, human pancreatic development consists of only one wave of 
NGN3 expression and endocrine differentiation (Nair & Hebrok, 2015).  
A critical function of Ngn3 expression is to facilitate cell cycle exit in order to promote 
differentiation towards a endocrine cell fate (Miyatsuka, Kosaka, Kim, & German, 2011). 
Shortly after induction of Ngn3 expression, cells exit the cell cycle, and only reenter after 
downregulation of Ngn3 (Miyatsuka et al., 2011). The exit from the cell cycle and subsequent 
differentiation is facilitated by Ngn3 induction of both negative regulators of the cell cycle, such 
as Cdkn1a, and endocrine differentiation genes, such as Pax4, Neurod1, Nkx2-2, and Rfx6. Pak3, 
a transcription factor downstream of Ngn3, also contributes to endocrine progenitor cell cycle 
exit, as Pak3 deficient mice show increased proliferation of Ngn3+ endocrine progenitors 
(Piccand et al., 2014). Therefore, the coupling of cell cycle exit and differentiation is facilitated 
by the transient expression of Ngn3 in endocrine progenitors. 
The production of the different endocrine cell types by Ngn3+ endocrine progenitors is 
temporally regulated (K. A. Johansson et al., 2007). For example, Ngn3+ cells become 
competent to make beta cells after E10.5, while delta cells are not produced until after E14.5 (K. 
A. Johansson et al., 2007). This results in different proportions of endocrine cells during 
development. Prior to E14.5, alpha cells make up the majority of endocrine cells being produced 
(K. A. Johansson et al., 2007). The production of gamma cells peaks around E14.5, while beta 
cells are produced in the highest proportion beginning around E14.5 until birth (K. A. Johansson 
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et al., 2007). These competency windows create waves of endocrine differentiation throughout 
development, where most endocrine cells are being produced but in varying proportions. 
The trajectory of a Ngn3+ endocrine progenitor to one of the hormone-producing cell 
lineages is dependent on multiple transcription factors with dynamic roles throughout pancreatic 
development. Pdx1, Nkx6-1, Nkx2-2, and Pax4 have been demonstrated to be important factors 
in beta cell differentiation, while Arx is critical for alpha cell differentiation. However, many of 
these factors are critical for more than one endocrine lineage and interact with other factors to 
regulate lineage allocation. In Pax4-/- mice, loss of beta and delta cells is accompanied by an 
increase in alpha and epsilon cells, suggesting that Pax4 regulates the decision toward a 
beta/delta or alpha/epsilon cell fate (Prado, Pugh-Bernard, Elghazi, Sosa-Pineda, & Sussel, 2004; 
Sosa-Pineda, Chowdhury, Torres, Oliver, & Gruss, 1997). Arx has been shown to oppose the 
action of Pax4 in order to promote the development of alpha cells at the expense of beta and 
delta cells (Collombat et al., 2003). Double knockout mice for Arx and Pax4 result in an absence 
of both alpha and beta cells, and replacement with delta cells, highlighting the complex 
interactions of transcription factors to regulate endocrine lineage allocation (Collombat, 2005). 
Nkx2-2-/- mice have reduced numbers of beta, alpha, and gamma cells, and instead show 
increased numbers of epsilon cells (Prado et al., 2004; Sussel et al., 1998). Downstream of Nkx2-
2, Nkx6-1 is required for production of proper numbers of beta cells through the maintenance 
and/or expansion of beta cell precursors following Ngn3 expression but prior to the production of 
insulin (Sander et al., 2000). Pdx1, required for early specification of pancreatic progenitors and 
expansion, is also critical for beta cell proliferation and survival (Gannon et al., 2008). Loss of 
Pdx1 in beta cells results in decreased numbers of beta cells and a concomitant increase of alpha 
and delta cells. The increase of alpha and delta cells is a result of increased proliferation rates of 
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these cell types, rather than conversion of lineages, suggesting that communication between 
inter-islet cell types is also important for endocrine lineage allocation (Gannon et al., 2008). 
Given the complex interactions between multiple factors, endocrine lineage allocation remains 
incompletely understood, including the timing and coordination of these events during the 
progression from a Ngn3+ endocrine progenitor to a fully differentiated hormone-producing cell.    
 
Pancreatic mesenchymal development 
Although prior work has focused extensively on the development of the pancreatic 
epithelial compartment, the epithelium does not develop in isolation. Multiple non-epithelial 
cells are in close proximity to the epithelium and are critical for proper epithelial development. 
At E8, secretion of factors from the neighboring mesoderm and notochord specifies the region of 
endoderm that will ultimately give rise to the pancreas (Hebrok et al., 1998; S. K. Kim, Hebrok, 
& Melton, 1997; Kumar, Jordan, Melton, & Grapin-Botton, 2003). Fusion of the dorsal aortae by 
E8.5 displaces the notochord, and brings the dorsal aorta in close proximity to the dorsal 
pancreatic primordium (Lammert, Cleaver, & Melton, 2001). Vitelline veins remain in close 
proximity to the ventral pancreatic primordium. These endothelial structures induce expression 
of key transcription factors required for proper pancreatic differentiation and insulin expression 
(Lammert et al., 2001; Yoshitomi, 2004). Around E9, a group of mesenchymal cells, collectively 
termed the mesenchyme, condense around the dorsal gut, and facilitate the growth of the budding 
epithelium (Bhushan et al., 2001; Golosow & Grobstein, 1962; Landsman et al., 2011; Slack, 
1995). As epithelial proliferation and branching morphogenesis proceeds, the epithelium 
protrudes into the surrounding cap of mesenchymal cells. The rapid growth of the epithelium 
results in a decreasing ratio of mesenchymal to epithelial cells during development, with rare 
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mesenchymal cells in the adult pancreas (Erkan et al., 2011; Landsman et al., 2011). Therefore, 
non-epithelial cell types are in constant contact with the pancreatic epithelium throughout 
development. 
Many of the mesoderm-derived structures involved in early pancreatic development are 
relatively well defined, such as the notochord and dorsal aorta. However, the cells that migrate to 
condense around the dorsal pancreatic primordium and persist into adulthood are broadly termed 
mesenchymal cells. The term mesenchymal implies that these cells originate from the 
mesodermal germ layer, although this has not been definitively demonstrated for the 
mesenchymal cells surrounding the pancreas. Indeed, in some regions of the embryo, such as the 
head, mesenchymal cells and structures are derived from the ectodermal neural crest (Gilbert, 
2000). Therefore, the assumption that all mesenchymal cells are derived from the mesoderm may 
not be correct for other areas of the embryo as well. In addition to their assumed mesodermal 
origin, these cells are annotated as mesenchymal based on morphological characteristics, such as 
an elongated, spindle shape, and in vitro behavior, such as attachment to plastic. There are a 
limited number of molecular markers that are used to identify mesenchymal cells, including 
collagens, vimentin, desmin, and platelet-derived growth factor receptor alpha. However, these 
markers may not always be specific to mesenchymal cells. For example, in E14.5 pancreas, 
Ngn3+ cells upregulate expression of vimentin transcripts and differentiated endocrine cells 
express the vimentin protein (Gouzi, Kim, Katsumoto, Johansson, & Grapin-Botton, 2011). 
There is a need for more specific molecular markers that can unambiguously identify 
mesenchymal cells in different organ systems.  
Although poorly defined, the importance of the mesenchyme in pancreatic development 
has been demonstrated by both physical and genetic ablation approaches. Experiments in the 
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1960s dissected E11 pancreatic epithelial buds and cultured the buds ex vivo(Golosow & 
Grobstein, 1962). Without the mesenchyme, the epithelial bud failed to undergo the growth and 
morphogenetic processes that occur in vivo. Addition of the dissected pancreatic mesenchyme 
back to the epithelial bud ex vivo rescued both growth and branching morphogenesis, 
demonstrating the requirement of this compartment for epithelial development. Adding back 
mesenchyme from other organs, such as retina or kidney, could also restore epithelial growth, 
suggesting that multiple organs may share features of the mesenchyme to facilitate epithelial 
processes. Additionally, the mesenchyme was able to support epithelial development across a 
porous filter, indicating that mesenchymal-secreted factors may mediate the growth and 
morphogenesis of the epithelium. Later ex vivo culture experiments demonstrated that while the 
mesenchyme supports exocrine development, it repressed endocrine development (Duvillié et al., 
2006; Miralles, Czernichow, & Scharfmann, 1998). Exocrine development was supported by 
close proximity to the mesenchyme, while endocrine development was supported with increased 
distance from the mesenchyme (Zhixing Li et al., 2004).  
The importance of the mesenchyme in epithelial development was further supported by 
genetic ablation approaches, removing the mesenchyme during development in vivo (Landsman 
et al., 2011). Unlike prior ex vivo culture experiments, however, the mesenchyme was found to 
support both exocrine and endocrine development, by inducing the proliferation of pancreatic 
progenitors that contribute to both exocrine and endocrine lineages. The differences between the 
ex vivo and in vivo studies could be due to the artificial environment of the culture system. It is 
also possible that additional factors or structures present in vivo but missing ex vivo play an 
important role in differentiation processes. Nonetheless, these studies demonstrate the critical 
role of the mesenchyme in facilitating the development of the pancreatic epithelium.  
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In addition to cellular ablation studies, which physically remove the mesenchymal cells, 
ablation of mesenchymal-expressed genes has also resulted in impaired epithelial development. 
Expression of Fgf10 within the mesenchyme is required for proper proliferation of Pdx1+ 
pancreatic progenitors (Bhushan et al., 2001). Depletion of Fgf10 results in hypoplastic 
pancreata that fail to undergo branching morphogenesis. Loss of Hox6, a gene expressed in the 
pancreatic mesenchyme, results in decreased Wnt5a signaling in the mesenchyme. The loss of 
Wnt5a signaling leads to a subsequent downregulation of WNT inhibitors, Dkk1 and Sfrp3,  in 
Ngn3+ endocrine progenitors, impairing the differentiation of Ngn3+ cells towards an endocrine 
cell fate (Larsen, Hrycaj, Newman, Li, & Wellik, 2015). Finally, BMP signaling within the 
mesenchyme has been shown to regulate endocrine differentiation in both chick and mice 
(Ahnfelt-Rønne, Ravassard, Pardanaud-Glavieux, Scharfmann, & Serup, 2010). Mesenchyme-
specific inhibition of BMP signaling in mouse pancreatic explants led to increased numbers of 
endocrine cells and reduced numbers of exocrine cells. These studies highlight mesenchymal-
derived signals that function specifically to support endocrine differentiation. The application of 
these secreted signals to in vitro differentiation platforms has been of high interest, and has 
helped improve the derivation of beta cells (Pagliuca & Melton, 2013). Indeed, bulk proteomic 
analyses have identified mesenchymal secreted factors that can enhance hESC differentiation 
towards a beta cell fate (Russ et al., 2016). Therefore, at least one important mechanism of 
mesenchymal-supported epithelial development is the secretion of growth factors. 
The ablation and genetic loss of function approaches described above treat mesenchymal 
cells as a single entity, by removing the entire mesenchyme or using whole body genetic 
knockouts. However, it remains unclear whether this compartment is truly composed of one 
homogeneous cell type or whether it contains multiple cell types with varying functions. It is 
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possible that different mesenchymal subtypes perform different functions to support either 
exocrine or endocrine differentiation and development. This may be reflected by contradictory 
evidence for the role of the mesenchyme in endocrine cell differentiation, with some studies 
suggesting an inhibitory role (Miralles et al., 1998), while others suggesting a supportive role. 
Perhaps a more definitive example of mesenchymal heterogeneity is the formation of the spleen, 
an entire organ, from a subgroup of cells within the pancreatic mesenchyme marked by Nkx2-5, 
Tlx1 and Wt1 (Hecksher-Sørensen et al., 2004). Therefore, there is evidence of functional 
differences between subtypes of mesenchymal cells during development. The use of bulk 
approaches, combined with the poor definition of mesenchymal cells, has hindered our ability to 
identify these mesenchymal subtypes and understand their potential differing functions. 
Without clear definitions of the various subtypes within the pancreatic mesenchyme, 
studying the lineage dynamics of this compartment has been even more challenging. The 
mesenchymal cells of the pancreatic epithelium have been assumed to be derived from the 
neighboring splanchnic mesoderm (Hecksher-Sørensen et al., 2004). An outer columnar layer of 
the splanchnic mesoderm, termed the splanchnic mesodermal plate, has also been hypothesized 
to give rise to the underlying mesenchymal cells detected in E10.5 pancreata (Hecksher-
Sørensen et al., 2004). Recently a study challenged these long-held assumptions (Angelo & 
Tremblay, 2018). By dye labeling various mesenchymal structures and tracing their cellular 
derivative, Angelo and Trembley identified the coelomic mesothelium, the lining of the 
abdominal cavity, rather than the splanchnic mesoderm, to act as a source of pancreatic 
mesenchymal cells. Beyond these early stages of development, very little is known about the 
lineage dynamics of the pancreatic mesenchyme.  
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The need for further studies on mesenchymal heterogeneity, function, and lineage is 
becoming more recognized in other organ systems. Studies of the lung mesenchyme have begun 
to characterize distinct mesenchymal cell types, their impact on epithelial development, and their 
lineage relationships (McCulley, Wienhold, & Sun, 2015). Similar to the pancreas, the 
mesenchyme surrounding developing epithelial lung buds are a critical source of signals that 
facilitate epithelial growth, morphogenesis, and differentiation processes (McCulley et al., 2015). 
Early tissue recombination studies revealed the presence of distal and tracheal mesenchymal 
compartments that direct the differentiation of the epithelium to either a distal or tracheal 
phenotype, highlighting the heterogeneity within the mesenchymal compartment (Shannon, 
Nielsen, Gebb, & Randell, 1998). Additionally, specific mesenchymal cell types with distinct 
markers have been noted to perform functions critical for proper epithelial development. For 
example, the migration and differentiation of alveolar smooth muscle cells, a mesenchymal cell 
type marked by PDGFR-alpha, is required for the process of alveologenesis, where the 
epithelium undergoes shape and differentiation processes to support efficient gas exchange 
within the lung (Lindahl et al., 1997). Finally, studies have begun to examine the origin and 
lineage dynamics of the different mesenchymal cell types (Agha et al., 2014; Kumar et al., 2014; 
Peng et al., 2013). They have revealed the presence of local mesenchymal progenitor niches that 
utilize a variety of mechanisms to produce diverse mesenchymal cell types (Kumar et al., 2014). 
The lung mesenchyme, once thought of as a homogenous, growth-factor secreting group of cells, 
is becoming recognized as a group of diverse, functionally relevant cell types with lineage 
dynamics as intricate and sophisticated as those of the epithelium (Kumar et al., 2014). The 
deeper understanding of mesenchymal development is critical to understanding lung 
development as a whole. 
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The similarities between lung and pancreas development, including their endoderm origin 
and branched epithelial structure, suggest that the pancreatic mesenchyme also contains 
functionally diverse cell types derived via various lineage trajectories. Understanding 
mesenchymal development and subsequently the epithelial-mesenchymal interactions that guide 
pancreatic development, will require the ability to study the function of individual cell types 
within each compartment.  
 
In vitro recapitulation of beta cell development 
Information about how the pancreas develops in vivo has been crucial for building 
differentiation protocols to derive beta cells from hESCs. By mimicking key steps of 
development with the addition of cocktails of exogenous signaling or growth factors, in vitro 
differentiation protocols aim to mimic the progression of pancreatic development in vivo towards 
a beta cell fate (Pagliuca & Melton, 2013). Recapitulation of developmental steps can be 
assessed by expression of the key transcription factors detected in vivo (Pagliuca & Melton, 
2013). The in vitro derivation of endoderm and Pdx1+ pancreatic progenitors from hESCs was 
accomplished by the addition of activin A, a TGF-beta family member with similar binding 
partners to Nodal, inhibitors of hedgehog signaling, retinoic acid, and FGF10, all signaling 
pathways involved in early endoderm and pancreatic differentiation(D'Amour et al., 2005; 2006; 
Pagliuca & Melton, 2013). From these hESC-derived Pdx1+ progenitors, Ngn3+ endocrine 
progenitors were produced by modulation of Notch signaling, and additional factors that were 
determined empirically (D'Amour et al., 2006). Since then, numerous protocols have generated 
pancreatic islet cells (Guo, Landsman, Li, & Hebrok, 2013; Kroon et al., 2008) and 
subsequently, insulin-producing beta cells capable of sensing and responding to glucose from 
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hESCs (Pagliuca et al., 2014; Rezania et al., 2014; Russ et al., 2015)2. Therefore, the 
information from developmental processes was critical for the development of these stem cell 
differentiation protocols.  
While there has been great progress in the production of beta cells in vitro, the resulting 
hESC-derived beta cells do not fully recapitulate their in vivo counterparts. Although recent 
protocols have produced functional hESC-derived beta cells that respond appropriately to 
fluctuating glucose levels (Pagliuca et al., 2014; Rezania et al., 2014; Russ et al., 2015; Zhu et 
al., 2016)2, their glucose-sensing function is not maintained long-term in vitro.  This phenotypic 
instability of hESC-derived beta cells greatly hinders transplantation, drug screening efforts, and 
studies of human beta cell physiology. Additionally, the efficiency of most stem cell platforms 
remains problematic for therapeutic applications, with the final product of most published 
protocols containing around 30% beta cells. These limitations to the current in vitro protocols 
suggest that additional optimization is required to produce stable, functional beta cells in large 
numbers. 
 There are multiple reasons why hESC-derived beta cells may not fully recapitulate in 
vivo beta cells. First, cellular intrinsic defects may be present. For example, cells may fail to 
express genes required for proper differentiation and function during in vitro differentiation. 
Although many genes required for beta cell differentiation, function, and stability have been 
identified, there may be additional unknown factors that are present in vivo but absent in vitro. 
On the other hand, hESC-derived cells may misexpress genes that are not normally expressed 
within the beta cell lineage in vivo. This concept is demonstrated by identification of adult beta 
cell “disallowed” genes. Disallowed genes are specifically downregulated in beta cells and 
disrupt beta cell function when improperly expressed (K. Lemaire, Thorrez, & Schuit, 2016). 
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Disallowed genes may also be present during beta cell differentiation processes in vivo and 
require inhibition during in vitro differentiation. Besides the absence or presence of particular 
genes, proper differentiation and function may require tight regulation of gene levels. Levels of 
Notch signaling dictate the differentiation of a pancreatic progenitor towards a ductal or 
endocrine fate (Shih et al., 2012). The dosage of Pdx1 is also critical for pancreatic development. 
The creation of hypomorphic Pdx1 alleles demonstrated a requirement for high levels of Pdx1 
for pancreatic development but lower levels for gut and stomach development (Fujitani et al., 
2006). If proper levels of critical genes are not replicated in vitro, the differentiation trajectory 
may be disrupted. Finally, as a third layer of regulation, the timing of gene expression may be 
dysregulated in vitro. Coordinated cascades of gene expression may be required to fully 
recapitulate in vivo processes (M. E. Wilson, Scheel, & German, 2003). These intrinsic defects 
related to gene expression may hinder the full maturation and stability of the hESC-derived beta 
cell.   
A second reason for the inability of current differentiation protocols to produce stable 
beta cells may relate to missing extrinsic signals. It is possible that the current emphasis on the 
production of a single cell type, the beta cell, has missed the importance of exogenous signals 
from other cell types. In vivo, beta cells develop within a complex structure that contains 
multiple cell types. The absence of these cell types in the in vitro platform, therefore, remains a 
stark difference to in vivo development. Focusing efforts on in vivo cellular interactions and 
tissue development as a whole can provide insight into crucial exogenous signals needed for 
proper beta cell function, maturation, and stability. Indeed, addition of mesenchymal cell types to 
the in vitro platform increased proliferation of pancreatic progenitor cells, greatly increasing the 
efficiency of the platform (Sneddon, Borowiak, & Melton, 2012). This effect could not be 
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replicated by addition of 16 different exogenous growth factors, suggesting that the increased 
progenitor proliferation by the mesenchyme is likely multifactorial (Sneddon et al., 2012). A 
clearer understanding of the various cell types, and their function, during pancreatic development 
can allow for the addition of missing signals to the in vitro platform and solve the remaining 
challenges of deriving beta cells from hESCs.  
 
Approaches to studying cellular heterogeneity of the developing pancreas 
 Prior approaches to understand cellular heterogeneity within a tissue have relied on the 
identification of individual genes to define or mark a group of cells. These approaches, including 
gene knockout and Cre-based lineage tracing, require prior knowledge of marker genes, and rely 
on that marker being specific to a particular population of cells. Cellular populations with 
distinct functions may be defined by sets of genes, rather than one individual gene, making their 
study by traditional approaches challenging. Identification of populations defined by multiple 
genes or novel genes can be done by screening assays, such as in situ or immunohistochemistry 
for a library of probes (Q. Zhou et al., 2007). However, these approaches require large 
investment of time and effort, and are still limited to the probes contained in the library. 
Genome-wide, unbiased methods, such as bulk RNA-sequencing have been used to overcome 
these limitations. By pooling together cells of interest, bulk RNA-sequencing can identify sets of 
genes expressed in specific populations without any prior knowledge of those genes. However, 
this approach requires the ability to separate a cell population of interest, either by physical 
dissection or fluorescence-activated cell sorting (FACS), which requires known cell surface 
markers.  
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Recent advances in molecular biology and microfluidics have allowed for development 
of methods to sequence whole genome or transcriptomes in thousands of individuals cells in 
parallel (Macosko et al., 2015; Zheng et al., 2017). Bioinformatic analyses can then classify cells 
into groups based on whole transcriptomic information, simultaneously identifying novel 
populations and the whole set of genes that define them. Single-cell RNA-sequencing has been 
used to assess cellular and transcriptional heterogeneity and identify novel populations in a 
variety of organs during development, adult homeostasis, and disease states (Potter, 2018). 
Recent studies of late embryonic, postnatal, and adult alpha and beta cells have demonstrated the 
power of single-cell transcriptomic profiling for unraveling endocrine lineage heterogeneity and 
revealing distinct transcriptional states of beta cell maturation (Dorrell et al., 2016; W.-L. Qiu et 
al., 2017a; Zeng et al., 2017). However, the application of this technology to the pancreas across 
early developmental time (before E17) has not been performed, and these studies focused solely 
on the epithelial compartment of the pancreas.  
 
Contribution to the field 
This work uses single-cell RNA-sequencing to identify and characterize a novel 
endocrine population within the epithelium and multiple subtypes of mesenchymal populations. 
In silico lineage modeling approaches predict the novel endocrine population to be derived from 
Ngn3+ progenitors and to give rise to alpha and beta cells during development. This approach 
also allowed for identification of candidate transcriptional regulators of the alpha or beta cell fate 
from the newly characterized endocrine progenitors. This work, therefore, enhances our 
knowledge of endocrine development, and specifically highlights an additional unknown cellular 
stage towards beta cell development. Transcriptional profiling of thousands of mesenchymal 
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cells identified, for the first time, distinct cell types of the pancreatic mesenchyme. This dataset 
also highlights a particular mesenchymal cell type, the mesothelium, that has been characterized 
as a critical regulator of mesenchymal cell development in multiple other organs but remains 
largely unstudied in the pancreas. Our in silico modeling predicts the lineage relationships 
among the pancreatic mesothelium and mesenchymal subtypes that can now be validated in vivo 
utilizing the transcriptional markers identified in our dataset. Additionally, we identify a role for 
the mesothelial-expressed factor, Fgf9, in regulating mesenchymal and epithelial compartment 
sizes, which ultimately regulates pancreatic size as a whole. Finally, we build single-cell RNA-
sequencing datasets for mesenchymal populations during adult homeostasis and fibrosis, which 
will facilitate studies on the mesenchymal cellular dynamics during disease. Therefore, this work 
identifies and describes pancreatic cellular heterogeneity in both the epithelial and mesenchymal 
compartments with implications for endocrine differentiation, and mesenchymal regulation of 
development and disease. 
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Chapter 2 
Identification of a novel endocrine progenitor population 
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Introduction 
 The derivation of hormone-producing cells from Pdx1+ pancreatic progenitors has been 
an area of intense research in the last few decades. Identification of distinct cellular stages during 
pancreatic progenitor differentiation has clarified the cellular origin of the major cell types of the 
adult pancreas. Neurogenin3 (Ngn3) marks a cellular stage that ultimately gives rise to all four 
endocrine cell types in the mature pancreas. The intervening steps between Ngn3 and hormone 
expression, however, remain unclear. A better mechanistic understanding of how Ngn3+ 
endocrine progenitors differentiate into multiple cellular fates is critical for informing in vitro 
beta cell differentiation protocols.  
The derivation of multiple cell types from one progenitor suggests that the Ngn3+ 
population may represent a heterogeneous group of progenitors already specified towards one 
particular endocrine cell fate. One study used clonal lineage tracing to show that each Ngn3+ 
progenitor gave rise to exactly one endocrine cell, supporting the hypothesis that Ngn3 is a broad 
marker for a heterogenous group of pre-specified unipotent cells (Desgraz & Herrera, 2009). 
However, this conclusion is complicated by the fact that Ngn3+ progenitors are post-mitotic; 
thus, it is possible that they are not pre-specified, but rather, have the capability to produce any 
endocrine cell type. Internal or external signals, downstream of Ngn3 expression, may then push 
the progenitor towards one particular cell fate. In the case of either Ngn3+ progenitor pre-
specification or post-specification of endocrine cell fates, a clonal lineage trace would result in 
the production of only a single endocrine cell. The heterogeneity within the Ngn3+ progenitor 
population, and whether this heterogeneity reflects a bias towards a particular endocrine cell fate 
remains an important unanswered question. 
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Attempts to isolate and study the Ngn3+ population have relied on a Ngn3-eGFP reporter 
mouse line and fluorescence-assisted cell sorting (FACS) to separate Ngn3+ progenitors from 
their downstream progeny (G. Gu et al., 2004; P. White, May, Lamounier, Brestelli, & Kaestner, 
2008). The transient expression of Ngn3 and extended half-life of eGFP (Corish & Tyler-Smith, 
1999), however, resulted in collection of more fully differentiated endocrine cells that no longer 
express Ngn3. Inclusion of these Ngn3-negative cell types was masked by downstream bulk 
analysis, confounding the expression profiles of Ngn3+ endocrine progenitors. To overcome the 
limitations of the eGFP reporter, one study identified cell surface markers to isolate Ngn3+ 
progenitors by fluorescence-assisted cellular sorting (FACS) (Sugiyama, Rodriguez, McLean, & 
Kim, 2007). Two markers were used to isolate Ngn3+ cells: CD133, which separated Ngn3+ 
cells from insulin+ and glucagon+ cells, and CD49f, which separated Ngn3+ cells from CarbA+ 
exocrine cells. While this technique could successfully isolate fully differentiated hormone+ cells 
from Ngn3+ cells, it does not account for cellular stages that may be both Ngn3-negative and 
hormone-negative. The cellular stages immediately following Ngn3 expression may be critical 
for determining the ultimate fate of a Ngn3+ endocrine progenitor. Therefore, there is a great 
need for specific isolation of Ngn3+ endocrine progenitors from their immediate descendants.  
To better segregate Ngn3+ progenitors from downstream progeny, a Ngn3 “timer” mouse 
line was developed (Miyatsuka, Li, & German, 2009). In this line, a fluorescence protein that 
shifts its emission peak from green to red over time is expressed under the Ngn3 promoter. 
Collection of distinct green, green/red (yellow), and red populations allows for increased 
temporal isolation of Ngn3+ progenitors and downstream progeny that recently expressed Ngn3 
but no longer do so. Gene expression analysis of these collected populations has allowed for 
increased resolution of gene expression cascades downstream of Ngn3, but the temporal 
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resolution is based on the timing of the fluorescent protein emission shifts, rather than alterations 
in cellular gene expression. The shift from green to yellow occurred within 6 hours of Ngn3 
expression, while yellow shifted to red within 12 hours. Ngn3 has been shown to be expressed 
for around 24 hours (Beucher et al., 2012), indicating that the timer mouse may not exactly 
match endogenous Ngn3 expression. Therefore, even with these improved tools, the distinct 
stages of Ngn3+ progenitor differentiation towards a particular endocrine cell fate has remained 
elusive. 
The advent of single-cell RNA-sequencing allows for the identification of novel cell 
populations or cellular states, independent of known markers. Here, we use this technology to 
identify an additional endocrine progenitor stage downstream of Ngn3 expression, marked by 
expression of the gene Fev. By ordering thousands of individual cells by their transcriptomic 
similarity along a pseudotime differentiation trajectory, we identify candidate regulators of alpha 
and beta cell fates. The Fev+ progenitor population is likely relevant to human endocrine 
biology, as we find this population in both human fetal pancreas and hESC-derived endocrine 
progenitors in vitro.  
 
Results 
Cellular heterogeneity in the murine pancreas 
We first characterized the major sources of cellular heterogeneity in the developing 
pancreas. Two batches of mouse pancreata at E14.5, a particularly active time of expansion, 
morphogenesis, and diversification (Pan & Wright, 2011) (Fig. 1a), were dissected from 
individual litters, dissociated into single-cell suspensions, sorted for live cells, and sequenced 
using the 10X Chromium Single-Cell version 1 (v1) kits (Fig. 1b and Fig. 2a-e). We performed 
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filtering, normalization, variable gene identification, linear regression for batch, and Principal 
Component Analysis (PCA) with the R package, Seurat (Fig. 2d,e and 3a,b). Graph-based 
clustering (Satija, Farrell, Gennert, Schier, & Regev, 2015) of batch-adjusted, merged data 
identified 19 distinct cell populations, classified as epithelial, mesenchymal, immune, or vascular 
populations based on the expression of known markers (Fig. 1c,d and Supplementary Data 1). 
We identified expected populations, including endocrine, exocrine (acinar and ductal), and 
endothelial cells (Fig. 1e). The proportions of endocrine, mesenchymal, immune, and vascular 
populations were similar between E14.5 batches (Fig. 3b-d).  Downsampling analysis confirmed 
that sufficient sequencing depth had been reached for calling clusters (Fig. 3e-g). These results 
reveal the power of single-cell RNA-sequencing to identify a broad range of cell types during 
development. 
 
A previously undescribed endocrine progenitor population 
We first sub-clustered the 2,049 cells from our E14.5 dataset that comprised just the 
epithelial populations (Fig. 4a and Fig. 5a). We identified 10 clusters, including acinar, ductal, 
beta, alpha, and Ngn3+ progenitor populations, as revealed by differential expression of known 
markers (Fig. 4a-b and Fig. 5b). Our analysis highlighted previously uncharacterized markers of 
acinar, Ngn3+, beta, and alpha cell populations, such as Reep5, Btbd17, Gng12, and Peg10, 
respectively (Fig. 4b). We also found Sst- and pancreatic polypeptide (Ppy)-expressing cells, but 
they did not cluster into their own populations (Fig. 5c).  
 After the ductal, acinar, Ngn3+, and hormone+ populations had been accounted for, there 
still remained one population that eluded classification based on known marker genes. This 
population was distinguished from all other epithelial populations by high-level expression of the 
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E26 transformation-specific (ETS) transcription factor Fev, previously shown to be expressed 
within the developing pancreas but not described as a marker of a distinct epithelial population 
(Ohta et al., 2011) (Fig. 4a,b). This Fev+ population expressed genes marking endocrine lineage 
cells, such as paired box 4 (Pax4), chromogranins A/B (Chga/b) and Neurod1 (Shih, Wang, & 
Sander, 2013) (Fig. 5d), but not mature endocrine markers, such as insulin1 (Ins1) or Gcg, or the 
transitory early endocrine lineage marker, Ngn3 (Fig. 4b,c). Pairwise comparison between the 
Fev+ and Ngn3+ clusters identified 99 genes more highly expressed in Fev+ and 87 more highly 
expressed in Ngn3+ cells, suggesting that they are distinct populations (Fig. 4d). This Fev+, 
Ngn3-, hormone- cluster will henceforth be referred to as the FevHi population. Pathway analysis 
of the Ngn3+ and FevHi populations revealed enrichment of cell cycle and Notch signaling 
pathways in Ngn3+ cells (Fig. 4e), likely reflecting the exit of Ngn3+ progenitors from the cell 
cycle (Miyatsuka et al., 2011) and the role of Ngn3 in Notch signaling (Shih et al., 2012). The 
FevHi cluster expressed genes in pathways related to serotonin and insulin signaling, Activating 
Transcriptional Factor 2 (ATF-2) signaling, and sphingosine-1-phosphate signaling, which have 
been reported to regulate endocrine differentiation29,30.This relationship to serotonin is consistent 
with prior work establishing Fev as a critical transcription factor in serotonergic neurons (Ohta et 
al., 2011; Spencer & Deneris, 2017). 
Further sub-clustering of all 661 cells within the endocrine lineage revealed additional 
sub-groups of Fev-expressing cells. The first was marked by high expression of Pax4 and runx1 
translocation partner 1 (Runx1t1) and lower levels of Ngn3. The second was marked by Chgb 
and vimentin (Vim) (Fig. 4f and Fig. 5e,f). Therefore, our analysis proposed the existence of 
multiple intermediate states, marked by Fev, within the endocrine lineage. The Fev gene was 
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also expressed at lower levels in a subset of the hormone-producing alpha, beta, and epsilon cell 
populations, which will collectively be referred to as hormone+/FevLo populations (Fig. 4b).  
 Given that the Fev+ populations expressed endocrine lineage genes, we utilized 
pseudotime ordering (X. Qiu et al., 2017b) to test the hypothesis that both Fev+ populations were 
lineage-related to the Ngn3+ progenitors that give rise to the endocrine compartment of the 
pancreas (G. Gu et al., 2002). This de novo reconstruction of the developmental trajectory placed 
both the Fev+/Pax4+ and FevHi/Chgb+ cells between Ngn3+ endocrine progenitors and alpha 
and beta cells (Fig. 4g and Fig. 5g), suggesting that FevHi cells comprise a progenitor stage 
following Ngn3 expression and before hormone acquisition. The Fev+/Pax4+ population was 
placed closer in pseudotime to the Ngn3+ population and was followed by the FevHi/Chgb+ 
population (Fig. 4g), indicating that the former represents an earlier cell state. Unlike alpha and 
beta cells, epsilon cells were found throughout the trajectory populated by the Fev+/Pax4+ and 
FevHi/Chgb+ populations (Fig. 4g), possibly reflecting their function as multipotent progenitor 
cells for alpha and gamma lineages during development(Arnes et al., 2012).  
To validate these lineage relationships, we performed an in vivo lineage trace of Ngn3+ 
cells. In E14.5 Ngn3-Cre; ROSA26mTmG mouse pancreata, where lineage-traced cells are 
membrane-GFP+ (Muzumdar, Tasic, Miyamichi, Li, & Luo, 2007), approximately 20% of all 
Ngn3-lineage traced cells were identified as the FevHi population by the presence of Fev and the 
absence of both Ngn3 and the pan-differentiated endocrine cell marker Islet1 (Isl1) (Fig. 6a,e, 
yellow arrows and bar, and Fig. 5h). We also detected the hormone+/FevLo population identified 
by our single-cell data (Fig. 6a, purple arrows) and cells that co-expressed Fev and Ngn3 (blue 
arrows), consistent with a model in which FevHi cells represent an intermediate progenitor state 
following Ngn3+ cells but prior to differentiated endocrine cells (Fig. 6g). 
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We next tested if the FevHi population was also present in developing human pancreatic 
tissue. In human fetal pancreas at 23 weeks post conception, we observed cells that expressed 
only NGN3 (Fig. 6b, grey arrows), only CHGA (magenta arrows), a marker of all hormone-
expressing endocrine cells, and both FEV and CHGA (purple arrows). We also detected cells that 
expressed FEV but not NGN3 or CHGA (Fig. 6c, yellow arrows), analogous to the murine FevHi 
population. The existence of these cellular states in human development suggests that the lineage 
relationships we identified generalize beyond murine pancreatic organogenesis to that of human, 
as well. 
We then probed hESCs undergoing directed differentiation towards the pancreatic beta 
cell lineage in vitro (Pagliuca et al., 2014). FEV was detected in endocrine progenitor-stage cells 
and beta-like cells (BLCs) at levels comparable to adult human islets, but not in undifferentiated 
hESCs (Fig. 5i). Further, we observed FEV+ (NGN3-/ISL1-) (yellow arrows), FEV+/ISL1+ 
(NGN3-) (purple arrows), and NGN3+/FEV+ (ISL1-) (blue arrows) populations in differentiating 
hESC-derived cells mid-way through the endocrine progenitor stage (Fig. 6d,f). While endocrine 
differentiation progresses as a wave throughout development (K. A. Johansson et al., 2007) in 
vivo, it is more synchronized in the hESC differentiation platform in vitro (Pagliuca et al., 2014). 
At a timepoint directly preceding beta cell differentiation, we found that nearly 70% of hESC-
derived cells were either NGN3+/FEV+ or FEV+ (Figure 6f, blue and yellow bars). These data 
place the FEV+ population at a timepoint consistent with an endocrine progenitor population 
during human beta cell differentiation in vitro.  
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Endocrine dynamics over developmental time 
 Although we had captured comparatively fewer epithelial cells at E12.5 and E17.5 than at 
E14.5, we could still identify the FevHi cells at both timepoints (Fig. 7a). To capture more 
epithelial cells and account for those that were missing from E12.5 and E17.5 version 1 (v1) 
runs, we re-performed an entirely new (version 2) set of single-cell RNA-sequencing 
experiments at E12.5, E14.5, and E17.5 after depletion of CD140a+ mesenchymal cells in order 
to enrich for epithelial cells (Fig. 7b,c). Given the high numbers of red blood cells at E17.5, we 
ran two wells of E17.5 cells (replicates 1 and 2) to increase our capture of epithelial cells and 
then aggregated the datasets. We first analyzed the exocrine compartment and identified acinar, 
ductal, and proliferating populations of both at all timepoints (Fig. 7). We then focused on the 
endocrine compartment, where we captured 584, 1,267, and 1,837 endocrine cells at E12.5, 
E14.5, and E17.5, respectively. We found similar gene expression topologies as in our v1 dataset 
but gained additional resolution with increased cell numbers and transcriptomic coverage (Fig. 
7e).  
To analyze how endocrine populations change over time, we merged all three v2 
timepoints into one dataset using canonical correlation analysis (A. Butler, Hoffman, Smibert, 
Papalexi, & Satija, 2018). We correlated the v2 dataset to the v1 dataset and could identify all 
populations present in the v1 dataset (Fig. 7f). We also found additional populations, including a 
cluster characterized by decreased expression of Fev and increased expression of Pdx1 and Mafb, 
genes with known roles in endocrine lineage decisions (Fig. 6h and Fig. 7g). This Pdx1+/Mafb+ 
population correlates most strongly with the FevHi/Chgb+ population, as well as both the alpha 
and beta cell populations in the v1 dataset (Fig. 7f). We also found a second beta cell population 
characterized by increasing expression of Ins1 and Ins2 and lower expression of Pdx1, perhaps 
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representing more mature beta cells (Fig. 7g). Indeed, this second beta cell group is almost 
entirely comprised of cells from the E17.5 timepoint (Fig. 6i). To examine how these populations 
shift over developmental time, we calculated the proportion of these populations at each 
timepoint (Fig. 6j). We found shifts in cell proportions that match those reported in literature, 
such as a high proportion of alpha cells early in development at E12.5 and increasing proportions 
of beta and delta cells at later timepoints (K. A. Johansson et al., 2007). The Ngn3+ population 
decreased over time, while the Fev+/Pax4+, FevHi/Chgb+, and Pdx1+/Mafb+ populations peaked 
at E14.5, consistent with previous studies that reported peak Ngn3 expression at approximately 
E14.5 and its subsequent downregulation as differentiation into endocrine lineage 
ensues(Villasenor et al., 2008). At E17.5, we also found an increasing proportion of proliferating 
endocrine cells, presumably those responsible for the expansion of endocrine cell mass in later 
embryonic development (Bonner-Weir, Aguayo-Mazzucato, & Weir, 2016). These results from 
the larger v2 dataset confirm our initial findings from the v1 dataset and add additional 
resolution to the endocrine populations during pancreatic development. 
 
Lineage decisions within the endocrine compartment 
As the in vivo lineage tracing data had revealed that the FevHi population is derived from 
the Ngn3+ population, we hypothesized that the FevHi population could then function as a 
progenitor for the endocrine populations of the developing pancreas. We utilized a Fev-Cre; 
ROSA26mTmG lineage tracing strategy to label Fev-expressing cells and their progeny. We found 
that 100% of alpha, beta, and delta cells, 90.1% of gamma cells, and 23.2% of epsilon cells were 
lineage-traced in E14.5 pancreas (Fig. 8a-e). These proportions of lineage labeling held true later 
in development (E17.5) and in adulthood (6 weeks) (Fig. 9 and 10). Epsilon cells are rare in the 
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adult pancreas(Arnes et al., 2012) and still exhibited only partial lineage tracing in E17.5 
pancreas (47.8% traced) (Fig. 9e). These results demonstrate that the majority of endocrine cells 
pass through a Fev-expressing stage during development. 
We next combined this lineage tracing approach with single-cell RNA-sequencing to 
identify transcriptional regulators of endocrine differentiation. FACS sorting was used to enrich 
for Fev-expressing cells and their progeny (membrane-GFP+) from Fev-Cre; ROSA26mTmG 
pancreata at E14.5 (Fig. 8f,g). All expected endocrine populations were identified in the resulting 
single-cell dataset (Fig. 8h,i). In addition, we found that eGFP reads mapped to all endocrine 
populations except the Ngn3+ population (Fig. 8i), further confirming that Fev expression turns 
on after Ngn3.  
We next set out to model the lineage relationships among the endocrine cells and identify 
transcriptional regulators of differentiation. Pseudotime ordering identified a trajectory that 
began with Ngn3+ cells, transitioned into Fev+ cells, and then split into two main branches (Fig. 
11a; see similar branching pattern in analysis of our first v1 dataset, Fig. 12a). The termini of the 
branches were populated by differentiated beta and alpha cells, suggesting that the branches 
represent a transition from a progenitor to fully differentiated hormone+ cell (Fig. 11a). 
We next used Monocle’s branched expression analysis modeling (BEAM) to identify the 
genes that distinguish the paths along the two branches to either alpha or beta cells. We found 
gene clusters that were upregulated along different segments of the pseudotime trajectory (Fig. 
11b) and performed pathway analysis to identify pathways enriched at each stage of pseudotime 
(Fig. 12c). Genes upregulated at the beginning of pseudotime in gene cluster 2 included early 
markers of endocrine differentiation, such as Sox4 and Ngn3 (Fig. 11b). Fev was in gene cluster 
6 and increased in both branches before ultimately decreasing in expression at the branch termini 
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(Fig. 11b,c). Gene cluster 6 also included other genes expressed within the FevHi population, 
including Cldn4, Vim, and Chgb (Fig. 11b,c and Fig. 12b). We found branch-specific clusters 
that included known markers of beta (Ins1) and alpha (Gcg) cells and known differentiation 
regulators of alpha (Arx, Pou3f4, Irx1, Slc38a5, and Tmem27) and beta (Pdx1, Pak3, and Nkx6-1) 
cells (Fig. 11c and Fig. 12b) (Pan & Wright, 2011; Petri et al., 2006; Piccand et al., 2014; Scott 
Heller et al., 2004; Stanescu, Yu, Won, & Stoffers, 2017). These clusters also contained genes 
that were enriched in either the alpha or beta branch but were expressed before acquisition of 
hormone expression (Fig. 12b). Within the alpha cell branch, Peg10, Smarca1, Auts2, and Wnk3 
increased in expression before upregulation of Gcg occurred (Fig. 12b). Peg10 and Auts2 have 
roles in differentiation (Dekel et al., 2006; Hishida, Naito, Osada, Nishizuka, & Imagawa, 2007) 
and migration (Hori et al., 2014), but a role in endocrine differentiation has not been described.  
As a regulator of chromatin states and an adult human alpha cell marker(Muraro et al., 2016), 
Smarca1 may be involved in the epigenetic regulation of alpha cell differentiation. Within the 
beta cell branch, Gng12, Tssc4, Ece1, Tmem108, Wipi1 and Papss2 increased in expression 
before upregulation of Ins1 (Fig. 12b). To our knowledge, a role in endocrine lineage decisions 
have not been described for these beta branch-specific genes. We found a similar endocrine 
differentiation trajectory by an orthogonal method that uses force-directed layouts to visualize 
gene topologies and infer lineage relationships within single-cell data (Tusi et al., 2018; 
Weinreb, Wolock, & Klein, 2018) (Fig. 12d). We hypothesize that the genes identified by the 
analysis above may represent regulators of the differentiation of an endocrine progenitor to a 
fully differentiated hormone-expressing cell.  
To validate our pseudotime results, we performed ISH for markers that defined each 
branch of the trajectory. First, we confirmed the expression of Peg10 and Gng12 within the FevHi 
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population (Fig. 11d,e, indigo and teal gradient arrows), validating the expression of these genes 
in a stage before hormone acquisition. We also validated the enrichment of Peg10 and Gng12 in 
alpha and beta cells, respectively (Fig. 11f,g, solid indigo and teal arrows). First, 95.8% of beta 
cells expressed Gng12 (n=46 cells, 6 pancreata), while 30.5% expressed Peg10 (n=71 cells, 7 
pancreata) (Fig. 11f and Fig. 13a). Additionally, 100% of alpha cells expressed Peg10 (n=31 
cells, 6 pancreata), while only 5.4% expressed Gng12 (n=32 cells, 4 pancreata) (Fig. 11g and 
Fig. 13b). The lineage relationships generated by pseudotime ordering, combined with the 
validation in vivo, lead us to hypothesize that the Fev+/Peg10+ cells are fated towards an alpha 
cell identity and Fev+/Gng12+ cells towards a beta cell identity (Fig. 11h). These results suggest 
that lineage allocation of endocrine progenitors towards alpha or beta cell fates may occur after 
the onset of Fev expression. 
 
Discussion 
Our identification of a FevHi endocrine progenitor population provides increased 
resolution of endocrine differentiation. The relative timing of expression of canonical endocrine 
lineage genes can now be mapped onto these additional differentiation stages. Several lines of 
evidence suggest that the gene Fev may be a direct target of Ngn3: Fev is the transcription factor 
most strongly expressed in Ngn3+ endocrine progenitors (Miyatsuka et al., 2009), and Ngn3 
knockout embryos do not express Fev in the developing pancreas (Ohta et al., 2011). Known 
target genes of Ngn3, such as Pax4 (Collombat et al., 2003) and Runx1t1i (Benitez et al., 2014), 
are expressed by the early-stage Fev+/Pax4+ population. Additionally, Pax6 is upregulated 
within the FevHi population. Although Chga and Chgb are often utilized as markers of 
differentiated endocrine lineages, we found that both are expressed in the FevHi population prior 
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to hormone acquisition. This result is consistent with previous work that identified Chga+, 
hormone- cells in rodent pancreatic development (A. E. Butler et al., 2016). The FevHi cell stage 
likely represents the cell stage during endocrine differentiation preceding specialized hormone 
production and may now serve as a cellular landmark for understanding endocrine lineage gene 
expression dynamics. 
The gene Fev has been previously studied mainly in serotonergic neurons, where it is a 
master transcriptional regulator required for cellular differentiation, maturation, and serotonin 
synthesis (Spencer & Deneris, 2017). Fev switches transcriptional targets from differentiation 
genes during development to maturation genes postnatally in serotonergic neurons (Wyler et al., 
2016). In an insulinoma cell line, Fev directly binds to the regulatory regions of serotonergic 
genes, such as Tph1, Tph2, Ddc, Slc18a2, and Slc6a4, as well as the Ins1 promoter itself (Ohta et 
al., 2011). Future ChIP-seq studies of embryonic pancreas will globally identify direct targets of 
Fev and Fev-regulated transcriptional networks in developing endocrine cells.  
Using genetic lineage tracing in vivo, we have demonstrated that the majority of 
endocrine cells in the developing pancreas transit through a Fev-expressing stage, and that Fev-
lineage cells contribute not only to embryonic, but also to adult pancreatic endocrine cells. The 
fraction of epsilon cells not derived from a Fev-lineage may represent the subset of Ghrl+ cells 
previously reported to give rise to the ductal and exocrine lineages (Arnes et al., 2012). As all 
adult gamma cells are Fev-lineage labeled, the small subset of gamma cells not lineage traced 
during pancreatic development may represent those that do not persist in the adult pancreas.  
 Further highlighting the relevance of FevHi progenitors during pancreatic development, 
our pseudotime analysis revealed that Fev-expressing cells may be pre-specified towards an 
alpha or beta cell fate. As expected, we found expression of Ins1 and Gcg at the termini of the 
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beta and alpha branches, and upregulation of Pdx1 and Arx, which are known regulators of 
endocrine cell fate decisions, earlier in pseudotime. In addition, our pseudotime analysis 
identified genes enriched along the alpha or beta branch and expressed prior to upregulation of 
hormones. These genes warrant further study as potential regulators of the acquisition of alpha or 
beta cell identity. 
 For the eventual application of this knowledge to human therapeutics, the findings in the 
murine model must be validated in human pancreatic development. Our staining of human fetal 
pancreas identified the analogous FEVHi population, consistent with our findings in murine 
pancreata. Directed differentiation of hESCs towards endocrine cell fates will provide a platform 
for modeling and manipulating the putative lineage regulators found in this study. Indeed, we 
have identified a FEV+ population within hESC-derived endocrine progenitor cells. Deeper 
knowledge of these lineage decisions may substantially improve directed differentiation efforts 
to efficiently generate functional beta cells for cellular replacement therapy for people with 
diabetes. This study highlights the power of combining single-cell transcriptomic information 
with in vivo lineage tracing to reconstruct developmental trajectories within cellular 
compartments. Discovery of populations and their lineage relationships will promote 
identification of the mechanisms that drive lineage decisions and commitment.  
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Figure 1. Single-cell sequencing identifies broad patterns of cellular heterogeneity in E14.5 
murine pancreas. (a) Overview of murine pancreatic development. (b) Schematic of 
experimental approach. (c) t-Distributed Stochastic Neighbor Embedding (t-SNE) visualization 
of populations from pooled E14.5 mouse pancreata (n=14). Each dot represents the transcriptome 
of a single cell, color-coded according to its cellular identity (epithelial, mesenchymal, or 
immune/vascular). Each cell compartment contains multiple sub-populations, represented by 
varying degrees of color shading. (d) Established marker genes identify epithelial cells (Cdh1+), 
endocrine cells (Chga+), mesenchymal cells (Vim+ and Col3a1+), endothelial cells (Pecam1+), 
and immune cells (Rac2+). (e) Heatmap depicting greater than 2-fold differentially-expressed 
genes in each cluster compared to all other clusters. Cells are represented in columns, and genes 
in rows. Specific genes used to annotate clusters are indicated to the right of the heatmap.  
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Figure 2. Quality Control for Single-cell RNA-sequencing Runs. (a) Representative FACS 
plot of single, live cells sorted from dissociated Swiss Webster embryonic pancreata and used for 
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single-cell sequencing. (b) Quality control statistics for all single-cell sequencing runs prepared 
with the Chromium Single Cell 3’ Reagent Version 1 Kit. The “valid barcodes” metric indicates 
the percentage of cells with barcodes that match a known barcode contained on a bead. “Mapped 
reads to transcriptome” refers to the percentage of reads that confidently map to a unique gene in 
the reference transcriptome. “Fraction Reads in Cells” is the percentage of reads that contain a 
cell-associated barcode. (c) Cellranger cell calls based on the number of UMIs. The dropoff 
indicates the threshold for the number of UMIs required for a barcode to be considered a cell. (d) 
Histogram of the number of genes per cell in all single-cell runs pre-filtering steps. (e) Histogram 
of the number of genes per cell in all single-cell runs post-filtering steps. E17.5 Batch 2 
contained a large number of red blood cells, which expressed fewer than 200 genes, resulting in 
their removal during minimum gene threshold filtering (see Methods). 
 
 
 
 
Figure 3. Single-cell RNA-sequencing Batch Information from E14.5 Pancreata. (a) 
Selection of variable genes in the E14.5 dataset (all cells) by Seurat’s MeanVarPlot function. (b) 
t-SNE visualization of merged E14.5 batches, color-coded by batch. Batch 1 and 2 contribute to 
all clusters, reflecting a successful batch correction. (c) Pearson’s correlation of E14.5 batch 1 
cells with E14.5 batch 2 cells within each cluster based on average expression of variable genes. 
Batch 1 cells correlate most highly with batch 2 cells within the same cluster, indicating proper 
merging of the two batches. (d) Cell type proportions in E14.5 batch 1 and 2 with exocrine 
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(acinar and ductal) clusters included (top panel) and excluded (bottom panel). All cell types 
except the exocrine compartment show high correlation between the two batches. (e) Pearson’s 
correlation between clusters from the E14.5 batch 1 full dataset and those from the E14.5 batch 1 
dataset downsampled to 50% of the reads, based on average expression of shared variable genes. 
(f) Maintenance of the number of median genes/cell after random downsampling of reads, 
indicating sufficient sequencing depth. (g) Maintenance of cluster structure after random 
downsampling of UMIs is reflected by the similar percentage of cells found within the same 
cluster with fewer UMIs. 
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Figure 4: Identification of epithelial cell populations in E14.5 mouse pancreas. (a) t-SNE 
visualization of epithelial groups only, as defined in Figure 1. (b) Dot plot depicting known and 
uncharacterized markers of epithelial populations, as well as markers specific to the FevHi 
population. Size of the dot represents proportion of the population that expresses each specified 
marker. Color indicates level of expression. (c) Expression of Fev and Ngn3 within epithelial 
cells. Color indicates level of expression. (d) Gene expression comparison between the Ngn3+ 
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and FevHi population. Genes greater than 2-fold differentially-expressed are highlighted in dark 
blue (higher in FevHi cells) or light blue (higher in Ngn3+ cells). (e) Pathway analysis of genes 
greater than 2-fold differentially-expressed in Ngn3+ and FevHi populations (f) t-SNE 
visualization of the 661 cells of the endocrine lineage (Ngn3+, FevHi, alpha, beta, and epsilon 
populations). (g) Pseudotime ordering of Ngn3+, Fev+/Pax4+, FevHi, alpha, and beta cell 
populations place Fev+ cells between Ngn3+ and hormone+ populations. 
 
 
 
Figure 5. Identification of Known and Novel Epithelial Cell Populations in E14.5 Pancreas.  
(a) t-SNE visualization of E14.5 epithelial batches, colored by batch. Significant overlap and 
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most importantly, clusters that include cells from both batches, reflects successful batch 
correction. (b) Comparison of bimodal likelihood ratio test adjusted p-values to adjusted p-values 
calculated by either MAST (left panel) or Wilcox rank sum (right panel) tests for all greater than 
2-fold differentially-expressed genes. Pearson’s correlation value is shown in top left corner. (c) 
Expression maps of Ppy and Sst hormones within E14.5 epithelial dataset. (d) Dot plot of 
endocrine lineage genes across the epithelial populations. (e) Heatmap depicting genes over 2-
fold differentially-expressed in Ngn3+ and Fev+ populations. Differentially-expressed genes 
were determined from the endocrine dataset depicted in Fig. 4f and only Ngn3+ and Fev+ 
populations were shown in the heatmap. (f) Expression of selected markers of early- and late-
Fev+ populations in all endocrine cell lineages. (g) Pseudotime ordering of Ngn3+, Fev+/Pax4+, 
FevHi, alpha, and beta cell populations, colored by batch. (h) Expression of Islet1 (Isl1) in E14.5 
epithelial cells is largely confined to hormone+ populations. (i) Quantification of FEV expression 
by quantitative RT-PCR in pluripotent hESCs, mid- and late-stage endocrine progenitor cells, 
beta-like cells (BLCs), and adult human islets. FEV expression is normalized to GAPDH. Error 
bars represent standard deviation. N.D = not detected.  
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Figure 6. FevHi cells are endocrine progenitors. (a) In situ hybridization (ISH) for Ngn3, Fev, 
and Isl1 in lineage-traced Ngn3-Cre; Rosa26mTmG E14.5 pancreata where Ngn3-lineage traced 
cells are mGFP+. Grey arrowheads identify Ngn3+ cells, presumably not yet Ngn3-lineage 
labeled due to the transient nature of Ngn3 expression and the delay of Cre-mediated 
recombination that permits expression of mGFP. Blue arrowheads identify Ngn3+/Fev+ cells 
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that are Ngn3-lineage traced. Yellow arrowheads identify Ngn3-lineage traced cells that are Fev+ 
but do not express Ngn3 or Isl1. Purple arrowheads identify Fev+/Isl1+ cells that are Ngn3-
lineage traced. Magenta arrowheads identify Isl1+ cells that are Ngn3-lineage-traced. (b-c) Dual 
ISH/immunofluorescence (IF) for NGN3 and FEV mRNA and CHGA protein in human fetal 
pancreas at 23 weeks of gestation (n=1 pancreas). Grey arrowheads identify NGN3+ cells. 
Yellow arrowheads identify FEV+ cells. Purple arrowheads identify FEV+/CHGA+ cells. 
Magenta arrowheads identify CHGA+ cells. (d) Multiplexed fluorescent ISH for NGN3, FEV, 
and ISL1 mRNA in hESC-derived endocrine progenitor cells. Blue arrowheads identify 
NGN3+/FEV+ cells. Yellow arrowheads identify FEV+ cells. Purple arrowheads identify 
FEV+/ISL1+ cells. (e) Quantification of each population detected in Ngn3-lineage traced 
pancreata as a percentage of Ngn3-lineage traced cells (n=464 cells, 6 pancreata). Data are 
represented as mean + standard deviation (SD). (f) Quantification of each population detected in 
hESC-derived progenitor cells as a percentage of total stained cells (n=418 cells, 3 clusters 
representing technical replicates from one hESC differentiation). Data are represented as mean + 
SD (g) Proposed model for the derivation of FevHi endocrine cells from Ngn3+ cells, and their 
differentiation into hormone+/FevLo endocrine cells. Colors of arrowheads and bars in a-f 
correspond to cell identity in g. (a and d) Scale bar: 10 um. (b and c) Scale bar: 20 um. (h) t-SNE 
visualization of v2 merged endocrine timecourse (E12.5, E14.5, aggregated E17.5). Clusters are 
annotated based on correlation with v1 dataset or top differentially-expressed genes. (i) 
Timepoint labels for v2 merged endocrine timecourse data. t-SNE is the same as Fig. 5h. (j) Cell 
type proportions at each timepoint, calculated from the clusters depicted in Fig. 5h.   
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Figure 7. Epithelial Populations over Developmental Time. (a) t-SNE visualization of merged 
version 1 epithelial clusters from E12.5 (n=18 pancreata), E14.5 (n=14 pancreata for batch 1; 
n=11 for batch 2), and E17.5 (n=8 pancreata). All panels depict the same t-SNE plot. In the far-
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left panel, cluster identity is denoted by different colors. Throughout figure, cells are color-coded 
by cluster identity. In the three remaining panels, cells from the indicated timepoint are 
represented by black dots; all cells from the other timepoints are gray. (b) FACS plots depicting 
CD140a negative selection from E12.5 (n=14), E14.5 (n=13), and E17.5 (n=13) pancreata. 
CD140a-negative cells were used for single-cell sequencing. (c) Quality control statistics for 
10X Chromium version 2 single-cell RNA-sequencing runs. These datasets are referred to as v2 
datasets. Two technical replicates of E17.5 cells were run from the same pancreata on two 
separate wells on the 10X Chromium machine. The two E17.5 runs were aggregated and 
analyzed as one dataset. (d) Individual t-SNE plots of v2 E12.5, E14.5, and E17.5 (aggregated) 
exocrine dataset. Clusters are annotated based on gene expression. (e) Individual t-SNE plots of 
v2 E12.5, E14.5, and E17.5 (aggregated) endocrine dataset. Clusters are annotated based on 
correlation with v1 datasets and differentially-expressed genes. (f) Pearson’s correlation among 
clusters from v1 merged endocrine timecourse and v2 merged endocrine timecourse. (g) Dot plot 
of top differentially-expressed genes for clusters in the v2 merged endocrine dataset. Clusters 
correspond to those depicted in t-SNE in Fig. 6h.  
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Figure 8. Differentiated, hormone+ endocrine cells transit through a Fev-expressing stage 
during pancreatic development. (a-e) Dual IF (for membrane GFP) and fluorescent ISH for 
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hormones in Fev-Cre; ROSA26mTmG lineage traced animals at E14.5. n=46 cells of 4 pancreata 
for Ins1 (100% labeled-lineage); n=103 of 4 pancreata cells for Gcg (100% lineage-labeled); n=6 
cells of 2 pancreata for Sst (100% lineage-labeled); n=26 cells of 2 pancreata for Ghrl/Gcg 
(23.2% lineage-labeled); n=71 cells of 8 pancreata for Ppy (90.1% lineage-labeled). Scale bar 
represents 10um. (f) Schematic of E14.5 Fev-Cre; ROSA26mTmG FACS sorting and single-cell 
RNA-sequencing. (g) Representative FACS plots of sorted single, live GFP+ and 
TdTomato+/GFP- cells from dissociated pancreata used for single-cell sequencing. (h) t-SNE 
visualization of endocrine cells in Fev-lineage traced E14.5 mouse pancreata (n=3). (i) 
Expression of major markers of endocrine cell types. Color indicates level of expression, except 
for the eGFP plot, which indicates presence or absence of eGFP counts. 
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Figure 9. In vivo Fev lineage tracing of E17.5 mouse pancreata. (a-d) Immunofluorescence 
(IF) for hormones INS (100% lineage-labeled), GCG (100% lineage-labeled), SST (96.7% 
lineage-labeled), and PP (100% lineage-labeled) in embryonic pancreatic hormones in Fev-Cre; 
ROSA26mTmG lineage traced animals at E17.5 (n=86 cells of 5 pancreata for INS; n=57 cells of 5 
pancreata for GCG; n=30 cells of 5 pancreata for SST; n=47 cells of 5 pancreata for PP). (e) 
Dual IF (for membrane-GFP) and multiplexed fluorescent ISH for Ghrl and Gcg in Fev-Cre; 
ROSA26mTmG lineage traced animals at E17.5 (n=23 cells of 2 pancreata for Ghrl/Gcg). 
Ghrl+/Gcg- cells (47.8% lineage-labeled) represent the epsilon population. Non-lineage labeled 
epsilon cells are denoted by the arrowheads, and lineage-labeled epsilon cells are denoted by the 
arrows. Scale bar represents 10um in a-e. 
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Figure 10. In vivo Fev lineage tracing of adult mouse pancreata. (a-d) IF for adult hormones 
in 6-week Fev-Cre; ROSA26mTmG lineage-traced pancreas. From one animal: n=172 cells for INS 
(100% lineage-labeled); n=65 cells for GCG (100% lineage-labeled); n=86 cells for SST (97.7% 
lineage-labeled); n=30 cells for PP (100% lineage-labeled). Scale bar represents 10um in a-d. 
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Figure 11. Identification of candidate regulators of beta and alpha cell fate decisions. (a) 
Pseudotime ordering of the endocrine cells at E14.5 depicted in Fig. 6h yields a bifurcated tree in 
which the two main branches terminate in cells that highly express Ins1 (beta cell branch) or Gcg 
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(alpha cell branch). (b) Heatmap depicting the expression of genes along each branch, in 
pseudotime. An independent expression pattern is calculated across the entire pseudotime 
trajectory for each branch. Therefore, the portion of the trajectory before the branch point is 
displayed for each branch separately. Genes are clustered based on expression pattern across 
pseudotime; selected genes with differential expression along the branches are highlighted to the 
right. (c) Gene expression plots depicting the kinetic trends along each branch. (d-e) Multiplexed 
fluorescent ISH for Fev, Gng12, and Islet1 (d) or Fev, Peg10, and Islet1 (e) in lineage-traced 
E14.5 Ngn3-Cre; ROSA26mTmG pancreas. Arrowheads identify lineage-traced Fev+/Islet1- cells 
with Gng12 (d, teal gradient arrowheads) or Peg10 (e, indigo gradient arrowheads) expression. 
(f) Multiplexed fluorescent ISH for Fev, Gng12, and Ins1. Teal arrowheads identify lineage-
traced Ins1+ beta cells that express Gng12.  (g) Multiplexed fluorescent ISH for Fev, Peg10, and 
Gcg. Indigo arrowheads identify lineage-traced Gcg+ alpha cells that express Peg10. (h) Model 
for FevHi (yellow) cell differentiation into distinct alpha or beta cells. Peg10 and Gng12 
expression in FevHi cells may represent progenitors pre-fated towards the alpha and beta 
lineages, respectively, during endocrine lineage allocation. (d-g) Scale bars represent 10 um. 
Blue staining represents DAPI-labeled nuclei. Colors of arrowheads match colors of cells 
represented in (h). 
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Figure 12. Identification of Candidate Genes and Pathways Enriched Along Beta and 
Alpha Cell Lineages. (a) Pseudotime ordering trajectory of v1 timecourse dataset, including 
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E12.5, E14.5 (batch 1 and batch 2), and E17.5 datasets. (b) Gene expression plots depicting the 
kinetic curves of individual genes (from Fig. 7b) across pseudotime in the alpha or beta 
branches. (c) Pathway analysis for clusters of genes from the BEAM analysis. Gene clusters 
correspond to Figure 7b. (d) SPRING plots for Fev-lineage traced dataset, including all 
endocrine cells. Colors match those in Fig. 6h and 7a. Expression of selected genes predicted 
from monocle BEAM analysis.  
 
 
 
Figure 13. Expression of Candidate Regulators within the Endocrine Lineage Prior to 
Alpha or Beta Cell Identity. (a) Multiplex fluorescent ISH for Fev (yellow), Peg10 (cyan), and 
Ins1 (magenta) in lineage-traced E14.5 Ngn3-Cre; ROSA26mTmG pancreas. Indigo-graded arrows 
highlight lineage-traced Fev+/Peg10+ cells that do not express Ins1. Teal arrows highlight Ins1+ 
beta cells that do not express Peg10. (b) Multiplex fluorescent ISH for Fev (yellow), Gng12 
(cyan), and Gcg (magenta) in lineage-traced E14.5 Ngn3-Cre; ROSA26mTmG pancreas. Teal-
graded arrows highlight lineage-traced Fev+/Gng12+ cells that do not express Gcg. Indigo 
arrows highlight Gcg+ alpha cells that are not enriched for Gng12.  
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Chapter 3 
Mesenchymal heterogeneity and lineage relationships in the developing pancreas 
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Introduction 
While previous studies have identified numerous markers of pancreatic epithelial 
populations (Pan & Wright, 2011), comparatively little is known about heterogeneity among 
pancreatic mesenchymal cells.  Across the body, mesenchymal cells continue to be a poorly 
understood cell type. The definition of a mesenchymal cell is based on their cellular origin, 
morphology and organization, and aspects of their behavior. First, mesenchymal cells are 
generally derived from the mesoderm germ layer, although mesenchymal cell types of the 
craniofacial region are neuroectoderm-derived (Gilbert, 2000). Mesenchymal cells are often 
described as “spindle-shaped”, with long, thin processes and display a loosely packed 
organization. While the organization of epithelial cells in adherent sheets limits their mobility, 
mesenchymal cells are highly migratory. Finally, upon isolation and culture, mesenchymal cells 
attach to plastic. These relatively undefined characteristics of mesenchymal cells have led to 
ambiguity in their identification and study across the body. 
The pancreatic mesenchyme refers to the cells that condense around the budding 
epithelium by E9. Endothelial cells and nerves, although important non-epithelial cells involved 
in pancreatic development, are not considered to be a part of the pancreatic mesenchyme. Both 
the dorsal and ventral pancreatic bud are surrounded by mesenchymal cells, and few studies have 
attempted to describe the similarities or differences of these groups. The gene islet1 (Isl1) has 
been shown to mark mesenchymal cells of the dorsal bud, but not the ventral bud (Ahlgren, 
Pfaff, Jessell, Edlund, & Edlund, 1997). Similarly, N-Cadherin is expressed in a dorsal-ventral 
gradient within the pancreatic mesenchyme, with highest expression in dorsal mesenchyme 
(Esni, Johansson, Radice, & Semb, 2001). Functionally, Isl1 and N-Cadherin are only required 
for dorsal pancreatic development. Upon fusion of the dorsal and ventral bud, whether this 
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mesenchymal heterogeneity is maintained is unknown. Indeed, most studies have utilized 
techniques that treat the mesenchymal cells as one homogenous entity, resulting in very little 
information about the heterogeneity within this compartment during pancreatic development. 
One approach to uncovering cellular heterogeneity within a group of cells is by 
fluorescence-activated cell sorting (FACS). This methodology uses fluorescence-activated 
antibodies to cell surface markers to sort individual cells into separate tubes. Once separated, 
distinct populations of cells can be analyzed for specific characterized or analyzed by unbiased 
methods such as bulk RNA-sequencing. Although commonly applied to other systems, the 
limited number of cell surface markers that are expressed in subpopulations of the pancreatic 
mesenchyme has hindered the success of this approach in the pancreas. Screening of genes by in 
situ hybridization has been employed to identify subtypes of pancreatic epithelial cells (Q. Zhou 
et al., 2007). Extensive time and labor are required for screening all the genes within the genome 
by staining approaches.  Therefore, most staining approaches select a subset of genes to test, 
such as transcription factors, potentially biasing the ability to discover novel heterogeneity in 
some cellular compartments. These challenges have resulted in very little knowledge of 
pancreatic mesenchyme subtypes. 
To overcome the challenges of prior approaches, we utilized single-cell RNA-sequencing 
to assess the cellular and transcriptional heterogeneity of the developing pancreatic mesenchyme. 
A major benefit of this approach is that it does not rely on known markers to capture and identify 
cell types. Rather, all cells of the pancreas can be captured and sequenced, and bioinformatically 
sorted into individual populations. Additionally, compared to staining-based screening 
approaches, single-cell RNA-Sequencing is a transcriptome-wide technique and thus does not 
require the selection of subsets of genes to test. 
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Using an unbiased, single-cell RNA-sequencing approach, we are able to identify 
multiple distinct mesenchymal subpopulations and define their transcriptomic signatures across 
developmental time. We find that a particular mesenchymal population, the mesothelium, 
displays timepoint-specific transcriptomic signatures, suggesting that it may have multiple 
functions throughout pancreatic development. In silico lineage modeling of a subset of the 
identified mesenchymal populations predicts the derivation of vascular smooth muscle-related 
populations from the pancreatic mesothelium. Furthermore, the in silico model highlights 
multiple putative progenitor stages that mesothelial cells transit through during differentiation 
towards a vascular smooth muscle fate. These results begin to divide the mesenchyme into 
distinct cellular populations and assemble potential lineage relationships among them, allowing 
for future studies to more easily target and manipulate mesenchymal subpopulations. 
 
Results 
Characterization of mesenchymal heterogeneity   
We characterized the mesenchymal compartment by sub-clustering only mesenchymal 
cells (5,069 cells) from the original E14.5 dataset (see Chapter 2) and re-performing the 
clustering analysis (Fig. 14a and Fig. 15a). Despite being less divergent from one another than 
were cells in the epithelial compartment (Fig. 14b and Fig. 15b), mesenchymal cells could still 
be sub-divided into 10 transcriptionally distinct mesenchymal clusters (Fig. 14a,c). We verified 
the differential gene expression analysis with three tests: bimodal likelihood ratio test (McDavid 
et al., 2012), Wilcoxon rank sum, and MAST (Finak et al., 2015) (Fig. 15c). We annotated two 
clusters based on the expression of known marker genes: cluster 1 is pancreatic mesothelial cells 
(Wt1, Krt19, and Upk3b) (Kanamori-Katayama et al., 2011; Winters & Bader, 2013) and cluster 
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3 represents vascular smooth muscle (VSM) cells (Acta2, Tagln, and Myl9) (Fig. 14c) (Majesky, 
Dong, Regan, Hoglund, & Schneider, 2011). Indeed, in E14.5 pancreas, WT1 expression was 
restricted to the tissue edge, as expected for mesothelial cells, while ACTA2 expression was 
localized to cells surrounding vessels, as expected for VSM cells (Fig. 15d,e). Cells in the 
mesothelial cluster also expressed the secreted factors Fgf9, Pdgfc, Rspo1, and Igfbp5 (Fig. 15f) 
and genes regulating prostaglandin hormone signaling and tight junctions (Fig. 14d).  
The remaining mesenchymal clusters included proliferating cells (clusters 6, 7, and 8), a 
large cluster (10) expressing pan-mesenchymal markers, and four clusters (2, 4, 5, and 9) each 
expressing a signature distinct from that of cluster 10 (Fig. 14a,c). Cluster 2 was defined by 
differential expression of stathmin 2 (Stmn2), a gene involved in neurite outgrowth and 
osteogenesis (Chiellini et al., 2008; Grenningloh, Soehrman, Bondallaz, Ruchti, & Cadas, 2003). 
We also found two populations, clusters 4 and 5, that differentially expressed multiple secreted 
factors. Cluster 4 expressed Ace2, the chemokines Cxcl12 and Cxcl13, and Vegfd, while cluster 5 
expressed high levels of the WNT antagonists secreted frizzled-related protein 1 and 2 (Sfrp1 
and Sfrp2) (Fig. 14c-e). Cluster 5 also expressed the transcription factor barH-like homeobox1 1 
(Barx1) and members of the Id DNA-binding protein family (Fig. 14c-e). Cluster 9 expressed 
Nk2 homeobox 5 (Nkx2-5) and Tlx1, transcription factors reported to contribute to splenic 
development during a window in which the embryonic pancreas and spleen share a mesenchymal 
compartment (Fig. 14c) (Hecksher-Sørensen et al., 2004). Pathway analysis identifies multiple 
signaling pathways that may be functionally relevant in these populations (Fig. 14d). We 
validated a subset of these distinct clusters using dual in situ hybridization/immunofluorescence 
(ISH/IF) on E14.5 pancreas for differentially-expressed markers of clusters 1 (Cav1 and Barx1), 
2 (Stmn2), and 5 (Barx1) (Fig. 14e-h). These gene expression profiles demonstrate a previously 
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underappreciated level of heterogeneity in the mesenchymal compartment of the developing 
pancreas.  
 
Mesothelial cells undergo changes across developmental time 
 During organogenesis, the dynamics of each lineage are defined by the expansion, 
differentiation, and maturation of its constituent cells. To address how these processes change 
across chronological time within the developing pancreas, we performed single-cell sequencing 
at two additional timepoints, E12.5 and E17.5 (Fig. 16a). We identified mesenchymal cells from 
E12.5, E14.5, and E17.5 timepoints, merged them into one dataset, and re-performed the 
clustering analysis. We identified the clusters detected in our E14.5 analysis (clusters 1-10) along 
with seven new clusters (11-17) (Fig. 16a and Fig. 15g-i). The addition of E12.5 and E17.5 cells 
revealed further sub-division of the mesothelium into timepoint-specific clusters (1, 11, and 17), 
each with unique transcriptomic signatures (Fig. 16a,b). Within the mesothelium, we verified 
paired-like homeodomain transcription factor 2 (Pitx2) expression at E12.5 and its absence at 
E17.5 and mesothelin (Msln) expression at E17.5 and its absence at E12.5 (Fig. 16c), consistent 
with the single-cell data. These data provide evidence of transcriptional maturation over 
developmental time within the mesothelial compartment. 
 While the mesothelium is a well-established mesenchymal progenitor cell population for 
VSM and fibroblasts in multiple other organs, both the role of the mesothelium and the origin of 
the mesenchymal cell types within the pancreas remain uncharacterized (Asahina, Zhou, Pu, & 
Tsukamoto, 2011; Bin Zhou et al., 2008; Que et al., 2008; Wilm, Ipenberg, Hastie, Burch, & 
Bader, 2005). We utilized our single-cell mesenchymal dataset to determine whether the 
pancreatic mesothelium may function as a mesenchymal progenitor cell population during 
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development.  We found six populations (clusters 2, 3, 4, 5, 12, and 13) that expressed VSM cell 
genes, such as Acta2 and Tagln, or genes known to regulate VSM development, such as Mgp 
(Speer et al., 2009), Fhl1 (Kwapiszewska et al., 2008; L.-L. Wang et al., n.d.), Barx1 
(Jayewickreme & Shivdasani, 2015), and Pitx2 (Shang, Yoshida, Amendt, Martin, & Owens, 
2008) (Fig. 16d). Based on these VSM-related gene expression profiles, we hypothesized that 
these populations could represent VSM progenitors derived from the pancreatic mesothelium. To 
test the lineage relationships among these populations, we ordered cells in pseudotime based on 
their transcriptional similarity (X. Qiu et al., 2017b). This analysis placed mesothelial cells on 
one side of the pseudotime trajectory (Fig. 16e). Mesothelial branches corresponded to either a 
maturation process, based on placement of E17.5 cells at the branch terminus, or proliferating 
mesothelium, based on expression of proliferation genes (Fig. 16e and Fig. 15j). VSM-related 
populations were placed on the other side of the trajectory (Fig. 16e and Fig. 15j). We calculated 
the proportion of each population over pseudotime and found a transition from the E12.5 
mesothelial population (cluster 11) to cluster 12, both of which share expression of the gene 
Pitx2 (Fig. 16e-g). Cluster 12 then transitioned into the Stmn2-expressing cluster 2, which split 
into a branch composed of VSM populations, clusters 3 and 13 (Branch 1), and a branch 
composed of clusters 4 and 5 (Branch 2) (Fig. 16e-g). Thus, this analysis proposes clusters 2 and 
12 as potential mesothelial-derived mesenchymal progenitor populations that can contribute to 
the VSM lineages (Fig. 16g). Our analysis has identified and validated multiple mesenchymal 
subtypes and possible lineage relationships among them. 
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Discussion 
The mesenchyme is critical for epithelial specification and proliferation throughout 
pancreatic development (Bhushan et al., 2001; Golosow & Grobstein, 1962; Landsman et al., 
2011), yet the individual cell types responsible for these processes remain unidentified. Our 
single-cell dataset has enabled the identification of multiple mesenchymal subpopulations and 
gene candidates for regulating epithelial-mesenchymal interactions. Secreted factors, such as 
mesothelial-derived FGF9, may play a similar role in the pancreas as in the lung (see Chapter 4), 
where it regulates mesenchymal cell proliferation and vascular formation (Yin, Wang, & Ornitz, 
2011).  Additionally, secretion of WNT antagonists by cluster 5 may regulate WNT signaling in 
the developing pancreas, influencing processes such as epithelial specification, expansion, and 
exocrine development (Murtaugh, 2008). Future work can focus on uncovering the functions of 
these individual mesenchymal populations in development, physiology, and pathology of the 
pancreas. 
With the cell types of the mesenchyme now enumerated and their markers identified, we 
can begin to elucidate the maturation and lineage relationships across the pancreatic 
mesenchymal compartment. Our timecourse data have provided evidence of maturation within 
the mesothelial population. Genes such as Pitx2, kallikren 13 (Klk13) and 8 (Klk8), were 
differentially expressed in younger, E12.5 mesothelial cells. Pitx2 regulates differentiation in 
multiple systems (Cao et al., 2013; Hernandez-Torres, Rodríguez-Outeiriño, Franco, & Aranega, 
2017; Shang et al., 2008), and the kallikren family are serine proteases involved in extracellular 
matrix and adhesive molecule degradation (Kapadia, Ghosh, Grass, & Diamandis, 2004). 
Expression of these genes suggests that the E12.5 mesothelial population may be primed for 
migration and differentiation. In contrast, the E17.5 mesothelial population expressed genes 
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related to barrier or immune function, such as dermokine (Dmkn) (Hasegawa et al., 2013; Huang 
et al., 2017), bone marrow stromal antigen 2 (Bst2), and retinoic acid receptor responder 2 
(Rarres2) (Ernst & Sinal, 2010). These results suggest stage-dependent roles for the mesothelium 
throughout development.  
The different roles for the mesothelium across time are also evident from our pseudotime 
analysis, which proposes that the mesothelium serves as a progenitor for other mesenchymal cell 
types during development. The mesothelium is a critical mesenchymal progenitor population in 
other organs, such as the heart, intestine, lung, and liver (Asahina et al., 2011; Bin Zhou et al., 
2008; Que et al., 2008; Wilm et al., 2005). Our data suggest that mesothelial progenitor activity 
occurs at E12.5 or earlier during pancreatic development, consistent with other organ systems 
(Bin Zhou et al., 2008; Que et al., 2008; Winters & Bader, 2013). Indeed, a recent study 
identified that parietal mesothelial cells can function as progenitor cells prior to pancreatic 
specification (Angelo & Tremblay, 2018). The transcriptomic information obtained by this study 
will allow the development of tools to target individual populations within the mesenchyme and 
perform lineage tracing, ablation, and expression studies in vivo. Furthermore, this 
developmental dataset can be compared to mesenchymal population dynamics during adult 
disease progression, where aberrant recapitulation of developmental pathways can lead to disease 
states in the pancreas (Jensen et al., 2005; Rhim & Stanger, 2010). Thus, this dataset is a broad 
resource for the implementation of future studies in pancreatic mesenchymal biology. 
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Figure 14: Identification of multiple uncharacterized mesenchymal populations. (a) t-SNE 
visualization of subclustered E14.5 mesenchymal clusters (from n=14 pancreata). (b) Density 
plot depicting Pearson’s correlation values (depicted in heatmap in Fig. 15b) within the epithelial 
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and mesenchymal populations based on average gene expression in each cluster. (c) Dot plot of 
top differentially-expressed markers of each mesenchymal population. Bars are color-coded by 
cluster identity in (a). The grey bar represents pan-mesenchymal markers. The size of each dot 
represents the proportion of cells within a given population that expresses the gene; the intensity 
of color indicates the average level of expression. (d) Pathway analysis of genes greater than 2-
fold differentially-expressed by cells in clusters 1, 2, 4, and 5. (e) Expression of genes marking 
clusters 1 (Cav1), 2 (Stmn2), 4 (Cxcl12), and 5 (Barx1) in all E14.5 mesenchymal cells. Color 
intensity indicates level of expression. (f-h) Multiplexed fluorescent ISH combined with EPCAM 
IF validates clusters 2 and 5 (e) and cluster 1 (f-g). EPCAM marks pancreatic epithelium. In (f), 
Barx1+ cells (red arrows, cluster 5) are distinct from Stmn2+ cells (green arrows, cluster 2), 
validating the single-cell data. In (g), Cav1+ cells (red arrows, cluster 1) are distinct from 
Stmn2+ cells (green arrows, cluster 2). In (h), Barx1+ cells that do not express Cav1 (red arrows) 
represent cluster 5, whereas Barx1+/Cav1+ cells (yellow arrows) represent cluster 1. Cav1+ cells 
that do not express Barx1 are also identified (green arrows), likely representing endothelial 
cells(Frank, 2003). Scale bar represents 50 um in f-h.  
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Figure 15. Transcriptomic Signatures and Lineage Dynamics among Mesenchymal 
Populations. (a) t-SNE visualization of E14.5 biological replicates, colored by batch, 
demonstrating effectiveness of batch correction. (b) Pearson’s correlation of E14.5 epithelial and 
mesenchymal clusters based on average expression of variable genes. (c) Comparison of bimodal 
likelihood ratio test adjusted p-values to adjusted p-values calculated by either MAST (left 
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panel) or Wilcox rank sum (right panel) tests for all greater than 2-fold differentially-expressed 
genes. Pearson’s correlation value is shown in top left corner. (d,e) IF validation of (d) 
mesothelium (Wt1+) and (e) vascular smooth muscle (Acta2+) cells in E14.5 pancreata. 
ECADHERIN (ECAD) marks epithelium, and VIMENTIN (VIM) marks mesenchyme. Scale 
bar: 50 um. (f) Expression of secreted factors within the mesothelium. Color indicates level of 
expression. (g) t-SNE visualization of merged mesenchymal timecourse dataset. E14.5 biological 
replicates are colored, serving as a measure of batch correction effectiveness within the merged 
mesenchymal timecourse dataset. Grey dots represent both E12.5 and E17.5 cells. (h) Correlation 
of E14.5 mesenchymal populations with merged (E12.5, E14.5 and E17.5) mesenchymal clusters 
based on average expression of the variable genes from all datasets. Merged populations were 
matched with E14.5 (Fig. 2) by highest correlation and assigned the same cluster identity (cluster 
1-10). Remaining merged clusters were assigned cluster identities 11-17. (i) Dot plot of 
differentially-expressed genes from each merged mesenchymal cluster. Colored bars correspond 
to t-SNE in Fig. 14a (j) Contribution of cells from each timepoint is mapped onto pseudotime 
plots. Expression of proliferation markers, Birc5 and Top2a, in the pseudotime trajectory. Color 
indicates level of expression. Contribution of cells from each timepoint is broken down by 
individual cluster and mapped onto pseudotime plots. Colors correspond to cell clusters in Fig. 
14a,e.  
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Figure 16. Mesothelial cells are dynamic over developmental time and are predicted to give 
rise to vascular smooth muscle populations. (a) t-SNE visualization of merged mesenchymal 
clusters from E12.5 (n=18 pancreata), E14.5 (n=14 pancreata for batch 1; n=11 for batch 2), and 
E17.5 (n=8 pancreata) tissue. Mesenchymal clusters were identified at each timepoint, 
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subclustered, merged together, and reanalyzed. Cells are colored by cluster or timepoint. Dotted 
circle highlights timepoint-segregated mesothelial clusters. (b) Dot plot of top differentially-
expressed genes in timepoint-specific mesothelial clusters (clusters 1, 11, and 17). Size of the dot 
represents proportion of the population that expresses each specified marker. Color indicates 
level of expression. (c) ISH for Pitx2 and Msln in E12.5 and E17.5 pancreata. Pitx2 expression 
was detected in E12.5 but not E17.5 mesothelium, whereas Msln was detected in E17.5 but not 
E12.5 mesothelium. VIMENTIN (VIM) IF staining depicts pancreatic mesenchyme. Dotted line 
indicates tissue boundary. Yellow arrows identify Pitx2+ mesothelial cells. Red arrows identify 
Msln+ mesothelial cells. Scale bar represents 50 um. (d) Expression levels of VSM-related genes 
in merged mesenchymal clusters. Color intensity indicates level of expression. (e) Pseudotime 
ordering of mesothelial and VSM-related merged mesenchymal clusters. Colors correspond to t-
SNE in (a). All clusters are individually plotted in Fig. 15j. (f) Cluster proportions over 
pseudotime. Pseudotime was binned into 10 groups and the proportion of each cluster within that 
bin of pseudotime was calculated. (g) Model of lineage relationships among mesothelial, 
vascular smooth muscle, and VSM-related mesenchymal populations based on pseudotime 
ordering in (e). 
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Chapter 4 
Characterization of the pancreatic mesothelium and role of Fgf9 in pancreatic development 
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Introduction 
The mesothelium is a single-cell layer of mesoderm-derived epithelial-like cells that line 
the body’s internal organs and body cavities (Mutsaers & Wilkosz, 2007; Winters & Bader, 
2013). The parietal mesothelial cells lining the three body cavities—pleura (lungs and 
diaphragm), peritoneal (abdomen and pelvis), and pericardial (heart)—form a continuous lining 
with the visceral mesothelial cells lining the internal organs. The diverse functions of mesothelial 
cells during development and in adult tissues has increased the attention to these cellular layers. 
Although located in association with different organs and cavities throughout the body, 
mesothelial cells share multiple common characteristics: cellular shape, unique intermediate 
filament expression pattern, cellular polarity, cell/cell adhesion, and production of a basement 
membrane (Michailova & Usunoff, 2006; Winters & Bader, 2013). Most mesothelial cells have a 
flattened squamous-like shape, although cuboidal mesothelial cells have been noted in certain 
areas of the pleura and viscera of the liver and spleen (Mutsaers & Wilkosz, 2007). As an 
epithelial-like mesoderm-derived cell, mesothelial cells express intermediate filaments 
characteristic of both mesenchymal cells, such as vimentin (Vim) and desmin (Des), and 
epithelial cells, such as cytokeratins (LaRocca & Rheinwald, 1984). The apical surface of 
mesothelial cells may be covered by microvilli and cilia and face towards the coelomic space 
(Gaudio, Rendina, Pannarale, Ricci, & Marinozzi, 1988; Michailova & Usunoff, 2006), while the 
lateral side is identified by localization of tight junction proteins (Andrée et al., 2000; Reese, 
Zavaljevski, Streiff, & Bader, 1999). In addition to tight junctions, mesothelial cells form 
numerous cell-cell junction complexes, including adherens, gap junctions, and desmosomes, 
helping facilitate their barrier formation (Michailova & Usunoff, 2006; Mutsaers & Wilkosz, 
2007). Finally, the mesothelium produces and rests on a basement membrane (Mutsaers & 
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Wilkosz, 2007; Winters, Thomason, & Bader, 2012). These characteristics are used to identify 
mesothelial cells throughout the body and across organisms. 
In the adult, the mesothelium functions as a protective barrier and source of surfactant to 
facilitate intra-organ movement (Michailova, 2004). As the barrier between the organ 
parenchyma and body cavity, mesothelial cells regulate the passage of fluids and cells, including 
immune cells, across the mesothelial monolayer (Mutsaers & Wilkosz, 2007). Additionally, 
mesothelial cells protect organs from foreign pathogens by the secretion of chemokines and 
cytokines and the presentation of antigens to recruit and activate immune cells (Valle et al., 
1995). Mesothelial cells are also critical during injury and repair processes, where they 
participate in regulating inflammation, coagulation, and fibrinolysis (Mutsaers et al., 2015). 
Therefore, the mesothelium plays an active role during both adult homeostasis and injury 
conditions. 
A major focus of mesothelial biology has been on its function as a mesenchymal 
progenitor cell during development. Mesothelial cells undergo a process similar to epithelial-to-
mesenchymal transition (EMT), often termed a mesothelial-to-mesenchymal transition (MMT), 
in which they leave the mesothelial layer, migrate into the organ parenchyma, and differentiate 
into various mesenchymal cell types (Ariza, Carmona, Cañete, Cano, & Chapuli, 2016). Studies 
of mesothelial progenitor function have utilized dye labeling and more recently, genetic Cre-lox 
technology, to label and trace migrating mesothelial cells (see table 1 for overview of genetic 
mouse lines used to study the mesothelium and their references). An understanding of the 
mesenchymal cell types derived from mesothelial layers has started to unravel the complex 
lineage relationships among mesenchymal cells in different organs. 
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The epicardium, the mesothelial layer lining the heart, has been shown to give rise to 
vascular smooth muscle, fibroblasts, endothelial, and myocardial cells (Bin Zhou et al., 2008; 
Dettman, Denetclaw, Ordahl, & Bristow, 1998). While studies have agreed that the majority of 
smooth muscle cells surrounding the coronary vessels and a portion of fibroblasts are derived 
from the epicardium (Dettman et al., 1998; Wessels et al., 2012), the derivation of endothelial 
cells from the epicardium remains controversial. Experiments utilizing quail-chick 
transplantations demonstrated an epicardial origin of coronary vascular cells, but these findings 
were not supported by lineage tracing in mice (Bin Zhou et al., 2008; Cai et al., 2008; Perez-
Pomares et al., 2002). The mouse studies utilized two different genetic lines with Cre expression 
driven by either Wt1 or Tbx18. These genes were shown to be expressed within the epicardium, 
as well as the progenitor cells that give rise to the epicardium, the proepicardium. A later study 
found that WT1 and TBX18 expression was heterogenous within the proepicardium (Katz et al., 
2012). A proepicardial domain that did not express WT1 nor TBX18, but instead expressed 
Semaphorin 3D (Sema3D) and Scleraxis (Sclx), was demonstrated to give rise to endothelial cells 
of the coronary vasculature. This study proposed that these distinct proepicardial domains could 
explain the divergent results from prior studies.  
The origin of myocardial cells, the muscle cells that compose the heart, has also remained 
controversial. Evidence for an epicardial origin of myocardial cells was provided by lineage 
tracing with Wt1-Cre, Wt1-CreER, and Tbx18-Cre driver lines (Bin Zhou et al., 2008; Cai et al., 
2008). The validity of these lines, however, has been called into question (Christoffels et al., 
2009; Rudat & Kispert, 2012). Rudat and Krispert reported sporadic and ectopic recombination 
of the Wt1-Cre allele throughout the embryo, suggesting that lineage tracing may lead to 
erroneous conclusions. Additionally, the recombination efficiency of the Wt1-CreER line in the 
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epicardium was both low and highly variable. These authors also found Wt1 and Tbx18 
expression in non-epicardial cells, suggesting that these markers are not specific to the 
epicardium (Christoffels et al., 2009; Rudat & Kispert, 2012). Whether myocardial cells are 
derived from the epicardium remains to be solved. 
Although the epicardium is the best studied mesothelial layer, studies in other organs 
have also provided evidence for a mesenchymal progenitor function. The majority of vascular 
smooth muscles of the gut and around 30% in the lung, have been shown to be derived from 
mesothelial layers of the respective organs by utilizing different Wt1-Cre lines than the line 
developed by Zhou and colleagues (E. Cano, Carmona, & Munoz-Chapuli, 2013; del Monte et 
al., 2011; Dixit, Ai, & Fine, 2013; Que et al., 2008; Wilm et al., 2005). These finding were also 
supported by a mesothelin-CreER line (Rinkevich et al., 2012). Both a portion of interstitial 
fibroblasts within the lung and interstitial cells of Cajal in the gut have been shown to be derived 
from mesothelial layers of the lung and gut, respectively (E. Cano et al., 2013; Carmona, Cano, 
Mattiotti, Gaztambide, & Munoz-Chapuli, 2013; Dixit et al., 2013). Cano et al. also 
demonstrated that a portion of lung endothelial cells is derived from Wt1+ pleural mesothelium.  
Dye labeling of the chick coelomic mesothelium demonstrated a mesothelial contribution to the 
liver sinusoidal endothelium (Pérez Pomares et al., 2004). A later study utilizing a Wt1-CreER 
mouse line found the liver mesothelium contributed to the stellate cells, a type of fibroblast, and 
perivascular cells (Asahina et al., 2011). Finally, cells from the coelomic epithelial on both sides 
of the gonad primordia migrate and differentiate into Sertoli and Leydig cells, which form the 
stroma of the developing gonads (Kusaka et al., 2010). These studies demonstrate the wide range 
of cell types derived from mesothelial layers throughout the body. 
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In addition to its progenitor function, mesothelial layers also act as a source of secreted 
factors to regulate organ development. FGFs, in particular, have been shown to be mesothelial-
secreted factors that influence organ development. A study by Lavine and colleagues showed 
that retinoic acid (RA)-regulated expression of Fgf9 within the epicardium, the mesothelial layer 
of the heart, induced myocardial proliferation (Lavine et al., 2005). Furthermore, the authors 
found that FGF signaling induced epicardial expression of sonic hedgehog (Shh), which 
subsequently induced myocardial expression of vascular endothelial growth factor (Vegf) 
ligands and angiopoietin-2 (Ang-2). Vegf and Ang-2 then regulated coronary vascular 
development (Lavine, 2006; Lavine & Ornitz, 2008).  
Similar to the heart, studies have identified a pro-proliferative role of Fgf9 during lung 
development (Colvin, White, Pratt, & Ornitz, 2001). A study utilizing Cre drivers for epithelial 
and mesenchymal compartments found a specific role for epithelial-expressed Fgf9 in epithelial 
branching and mesothelial-expressed Fgf9 in mesenchymal proliferation (Yin et al., 2011). FGF9 
has also been shown to regulate differentiation processes, specifically the inhibition of vascular 
smooth muscle cells (Weaver, Batts, & Hogan, 2003). The authors hypothesized that the 
localized secretion of FGF9 from the mesothelium maintains mesenchymal cells along the outer 
edge of the lung in an undifferentiated state. These studies suggest multi-faceted roles for FGF9 
during lung development. 
Intestinal development is also dependent on Fgf9, as the small intestines of Fgf9 -/- mice 
were shorter than wild-type controls, due to reduced mesenchymal proliferation and premature 
differentiation (Geske, Zhang, Patel, Ornitz, & Stappenbeck, 2008).  However, expression of 
Fgf9 in both epithelial and mesothelial cells suggests that some of these defects could be due to 
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epithelial-expression of Fgf9, as found in the lung. Finally, Fgf9 is also expressed in the hepatic 
mesothelium, but its function during development has not been determined (Colvin et al., 2001). 
In addition to FGF signaling, the epicardium also expresses the secreted factor, insulin 
growth factor 2 (Igf-2) (Peng Li et al., 2011). Igf-2 was found to regulate the proliferation of the 
myocardium, identifying an additional mesothelial-derived mitogen that acts on underlying 
mesenchymal cells. Further work identified a relay system of signals that results in proliferation 
of myocardial cells; RA signaling induced the expression of erythropoietin (Epo) in the liver, 
which traveled to the heart and induced expression of Igf-2 in the epicardium, ultimately 
resulting in IGF-2 secretion and proliferation of underlying myocardial cells (Brade et al., 2010).  
RA signaling has been shown to regulate upstream processes that lead to expression of 
Fgf9 and Igf-2 in the epicardium. In the liver, however, RA has been proposed as a mesothelial-
secreted mitogen that regulates hepatoblast proliferation (Ijpenberg et al., 2007). In Wt1 
knockout embryos, expression of the retinoic acid synthesizing enzyme (Raldh2), is 
downregulated in the hepatic mesothelium. These animals displayed decreased hepatoblast 
proliferation and increased differentiation of vascular smooth muscle cells. Inhibition of RA 
synthesis in chick embryos also resulted in decreased hepatoblast proliferation and a smaller 
liver (Ijpenberg et al., 2007), suggesting that the proliferation defects are a direct effect of RA 
signaling. Therefore, mesothelial layers have been shown to secrete multiple mitogenic factors in 
order to regulate organ size during development. 
While mesothelial layers have been well-studied in organs such as the lung and heart, the 
development and function of the pancreatic mesothelium is unknown. One study examined the 
origin of the pancreatic mesothelium by chick-quail transplantation of dorsal pancreatic buds 
(Winters, Williams, & Bader, 2014). These experiments suggested that the pancreatic 
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mesothelium was derived from resident progenitors within the transplanted pancreatic tissue, 
rather than an exogenous source from the host. However, this study only transplanted the dorsal 
pancreatic bud, and has yet to be verified in other organisms or by more defined lineage tracing 
experiments. The timing and mechanism of pancreatic mesothelial formation has not been 
reported.  
Studies have only just begun to identify the downstream progeny of mesothelial layers in 
the pancreas. Angelo and Trembley found that the condensed dorsal mesenchymal cells are 
derived from the coelomic mesothelial layer from E9.5 – E10.5 (Angelo & Tremblay, 2018). The 
ventral coelomic mesothelial layer contributed to the ventral pancreatic mesenchyme, suggesting 
that both the dorsal and ventral buds may share a source of mesenchymal cells. As this study 
utilized dye labeling of early mesodermal structures, it is possible that the coelomic mesothelium 
gives rise to the visceral pancreatic mesothelium, which subsequently produces the mesenchymal 
cells of the developing pancreas. Additional studies that can specifically label the visceral 
mesothelial layer of the pancreas will clarify the downstream progeny of pancreatic 
mesothelium.  
Finally, whether mesothelial-derived secreted factors regulate pancreatic development is 
unknown. FGF signaling has been shown to be a mesothelial-regulated pathway important for 
the development of multiple organs. While secretion of FGF ligands by the pancreatic 
mesothelium has not been demonstrated, expression of multiple FGF ligands and receptors has 
been detected during pancreatic development. Utilizing quantitative real-time PCR, expression of 
FGF ligands, including Fgf1, Ffgf7, Fgf9, Fgf11, and Fgf18, was found throughout pancreatic 
development (Dichmann, Miller, Jensen, Scott Heller, & Serup, 2003). This study also analyzed 
expression of the various FGF receptor isoforms, which include the “b” and “c” isoforms. “b” 
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isoforms have been shown to be expressed in epithelial cells, while “c” isoforms are expressed in 
mesenchymal cells (Ornitz & Itoh, 2015). Fgfr1b, Fgfr1c, Fgfr2b, Fgfr2c, Fgfr3b, and Fgfr4 
were found to be expressed in varying patterns during pancreatic development. Fgfr1b and 
Fgfr2b showed a similar pattern of expression, which peaked at E14 and remained at lower 
levels until birth. Fgfr1c, Fgfr2c, and Fgfr4 were most highly expressed at E12, and 
subsequently downregulated at later gestational ages. Fgfr3b increased in expression over 
developmental time. While this study did not distinguish expression between the epithelium and 
mesenchyme, another study determined the expression FGF receptors at E11.5 within each of 
these compartments (Sylvestersen, Herrera, Serup, & Rescan, 2011).  Fgfr2b and Fgfr4 were 
found to be expressed specifically within the epithelium, Fgfr2c and Fgfr1c were enriched in the 
mesenchyme, and Fgfr3c was expressed in both the epithelium and mesenchyme by quantitative 
PCR measurements. This study detected very low expression of Fgfr1b and Fgfr3b in both 
compartments, which fits with the patterns of expression detected by Dichmann and colleagues 
(Sylvestersen et al., 2011).  The varying expression patterns of both FGF ligands and receptors 
indicates that they may have distinct roles in regulating pancreatic development. 
Indeed, a functional role for FGF signaling has been noted by multiple studies. 
Mesenchymal-derived Fgf10 has been identified as a critical mitogen for early pancreatic 
progenitors, regulating the size of the developing pancreatic organ (Bhushan et al., 2001; Ohuchi 
et al., 2000). Fgf10 is thought to function through Fgfr2b, an epithelial-expressed receptor, in 
order to maintain Notch expression, enhance proliferation, and block differentiation in pancreatic 
progenitor cells (Hart, Papadopoulou, & Edlund, 2003). FGF10, therefore, directly acts on 
epithelial cells to influence pancreatic development. It is also possible that FGF signaling can 
influence mesenchymal cell development. Misexpression of Fgf4, a ligand not normally found to 
 78 
be expressed in the developing pancreas, under the Pdx1-promoter (Pdx1-Fgf4) led to defects 
within both the epithelial and mesenchymal compartment (Dichmann et al., 2003). Pdx1-Fgf4 
pancreata displayed large fluid-filled cysts, with interspersed groups of cells resembling acini 
and increased number of disorganized ductal structures. By E19, when wild type pancreata have 
already formed large clusters of endocrine cells that will become the islets of Langerhans, 
Pdx1-Fgf4 pancreata showed dispersed endocrine cells that failed to aggregate and were reduced 
in total number. Instead, the majority of the pancreas was composed of mesenchymal cells, a 
large number of which were proliferating.  FGF4 binds preferentially to the FGFR “c” isoforms, 
which are expressed in the mesenchyme (Ornitz & Itoh, 2015). The authors of the study, 
therefore, suggest the effects of FGF4 may function directly on mesenchymal cell development, 
which in turn effects epithelial development. Additionally, they hypothesize that FGF9 may 
mimic the role of FGF4, as FGF9 also preferentially binds FGFR “c” isoforms (Ornitz & Itoh, 
2015) and is endogenously expressed during pancreatic development. FGF4 also binds with 
lower affinity to FGFR “b” isoforms and FGFR4, and so it is also formally possible that some of 
these effects are a result of direct actions on epithelial cells. These studies highlight the role of 
FGF signaling in regulating epithelial-mesenchymal interactions and overall pancreatic 
development. 
Work in this chapter validates the gene expression profile of the pancreatic mesothelium 
detected in our single-cell RNA-sequencing datasets (see Chapter 3), highlights the need for new 
tools for lineage tracing the mesothelium, and identifies a novel role for Fgf9 in pancreatic 
development. We first validate expression of multiple markers of the mesothelium detected in 
our single-cell RNA-sequencing by performing immunohistochemistry in vivo.  Many of these 
markers are known mesothelial markers in other organ systems, but we also identify two 
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additional markers not previously associated with mesothelial layers. Next, we perform 
experiments to lineage trace the pancreatic mesothelium during development. These experiments 
highlight the limitations of the current set of tools for accurately studying the lineage of this cell 
type. The novel markers identified, therefore, are candidates for future tools to more specifically 
label the pancreatic mesothelium. Our single-cell RNA-sequencing datasets also identify 
multiple secreted factors expressed within the pancreatic mesothelium. We find that embryos 
lacking Fgf9 have hypoplastic pancreata, indicating a functional role for FGF9 in pancreatic 
development. This chapter, therefore, validates and begins to study the functional role of a 
specific mesenchymal subtype during pancreatic development. 
 
Identification of pancreatic mesothelial markers 
In chapter 3, we identified a mesothelial population present in E12.5, E14.5, and E17.5 
pancreatic single-cell RNA-sequencing datasets. Therefore, we set out to validate the expression 
of markers identified within these datasets in pancreatic mesothelial cells. The most common 
marker used to identify the mesothelium in other organs is wilms tumor 1 (Wt1). We also 
detected Wt1 expression in our single-cell RNA-sequencing datasets (Fig. 17a-c). Wt1 was 
enriched within the mesothelium, and also expressed in other mesenchymal cell types. We next 
stained for WT1 protein and detected expression in mesothelial layers and mesenchymal cells of 
E12.5, E14.5, and E17.5 pancreata, matching the expression data from the single-cell sequencing 
datasets (Fig. 17a-c). WT1 protein appeared to be more highly expressed in mesothelial cells 
than mesenchymal cells.  Our findings contrast with other reports of WT1 as a specific marker of 
the mesothelium in other organs, as Wt1 RNA and WT1 protein were detected in both 
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mesothelial (arrows) and non-mesothelial (arrowheads) mesenchymal cells during pancreatic 
development. 
In addition to Wt1, we also validated other known and novel markers highly expressed in the 
mesothelium in our E14.5 single-cell RNA-sequencing dataset. Using immunohistochemistry on 
both tissue sections and in whole mount pancreata, we aimed to identify markers with high 
specificity to the mesothelium. Caveolin1 (CAV1) was expressed in the mesothelium, as well as 
endothelial cells, as predicted by our single-cell data and previously reported (Parton & Simons, 
2007) (Fig. 18a). Additionally ezrin-radixin-moesin binding phosphoprotein-50 (EBP50) and 
crystalline alpha B (CRYAB) showed specific expression on the membrane of the mesothelium, 
with some weaker staining around the acini (Fig. 18b-c). These antibodies also successfully 
stained the mesothelium in a whole mount staining approach with a clearing step to allow for 
three-dimensional (3D) imaging (Fig. 18b-c). These results identify and validate two novel 
markers of the pancreatic mesothelium, EBP50 and CRYAB, that offer superior specificity than 
classical markers of mesothelial layers, such as WT1 and CAV1. 
 
Lineage tracing the pancreatic mesothelium 
 The mesothelium has been demonstrated to give rise to multiple mesenchymal cell types 
during development of the liver, heart, lung, and intestine (Asahina et al., 2011; Bin Zhou et al., 
2011; Que et al., 2008; Wilm et al., 2005). Predictions from our in silico lineage modeling 
suggest the pancreatic mesothelium gives rise to vascular smooth muscle cells (see Chapter 3). 
To validate these predictions in vivo, appropriate Cre driver lines are required to specifically 
label the pancreatic mesothelium. Prior studies have utilized the Wt1-EGFP-Cre mouse line to 
lineage trace mesothelial populations (see Table 1 for list of mouse lines and references). When 
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we crossed the Wt1-EGFP-Cre line to the Rosa26mTmG reporter to lineage trace Wt1+ expressing 
cells, we found that a large number of epithelial cells were labeled in adult pancreata (Fig. 19a). 
Given the specificity of Wt1 expression in mesothelial and mesenchymal populations (Fig. 17a-
c), we suspect that this epithelial recombination may be a result of inappropriate recombination 
of the Cre allele. Indeed, there have been reports that this Cre line undergoes sporadic and 
ectopic recombination throughout the embryo (Rudat & Kispert, 2012). These results suggest 
that the Wt1-EGFP-Cre line is not suitable for lineage tracing the pancreatic mesothelium.   
We next analyzed the recombination of two cytokeratin inducible Cre driver lines, Krt19-
CreER and Krt18-CreER by crossing these lines to Rosa26mTmG reporter mice (Table 1). Both 
Krt19 and Krt18 are expressed in the developing pancreatic mesothelium (Fig. 19b-c). We were 
unable to achieve high efficiency labeling of the mesothelium with either the Krt19-CreER or 
Krt18-CreER drivers (Fig. 19b-c). Although we occasionally identified lineage-labeled 
mesothelial cells with the Krt19-CreER driver, this required two 4.5 mg doses of tamoxifen 
injected at E12 and E13, often resulting in deformed embryos (Fig. 19b). Lineage-labeled 
mesothelial cells were even more rare with the Krt18-CreER driver, as most lineage-labeled cells 
were located within the pancreatic parenchyma and likely represented ductal cells (Fig. 18c). We 
conclude that these three lines are not suitable for high efficiency, specific labeling of the 
pancreatic mesothelium. 
Although the constitutive Wt1-EGFP-Cre driver was determined to be unsuitable, we 
hypothesized that the inducible Wt1-CreER driver may show higher specificity for the pancreatic 
mesothelium (Table 1). To test this, we crossed the Wt1-CreER line to the Rosa26mTmG reporter 
line and delivered two doses of 2.5 mg of tamoxifen 8 hours apart by oral gavage to pregnant 
dams at E12.5 (Fig. 20a). Pancreata were collected at E13.5 to assess the initial labeling 
 82 
capability of the driver line. We found lineage-labeled mesothelial cells and more rarely, 
mesenchymal cells, but not epithelial cells (Fig. 20b). This matched the endogenous expression 
of WT1, which is highly expressed in the mesothelium, more lowly expressed in mesenchymal 
cells, and absent in the epithelium (Fig. 17a-c). Pancreata collected at E17.5 with the same 
tamoxifen dosing showed a similar lineage-labeling pattern, with mesothelial and mesenchymal 
lineage labeling (Fig. 20c). More mesothelial cells were labeled than at E13.5, perhaps due to 
proliferation of labeled cells during development. Similar to E13.5, mesenchymal cells were 
more rarely labeled (Fig. 20c). These results suggest that the Wt1-CreER line is a more suitable 
driver than the Wt1-EGFP-Cre. However, as demonstrated by both immunohistochemistry and 
the Wt1-CreER lineage tracing results, Wt1/WT1 is not specifically expressed within the 
mesothelium. 
 
Expression of secreted factors by the pancreatic mesothelium 
In addition to its described role as a mesenchymal progenitor cell, the mesothelium has 
also been shown to secrete factors that regulate organ development (A. C. White et al., 2006; Yin 
et al., 2011). Therefore, we looked for expression of secreted factors, their receptors, and 
downstream targets in three pathways known to have roles in pancreatic development. Of the 28 
different FGF ligands, we only detected appreciable levels of Fgf9 (Fig. 21a-d). Expression of 
this factor was largely restricted to the pancreatic mesothelium, with sparse expression in the 
ductal and endocrine populations (Fig. 21a-d). We also found expression of the Fgfr1 expression 
in the mesenchyme and sparser expression of Fgfr1-4 in the epithelium (Fig. 21a-d). Fgfr2 was 
enriched within the ductal cells (Fig.21 c-d). Due to the 3’ biased sequencing approach, we were 
not able to obtain isoform information for the receptors. Finally, we detected expression of FGF 
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downstream transcription targets, Spry1 and Spry4, which overlapped to varying degrees with the 
expression of the FGF receptors (Fig. 21a-d). These results highlight the specific expression of 
Fgf9 in the pancreatic mesothelium, and potential regulation of both the epithelial and 
mesenchymal compartments through their expression of various FGF receptors. 
Within the WNT signaling pathway, multiple receptors were expression in both the E14.5 
mesenchyme and epithelium (Fig. 22). Of the expressed receptors, most were widely expressed 
in the mesenchyme, such as Fzd1, Fzd2, Fzd3, Fzd7, Lrp5,  and Lrp6 (Fig. 22a-b). The exception 
was Fzd4, which was enriched within the mesothelial compartment (Fig. 22a-b). Overall, WNT 
receptors were expressed more sparsely in the epithelium, but some displayed differential 
expression in various populations. For example, Fzd2 was largely absent from endocrine cells 
while Fzd3 was more sparsely expressed in the ductal population (Fig. 22c-d). We also found 
expression of genes that are downstream of the WNT receptors, including Dvl2, Axin2, and the 
transcription factors Lef1, Tcf3, and Tcf4. Lef1 was enriched in the mesothelium while Tcf4 was 
enriched in the non-mesothelial mesenchymal populations (Fig. 22a-b). Finally, we identified 
expression of multiple WNT ligands that were enriched in the mesothelium, such as Wnt2b and 
Wnt9a (Fig. 22a-b). In the epithelium, Wnt2b was specifically expressed within the ductal cells 
(Fig. 22c-d). Prior studies have utilized qPCR and in situ hybridization to study WNT pathway 
expression, but focused on early (E10) and late (E17) gestational timepoints(Heller et al., 2002). 
Additionally, single-cell resolution now allows us to more accurately map on the expression of 
WNT members in a cell type specific manner. 
In addition to FGF and WNT, we also found expression of components of the BMP 
signaling pathway. BMP ligands expressed by the mesenchyme include Bmp1, Bmp7, and at 
lower levels, Gdf11 (Fig. 23a-b). Bmp2 and Bmp4 were highly enriched in the mesothelium, and 
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Gdf6 was enriched in both the mesothelium and cluster 2, the Stmn2+ population (Fig. 23a-b). 
These ligands also displayed cell-type specific expression patterns in the epithelium, where 
Bmp1 was enriched in the Ngn3+ and beta cell populations, but largely absent from the Fev+ 
population (Fig. 23e-f). Bmp7, on the other hand, was restricted to ductal and acinar cell 
populations but was absent in the endocrine cells. Most BMP receptors were expressed at lower 
levels and did not display obvious enrichment in either the mesenchymal or epithelial 
compartments, although Acvr2b was slightly enriched in the mesothelium (Fig. 23a,c,e-f). 
Finally, the mesenchymal populations expressed Smad1/4-7, proteins that act as signal 
transducers for BMP signaling (Fig. 23a, d).  
 
Fgf9 is required for proper pancreatic development 
 Our single-cell RNA-sequencing dataset identified numerous candidate mesothelial-
secreted factors (Fig. 21-23, see Chapter 3). One of the factors most specifically expression by 
the mesothelium was Fgf9 (Fig. 24a). Although Fgf9 has also been shown to regulate vascular 
development in the heart and lung (Olivey & Svensson, 2010; A. C. White, Lavine, & Ornitz, 
2007; Yin et al., 2011), intestinal elongation (Geske et al., 2008), and cecum formation (Alam et 
al., 2012), the role of Fgf9 in pancreatic development is unknown. 
 We next set out to determine the role of Fgf9 during pancreatic development. E12.5, 
E14.5, and E17.5 single-cell RNA-sequencing datasets revealed a high specificity of Fgf9 to the 
mesothelium, although there was low expression in some ductal and endocrine populations as 
well (Fig. 24a). We utilized a mouse line with a LacZ knock-in allele in the Fgf9 locus (Huh, 
Warchol, & Ornitz, 2015). As mice lacking both alleles of Fgf9 do not survive to adulthood, we 
crossed Fgf9 heterozygous (Fgf9 +/-) animals to obtain homozygous wild-type (Fgf9 +/+), 
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heterozygous (Fgf9 +/-) and homozygous null (Fgf9 -/-) embryos. Fgf9 -/- embryos were smaller 
in size than their Fgf9 +/+ littermates (Fig. 24b), and dissection of the gut tube region containing 
the stomach, spleen, pancreas, and proximal intestine revealed multiple defects (Fig. 24c). 
Fgf9 -/- embryos had a hypoplastic stomach and pancreas and lacked a discernable spleen (Fig. 
24c-d). Fgf9 +/- embryos and gut tube regions were indistinguishable from Fgf9 +/+ littermate 
controls (data not shown). Whole mount staining for the epithelial marker, CD326 (Epcam), 
revealed that Fgf9 -/- embryos had less branching than pancreata from littermate Fgf9 +/+ 
embryos (Fig. 24e). Therefore, we concluded that Fgf9 is required for the proper development of 
multiple gut tube-derived organs, including the pancreas. 
 The smaller size of Fgf9 -/- pancreata may be due to the failure of particular cell types to 
develop in the absence of Fgf9.  To determine whether the major cell lineages were present in 
Fgf9 -/- pancreata, we performed immunohistochemistry on E17.5 pancreata from Fgf9 +/+ and 
Fgf9 -/- embryos (Fig. 25). We identified the major lineages of the pancreas in both Fgf9 +/+ and 
Fgf9 -/- pancreata, including acinar (Cpa1+), ductal (Krt19+), mesothelial (Krt19+, localized to 
tissue edge), alpha (Gcg+), beta (Ins+), mesenchymal (Vim+), vascular smooth muscle (Sma+), 
and endothelial cells (CD31+) and did not observe obvious differences between homozygous 
wild type and mutant pancreata at this stage. These results suggest that the diminished pancreatic 
size is not due to loss of a particular cell type. 
 We next analyzed whether the pancreatic lineages were also present at an earlier 
developmental stage, as Fgf9 has been demonstrated to function at early stages and 
compensation effects may allow for recovery by late developmental stages. Similar to E17.5, the 
major pancreatic lineages were present at E13.5, including acinar, ductal, mesothelial, 
mesenchymal, endothelial, and low numbers of alpha and beta cells (Fig. 26a-f). We did not 
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detect Sma+ vascular smooth muscle in either Fgf9 +/+ or Fgf9 -/- pancreata, although they are 
reported to be recruited to blood vessels by E13.5 in the pancreas (Azizoglu et al., 2016). Upon 
comparison of the epithelial and mesenchymal compartments, we observed a reduction of the 
mesenchymal compartment (Fig. 26g-h). Additionally, we found less space occupied by 
mesenchymal cells between the CD326+ epithelial branches, contributing to the compact 
phenotype identified in whole mount imaging (Fig. 24e). As prior studies in the lung have 
identified Fgf9 as a mesothelial-secreted factor that regulates mesenchymal proliferation, we 
quantified the number of epithelial (CD326+) and non-epithelial (CD326-) cells in Fgf9 +/+ and 
Fgf9 -/- pancreata. We found E13.5 Fgf9 -/- pancreata had differing proportions of epithelial and 
non-epithelial cells in comparison to Fgf9 +/+ controls (Fig. 26g-i). In Fgf9 -/- embryos, 80.8% 
of the pancreas was CD326+ and 19.2% CD326-negative while cells of the same organ of 
Fgf9 +/+ littermates were nearly equally distributed, with 43.3% CD326+ and 56.7% CD326-
negative (Fig. 26i). The results of this molecular analysis reveal a bias in the size of the epithelial 
and non-epithelial compartment in E13.5 Fgf9 -/- pancreata.  
 
Discussion 
 Lineage tracing the mesothelium remains challenging with existing markers and genetic 
tools. The utility of the Wt1-EGFP-Cre driver line has been called into question by other groups 
(Rudat & Kispert, 2012), due to sporadic and ectopic recombination of the Cre allele. The high 
degree of recombination within the epithelial compartment of the pancreas could be a result of 
early, ectopic recombination of this allele in the embryo, as reported by Rudat and Kispert. 
Another possibility, although unlikely, is that Wt1 is endogenously expressed in pancreatic 
epithelial precursors at some point during development or adulthood, and the resulting lineage 
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labeled cells reflect true Wt1 expression. In either case, these results suggest that the Wt1-EGFP-
Cre line will be not be useful for specific lineage labeling of the pancreatic mesothelium. 
 To overcome the problems with the Wt1-EGFP-Cre line, we tested multiple other 
inducible Cre driver lines for mesothelial specificity. We found that the Wt1-CreER was the 
most successful in terms of efficiency. However, we also found recombination in non-
mesothelial mesenchymal cells one day after tamoxifen injection. The labeling of non-
mesothelial cells at E13.5 could be occurring by two mechanisms. First, the lower levels of WT1 
expression in non-mesothelial mesenchymal cells may be enough to drive recombination. The 
second possibility is that these cells are truly derived from the mesothelium, and are in the 
process of downregulating WT1 expression during differentiation, as hypothesized in the lung 
(E. Cano et al., 2013). Although prior studies have assumed the low levels of WT1 in non-
mesothelial mesenchymal cells represent recently delaminated mesothelial cells, this has not 
been formally demonstrated in the pancreas. These challenges highlight the need for improved 
tools to specifically label and trace the mesothelium. 
 Even with the uncertainty of the specificity of the Wt1-CreER, after pulsing with 
tamoxifen at E12.5, there were very few lineage-traced mesenchymal cells by E17.5. If all or 
only a proportion of these lineage-labeled cells are truly derived from the Wt1+ mesothelium, 
this represents a very small proportion of the pancreatic mesenchyme. The mesothelium may not 
actively give rise to mesenchymal cells at all stages of development. Indeed, most other organ 
systems show evidence of MMT and differentiation at earlier stages of development, typically 
between E10.5 – E12.5 (Asahina et al., 2011; Gise et al., 2016; Wilm et al., 2005). For example, 
in the lung, the mesothelium could be efficiently labeled from E10.5 – E11.5, and was shown to 
contribute to mesenchymal lineages (Dixit et al., 2013). However, the ability to label and trace 
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the mesothelium was reduced at later gestational stages, as the expression of Wt1 decreased. 
Tracing the pancreatic mesothelium at earlier stages may allow for higher efficiency labeling. 
Additionally, the mesothelium may be most active during these earlier stages and subsequently 
contribute fewer cells to mesenchymal lineages at later stages in development.  
Our hypothesis that the pancreatic mesothelium was active at earlier stages of 
development was supported by a recent study, published during the completion of this work, that 
traced the developing pancreatic mesothelium (Ariza, Cañete, Rojas, Chapuli, & Carmona, 
2018). Utilizing the Wt1-CreER line, the authors found that the pancreatic mesothelium 
contributed to the developing mesenchyme when labeled between E9.5 and E11.5. Labeling the 
mesothelium at E9.5 only produced rare labeled parenchyma cells and the authors did not test 
later labeling of the mesothelium. In agreement with our findings, the authors noted the 
expression of low levels of WT1 protein in non-mesothelial mesenchymal cells in E12.5 and 
E13.5 embryos. The expression pattern of WT1 at earlier timepoints, when the tamoxifen pulsing 
was performed to label the mesothelium, was not shown. Additionally, the initial labeling 
immediately after pulsing with tamoxifen was not shown. Therefore, it is possible that WT1 and 
subsequent labeling with the Wt1-CreER line, was not specific to the mesothelium during this 
time, consistent with both this work and the author’s own findings at E12.5 and later. The low 
levels of WT1 expression in non-mesothelial mesenchymal cells at E12.5 was attributed to 
delaminated mesothelial cells that are downregulating WT1 as they differentiate into 
mesenchymal cell types, as had been reported in other systems (E. Cano et al., 2013). Whether 
this assumption is true remains to be tested. Therefore, the results of these Wt1-CreER 
experiments should be interpreted with caution until the line’s specificity to the mesothelium can 
be demonstrated. 
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The creation of additional Cre driver lines for the mesothelium to validate the findings 
from the Wt1 lines would be of great value to the mesothelial field. One of the most specific 
markers from the single-cell RNA-sequencing data is Uroplakin3b (Upk3b). An inducible Cre 
line was created under this promoter, but did not induce the expression of Cre in mesothelial 
tissues (Rudat et al., 2014). Our identification of additional mesothelial markers, including 
Ebp50 and Cryab, provide promising candidates for more specific markers of the mesothelium. 
The expression pattern of these genes should be extended to pre-E12.5 and post-E17.5 
timepoints during pancreatic development to test their specificity throughout pancreatic 
development. 
Besides its function as a possible mesenchymal progenitor cell, the mesothelium also 
secretes growth factors to regulate organ development (Olivey & Svensson, 2010; Yin et al., 
2011). We find expression of multiple secreted factors in the pancreatic mesothelium and 
identify a role for Fgf9 in the development of the pancreas. The hypoplastic phenotype of 
Fgf9 -/- pancreata is reminiscent of the proliferation defects within both the epithelial and 
mesenchymal compartments in the lung of Fgf9 -/- embryos (Colvin et al., 2001). Later work in 
the lung described distinct roles for mesothelial and epithelial-expressed Fgf9 (Yin et al., 2011). 
Fgf9 from the mesothelium regulated mesenchymal proliferation and WNT signaling while Fgf9 
from the epithelium regulated branching. The high expression of Fgf9 in the pancreatic 
mesothelium and reduced size of the mesenchymal compartment, suggests that a similar 
mechanism may occur in pancreatic development. We find a potential branching phenotype, 
where the epithelium appears more compact with less extended branches than wild type 
pancreata. We also detect very low levels of Fgf9 in ductal and endocrine cells in our single-cell 
RNA-sequencing datasets. The reduced size and branching of the epithelium, therefore, may be 
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an indirect effect of mesenchymal dysregulation, a direct effect of mesothelial-secreted FGF9 on 
the epithelial cells, or a direct effect of FGF9 from epithelial cells. Experiments using 
mesenchymal and epithelial Cre drivers with the Fgf9 floxed allele line can clarify the function 
of Fgf9 from the mesothelium or epithelium during development. 
Our E13.5 and E17.5 immunohistochemistry experiments do not indicate that the major 
cellular lineages of the pancreas are absent in Fgf9 -/- pancreata. However, this study remains 
incomplete and requires analysis of additional markers of both the epithelium and mesenchyme. 
Staining for the Ngn3+ endocrine progenitor population and the remaining hormone-producing 
cells (delta, gamma, and epsilon) will be important for verifying the proper differentiation of the 
epithelium. Additionally, we have not yet determined whether the reduction in the mesenchyme 
is due to the loss of a particular mesenchymal cell type or an overall reduction of all 
mesenchymal cell types. Now that we have cataloged the mesenchymal populations, and have 
sets of marker genes to identify them, we can look for the presence of these populations in 
developing Fgf9 -/- pancreata. These experiments will establish whether Fgf9 is required for 
differentiation of specific cellular lineages within the developing epithelium and mesenchyme. 
Rather than an absence of cellular lineages, the reduced size of Fgf9 -/- pancreata could 
be due to decreased proliferation of various cell types or increased cell death. Measuring the 
rates of proliferation and cell death across developmental time, therefore, will be conducted. 
Additionally, the ratios of specific cell types will be quantified in order to determine if the loss of 
Fgf9 leads to biases in the production of particular cell types. These experiments will help 
determine the underlying mechanism of Fgf9 function in pancreatic development.   
Uncovering the signaling pathways affected by loss of Fgf9 -/- will also be crucial for 
gaining a mechanistic understanding of Fgf9 function. As a secreted factor, the localization of 
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the FGF9 receptors can give insight into the signaling pathway regulating pancreatic size. FGF9 
binds to the “c” isoforms of FGF receptors 1, 2 and 3 (FGFR1c, FGFR2c, FGFR3c), the “b” 
isoform of FGF receptor 3 (FGFRb), and FGR receptor 4 (FGFR4) (Ornitz & Itoh, 2015). 
Studies have yet to determine the receptor through which FGF9 acts within the pancreas, 
although Fgfr2c and Fgfr1c were reported to be expressed in the pancreatic mesenchyme at 
E11.5 (Sylvestersen et al., 2011). FGF9 can also signal through FGFR4, which is expressed in 
the pancreatic epithelial (Sylvestersen et al., 2011). It is possible FGF9 functions through 
multiple receptors, in either a spatially or temporally regulated manner. Although we found 
expression of FGF receptors in our dataset, we were not able to identify the receptors isoforms. 
Determining the localization pattern of these FGF receptor isoforms, either by 
immunohistochemistry or in situ hybridization, will help shed light on the potential interactions 
with secreted FGF9 from the mesothelium. 
Studies in the lung have identified key pathways regulated by Fgf9 signaling. Loss of 
Fgf9 within the entire lung results in decreased Fgf10 expression, which is hypothesized to lead 
to a reduction in epithelial branching (Colvin et al., 2001; A. C. White et al., 2006). In contrast to 
this result, mesothelial specific loss of Fgf9 did not affect Fgf10 signaling in the lung. The 
discrepancy between the whole body Fgf9 knockout and the mesothelial specific knockout 
implies that epithelial-expressed Fgf9 may be important for Fgf10 expression in the 
mesenchyme. During cecal bud formation in the gut, Fgf9 signals via the transcription Pitx2 to 
regulate Fgf10 expression in the mesenchyme (Alam et al., 2012). A role for Fgf10 in pancreatic 
proliferation is well established. A model where Fgf9 signaling from the mesothelium regulates 
Fgf10 expression in the mesenchyme to ultimately control organ size would fit the results 
described in this work. Detecting changes in Fgf10 expression levels, either at the transcript or 
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protein level, in Fgf9 -/- pancreatea can help clarify the effect of Fgf9 on Fgf10 signaling. If 
Fgf10 is downregulated in Fgf9 -/- pancreata, rescuing the Fgf9 -/- phenotype by addition of 
exogenous FGF10 will solidify an upstream role for Fgf9 in regulating Fgf10 signaling. 
Besides Fgf10 signaling, WNT/Beta-catenin signaling was disrupted in the mesenchyme 
of lungs with a mesothelial specific loss of Fgf9 (Yin et al., 2011). The authors suggest a model 
whereby Fgf9 regulates Wnt2a expression in the mesenchyme, which in turn regulates 
mesenchymal WNT/Beta-catenin and mesenchymal Fgfr expression. Loss of either Fgf9 or 
WNT/Beta-catenin signaling resulted in increased Noggin expression, a BMP inhibitor, 
suggesting that the BMP pathway is downstream of Fgf9-regulated WNT/Beta-catenin signaling. 
As BMP signaling is known to regulate epithelial proliferation of the lung (Eblaghie, Reedy, 
Oliver, Mishina, & Hogan, 2006), this may be the mechanistic link of Fgf9 to epithelial 
development.  
Both WNT and BMP signaling have been demonstrated to have important roles in 
pancreatic development (Ahnfelt-Rønne et al., 2010; Larsen et al., 2015). Multiple ligands and 
receptors from both the WNT and BMP pathways are expressed in the mesenchymal and 
epithelial populations of E14.5 pancreata. Expression of the BMP receptor, Acvr2b, was enriched 
in the mesothelial compartment, along with BMP ligands, Bmp2 and Bmp4. It is possible that 
mesothelial-secreted factors function in an autocrine manner to regulate mesothelial cell function 
and development. Epithelial populations also display cell-type specific expression of Bmp1 and 
Bmp7. Expression of these ligands may be regulated by upstream pathways originating in the 
mesothelium, analogous to findings in the lung (Yin et al., 2011). Alternatively, these pathways 
may function independently of each other to regulate discreet aspects of pancreatic development. 
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In either case, the expression patterns found in this work can inform future approaches to unravel 
the relationship between Fgf9, WNT, and BMP signaling. 
Understanding how WNT, BMP, and Fgf10 signaling pathways are affected upon loss of 
Fgf9 in the pancreas will be informative for understanding how Fgf9 regulates pancreatic 
epithelial size and branching. These pathways can be tested by qPCR experiments, 
immunohistochemistry or sequencing approaches in Fgf9 +/+ and Fgf9 -/- pancreata. Temporal 
and spatial control over Fgf9 knockout by use of the Fgf9 floxed allele will help uncover the 
specific role of mesothelial-expressed Fgf9 in regulating these pathways. 
 
 
Table 1. Mouse lines used for mesothelial lineage tracing. Study that created line is noted in 
“Creator” and additional studies that utilize the line for mesothelial lineage tracing are listed in 
“Additional Relevant References”. Gene driver and specific line is shown along with whether the 
line expresses a constitutive or inducible Cre. 
 
 
Creator Additional Relevant References Line Gene Driver Cre Expressed
Zhou et al. 2008 this study Wt1tm1(EGFP/cre)Wtp Wilms tumor 1 Cre
Wilm et al. 2005 Que et al. 2008 Tg(WT1-cre)AG11Dbdr Wilms tumor 1 Cre
Del Monte et al. 2011 Cano et al. 2013, Carmona et al. mWt1/IRES/GFP-Cre Wilms tumor 1 Cre
Zhou et al. 2008 this study, Dixit et al. 2013, Asahina et al. 2011, von Gise et al. 2016 Wt1tm2(cre/ERT2)Wtp Wilms tumor 1 CreER
Rinkevich et al. 2012 MSLN–CreERT2– IRES–lacZ) Mesothelin CreER
Means et al. 2008 this study Krt19-CreER Cytokeratin 19 CreER
Van Keymeulen et al. 2009 this study Krt18-CreER Cytokeratin 18 CreER
Cai et al. 2008 Tbx18-Cre
T-box 
transcription 
factor 18
Cre
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Figure 17. Expression of Wt1 during pancreatic development. a-c) Expression of Wt1 
transcript in single-cell RNA-sequencing dataset from E14.5 pancreata (all cells) (left panel) and 
WT1 protein in vivo (four right panels) in E12.5 (a), E14.5 (b), and E17.5 (c) pancreata. Dotted 
circle highlights mesothelial populations in left panels. In right panels, arrows point to Wt1+ 
mesothelial cells and arrowheads point to Wt1+ non-mesothelial cells. Scale bars are 50 um. 
 
 
 
Figure 18. Identification of pancreatic mesothelial markers. (a) Immunohistochemistry for 
CAV1 in E17.5 pancreata. Positive signal in the internal tissue consists of Cav1+ endothelial 
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cells and auto-fluorescence from red blood cells. (b-c) Immunohistochemistry for novel markers, 
EPB50 (b) and CRYAB (c), in the mesothelium of E14.5 pancreata, as predicted by single-cell 
RNA-sequencing. Whole mount staining and 3D imaging for markers are depicted in right 
panels. (a-c) Arrows point to mesothelial cells. Scale bars represent 50 um. 
 
 
 
 
 
Figure 19. Unsuitable Cre drivers for mesothelial lineage tracing. (a) Immunohistochemistry 
for GFP (green), VIM (red) and DAPI in Wt1-Cre; Rosa26mTmG adult pancreata. (b) 
Immunohistochemistry for GFP (green) and DAPI in Krt19-CreER; Rosa26mTmG E17.5 
pancreata. Pregnant dams were injected with 4.5 mg tamoxifen at E12.5 and E13.5. Arrows point 
to GFP+ mesothelial cells. Rightmost panel shows expression of Krt19 in E12.5 single-cell 
RNA-sequencing dataset. Dotted circle highlights mesothelial population. (c) 
Immunohistochemistry for GFP (green) and DAPI in Krt18-CreER; Rosa26mTmG E18.5 
pancreata. Pregnant dams received 3 mg tamoxifen at E11.5 and E12.5 by oral gavage. 
Arrowheads point to GFP+ non-mesothelial cells. Rightmost panel shows expression of Krt18 in 
E12.5 single-cell RNA-sequencing dataset. Dotted circle highlights mesothelial population. Solid 
circle highlights ductal population. (a-c) Scale bar represents 50 um. 
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Figure 20. Lineage tracing Wt1+ cells in the embryonic pancreas. a) Tamoxifen delivery 
scheme for lineage tracing. Pregnant dams received two 2.5 mg doses of tamoxifen 8 hours apart 
at E12.5 and pancreata were collected at either E13.5 or E17.5. b-c) Immunohistochemistry for 
GFP (green), WT1 (red), and DAPI in lineage-traced pancreata collected at E13.5 (b) or E17.5 
(c). (b-c) Scale bars represent 50 um. White arrows highlight GFP+ non-mesothelial cells. 
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Figure 21. Expression of FGF signaling pathway components in E14.5 pancreata. (a-b) 
E14.5 pancreatic mesenchymal cells (from Chapter 3). a) t-SNE visualization of mesenchymal 
clusters, labeled by cluster ID. b) Expression of FGF ligands, receptors, and downstream targets. 
(c-d) E14.5 pancreatic epithelial cells (from Chapter 2). C) t-SNE visualization of epithelial 
clusters, labeled by cluster ID. d) Expression of FGF ligands, receptors, and downstream targets. 
(b, d) Color indicates level of expression, as depicted by legend in (b). 
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Figure 22. Expression of WNT signaling pathway components in E14.5 pancreata. (a-b) 
E14.5 pancreatic mesenchymal cells (from Chapter 3). a) t-SNE visualization of mesenchymal 
clusters, labeled by cluster ID. b) Expression of WNT ligands, receptors, and downstream 
targets. Color indicates level of expression. (c-d) E14.5 pancreatic epithelial cells (from Chapter 
2). C) t-SNE visualization of epithelial clusters, labeled by cluster ID. d) Expression of WNT 
ligands, receptors, and downstream targets. (b,d) Color indicates level of expression, as indicated 
by legend in (d). 
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Figure 23. Expression of BMP signaling pathway components in E14.5 pancreata. (a-d) 
E14.5 pancreatic mesenchymal cells (from Chapter 3). a) t-SNE visualization of mesenchymal 
clusters, labeled by cluster ID. (b-d) Expression of BMP ligands (b), receptors (c), and 
downstream targets (d). (e-f) E14.5 pancreatic epithelial cells (from Chapter 2). e) t-SNE 
visualization of epithelial clusters, labeled by cluster ID. f) Expression of BMP ligands, 
receptors, and downstream targets. (b-d,f) Color indicates level of expression, as depicted in 
legend in (f). 
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Figure 24. Loss of Fgf9 results in a hypoplastic pancreas. a) Expression of Fgf9 in single-cell 
RNA-sequencing datasets from E12.5, E14.5, and E17.5 pancreata. Expression level is indicated 
by red color. Dotted circle highlights mesothelial population. b) Littermate Fgf9 +/+ and Fgf9 -/- 
embryos. Dotted circle highlights pancreas in Fgf9 +/+ embryo. c) Dissected whole gut tube 
from Fgf9 +/+ and Fgf9 -/- embryos, including stomach, spleen, pancreas, and proximal 
intestine. Dotted circle highlights pancreas. d) Dissected pancreata from Fgf9 +/+ and Fgf9 -/- 
embryos. e) Whole mount imaging of pancreata stained with CD326. Fgf9 +/+ image contains 
only dorsal pancreas. Fgf9 -/- pancreata includes both dorsal and ventral pancreas. 
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Figure 25. Major lineages of the pancreas are present in E17.5 Fgf9 -/- pancreata. (a-h) 
Immunofluorescence on E17.5 pancreata from Fgf9 +/+ embryos (a-d) or Fgf9 -/- (e-h) embryos. 
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Expression of mesenchymal marker, VIM (green), and epithelial marker, CD326 (purple). (b,f) 
Expression of acinar cell marker, CPA1 (green), ductal and mesothelial cell marker, KRT19 
(red) and epithelial marker, CD326 (purple). (c,g) Expression of alpha cell marker, GCG (green), 
beta cell marker, INS (red), and epithelial marker, CD326 (purple). (d,h) Expression of vascular 
smooth muscle cell marker, SMA (green), endothelial cell marker, CD31 (red), and epithelial 
marker, ECAD (purple). (a-h) Scale bars represent 50 um. DAPI is included in all merged 
images. 
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Figure 26. E13.5 Fgf9 -/- pancreata have a shifted ratio of mesenchymal to epithelial cells 
(a-h) Immunofluorescence on E13.5 pancreata from Fgf9 +/+ (a-c, g) or Fgf9 -/- (d-f, h) 
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embryos. (a,d) Expression of acinar cell marker, CPA1 (green), ductal and mesothelial cell 
marker, KRT19 (red), and epithelial marker, CD326 (purple). (b,e) Expression of alpha cell 
marker, GCG (green), beta cell marker, INS (red), and epithelial marker, CD326 (purple). (c,f) 
Expression of vascular smooth muscle cell marker, SMA (green), endothelial cell marker, CD31 
(red), and epithelial marker, ECAD (purple). (g,h) Expression of mesenchymal marker, VIM 
(green), and epithelial marker, CD326 (purple). Brackets indicate the size of surrounding 
mesenchymal compartment. i) Quantification of CD326+ and CD326-negative cells in Fgf9 -/- 
and Fgf9 +/+ pancreata. 3 fields of view from n=1 embryo was counted. Error bars represent 
standard deviation. (a-f) Scale bars represent 50 um. DAPI is included in all merged images. 
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Chapter 5 
Mesenchymal heterogeneity in adult homeostasis and fibrotic disease 
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Introduction 
Pancreatitis is a set of inflammatory diseases that result in degradation of the pancreas. 
Acute pancreatitis is characterized by infiltration of monocytes, leukocytes, and granulocytes, 
loss of acinar cells, and activation of a fibroblast population called pancreatic stellate cells 
(PSCs) (Manohar, Verma, Venkateshaiah, Sanders, & Mishra, 2017). Upon repeated insult to the 
pancreas, prolonged inflammation and activation of PSCs results in production and deposition of 
extracellular matrix, ultimately leading to fibrosis and development of chronic pancreatitis 
(Manohar et al., 2017). Globally, 13-45 per 100,000 persons are diagnosed with acute 
pancreatitis annually (Yadav & Lowenfels, 2013), and acute pancreatitis is the leading cause of 
hospitalizations for gastrointestinal disorders in the United States (Peery et al., 2012).  5-12 per 
100,000 persons are diagnosed with chronic pancreatitis every year with a prevalence of about 
50 per 100,000 persons globally (Yadav & Lowenfels, 2013). Multiple risk factors for the 
development of pancreatitis, including alcohol consumption, smoking, obesity, gallstones, and 
genetic susceptibility, suggest a multifactorial etiology of pancreatitis (Lee, Zhao, & Habtezion, 
2017). 
Individuals with acute pancreatitis suffer from severe abdominal pain and are at risk for 
persistent organ failure and death while those with chronic pancreatitis can develop pancreatic 
insufficiency and diabetes (Mandalia, Wamsteker, & DiMagno, 2018; Pham & Forsmark, 2018). 
Treatments include supportive care and lifestyle changes for acute pancreatitis and replacement 
of digestive enzymes and insulin by exogenous sources in the case of chronic pancreatitis. 
Currently, there are no treatments that can prevent or reverse the progression of chronic 
pancreatitis and fibrosis, highlighting a critical need for improved understanding of disease 
pathology and identification of disease targets.  
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Studying the pathology of pancreatitis requires the development of model systems that 
can replicate disease onset and progression. The complex etiology of pancreatitis has made the 
development of model systems challenging. Our current mechanistic understanding of 
pancreatitis has been derived from in vitro studies, animal models, and limited experiments with 
tissue from pancreatitis patients (Gorelick & Lerch, 2017; Lerch & Gorelick, 2013). While each 
model can provide key benefits for studying pancreatitis, no single model captures all aspects of 
disease development, progression, and regeneration. Nevertheless, multiple animal models of 
both acute and chronic pancreatitis display a disease phenotype that resembles the human 
condition, allowing for study of the mechanistic regulation of the disease. 
One of the most common models of acute pancreatitis is the injection of 
supraphysiological levels of the drug caerulein, a peptide orthologue of cholecystokinin (CCK) 
(Lerch & Gorelick, 2013). CCK is a hormone that regulates the secretion of digestive enzyme 
from acinar cells (Smith & Solomon, 2014). Injection of caerulein at 10-100 times the 
physiological levels of CCK results in premature activation of pancreatic proteases that lead to 
autodigestion of the pancreas in rats and mice (Lampel & Kern, 1977; Niederau, Ferrell, & 
Grendell, 1985; Yamaguchi, Kimura, Mimura, & Nawata, 1989). The caerulein injections induce 
a phenotype that resembles acute pancreatitis, including edema, necrosis, and inflammation. 
Additionally, caerulein-injected pancreatat recover within a few days,  modeling the recovery of 
human patients from an acute attack. The caerulein model is relatively easy to perform and 
reproducible, and allows for the study of the intracellular mechanisms during disease 
progression, leading to its popularity as an acute pancreatitis model (Gorelick & Lerch, 2017). 
Additionally, this model can be combined with other methods, such as duct ligation (Sendler et 
al., 2015), or modified, such as performing repeated injections over multiple weeks, to induce 
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pancreatic fibrosis, resembling chronic pancreatitis (Neuschwander-Tetri et al., 2000). The 
induction of pancreatitis modeled by caerulein injections most closely resembles the induction 
caused by scorpion venom (Becerril, Marangoni, & Possani, 1997) or cholinergic toxins (Singh, 
Bhardwaj, Verma, Bhalla, & Gill, 2016), which does not represent the etiology for most 
pancreatitis patients. Additionally, disease progression differs between mice and rats, and the 
severity of disease depends on the strain of mice. Nevertheless, the caerulein model offers the 
advantages of reproducibility and ease of use for studying the cell biology of pancreatitis, and is 
thus the most popular model to date (Gorelick & Lerch, 2017; Su, Cuthbertson, & Christophi, 
2006). 
In contrast to the limited relevance of the caerulein-induced etiology, ethanol-induced 
pancreatitis aims to model the effects of alcohol, a major risk factor for pancreatitits, on the 
induction of the disease. However, treatment with ethanol alone has not produced pancreatitis in 
animals, and instead requires sensitization by co-treatment with CCK (Saluja & Bhagat, 2003) or 
the bacterial endotoxin lipopolysaccharide (LPS) (Vonlaufen et al., 2007). These models have 
been used to study the effects of ethanol metabolites on acinar cells and microcirculation during 
pancreatitis (Su et al., 2006). The model of ethanol-feeding with LPS stimulation is thought to be 
one of the most clinically relevant models, as patients with chronic alcoholism display increased 
serum levels of LPS (Urbaschek et al., 2001). The mechanisms by which LPS may contribute to 
acute pancreatitis development remain unclear, but LPS has been shown to evoke expression of 
inflammatory mediators in acinar cells, which was exacerbated by alcohol metabolites (H. Gu et 
al., 2013). Therefore, these combinatory models may help provide insight into the etiology of 
alcohol-associated acute pancreatitis.  
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Genetic mouse models of pancreatitis have also been developed based on discovery of 
human mutations that lead to the development of pancreatitis, termed hereditary pancreatitis 
(Aghdassi et al., 2011; Whitcomb et al., 1996). Individuals with mutations in the serine protease 
inhibitor Kazal type 1 (SPINK1), cystic fibrosis transmembrane conductance regulator (CFTR), 
chymotrypsinogen C (CTRC) and calcium-sensing receptor (CASR), are at increased risk for 
chronic pancreatitis (Keim et al., 2001).  Correspondingly, mutations in genes such as trypsin 4 
(Try4), serine protease inhibitor Kazal type 3 (Spink3), and Cftr in mice result in the 
development of various characteristics of pancreatitis, such as enhanced trypsin activity, 
inflammation, and acinar cell necrosis (Dimagno et al., 2005; Ohmuraya, Hirota, Araki, Baba, & 
Yamamura, 2006; Ohmuraya et al., 2005; Selig et al., 2006). While these models allow for the 
study of individual gene function in pancreatitis, the constitutive loss of these genes throughout 
the body may induce systemic and secondary effects that confound our understanding of the 
gene’s role within the pancreas. 
Another model of pancreatitis entails the administration of L-arginine (Arg) (Mizunuma, 
Kawamura, & Kishino, 1984), which induces acinar cell necrosis in a dose-dependent manner in 
rats. Lower, repeated doses of Arg can led to chronic pancreatitis in rats. The mechanism of 
action for Arg remain unclear, although it is hypothesized that the production of free radicals, 
Arg metabolites, and cytokines lead to disease development. The ability to regulate the severity 
of pancreatitis is an advantage of this model. However, Arg-induced pancreatitis in mice has 
been inconsistent with the findings in rats, and the relevance of this model to the development of 
pancreatitis in humans remains unknown (Su et al., 2006).  
Besides treatment with exogenous inducers, surgical procedures have also been used to 
model pancreatitis in animals. Ligation of the pancreatic duct, infusion of bile salts into the 
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pancreatic duct, perfusion of the pancreatic duct, and closing the duodenal loop have all been 
performed to model different aspects of pancreatitis (Su et al., 2006). These models most closely 
resemble the etiology of gallstone-induced pancreatitis. Many of these techniques require 
surgical expertise, have limited reproducibility, or show incomplete development of pancreatitis. 
The combination of multiple experimental models of pancreatitis, in vitro studies, and 
studies of human tissue have helped shed light on the underlying pathology of pancreatitis (Fig. 
27a). Acute pancreatitis is characterized by improper activation and secretion of acinar-produced 
digestive enzymes, protease-induced injury to cellular membranes, infiltration of immune cells, 
and activation of PSCs (Lankisch, Apte, & Banks, 2015). Identification of a mutation in the 
trypsinogen gene, which produces a degradation-resistant protease, in patients with hereditary 
pancreatitis, suggested that improper activation of digestive enzymes could cause pancreatitis 
(Whitcomb et al., 1996). Further studies demonstrated that dysfunctional lysosomes led to an 
imbalance of lysosomal hydrolases, cathepsins, resulting in a failure to degrade trypsin and an 
accumulation of trypsin in autophagic vacuoles within acinar cells (Gukovsky & Gukovskaya, 
2010; Gukovsky et al., 2012). The accumulation of trypsin activates digestive enzymes that can 
result in auto-digestive injury and improper release of active trypsin into the surrounding 
interstitial space (Gaisano et al., 2001; Lankisch et al., 2015). The injury wrought by the release 
of active trypsin stimulates an inflammatory response, with the infiltration of neutrophils, 
eosinophils, macrophages, and monocytes and secretion of multiple chemokines and cytokines 
(Manohar et al., 2017). These inflammatory signals can then activate PSCs, which themselves 
then secrete additional cytokines and chemokines. Ultimately, this cascade of events induces 
apoptosis and necrosis of the pancreatic parenchyma, which can result in additional damage to 
 111 
surrounding tissue, such as the vasculature (Barge & Lopera, 2012; Gukovskaya & Pandol, 
2004).  
Upon clearing of the initial insult, the pancreas recovers from the damage of an acute 
pancreatitis attack within days to weeks (Murtaugh & Keefe, 2015). Studies have sought to 
understand the cellular mechanisms underlying the reduction of the inflammatory response and 
regenerative capacity of the exocrine pancreas after injury. In addition to immune cell 
infiltration, PSC activation, and cellular death, tubular structures, also termed acinar-to-ductal 
metaplasia (ADM), are a hallmark of pancreatitis in both human tissue and mouse models 
(Bockman, Boydston, & Anderson, 1982; Ebert et al., 1999; Zang et al., 2015). These structures 
are thought to be a result of acinar cell dedifferentiation, marked by upregulation of 
developmental genes Pdx1 and Hes1 (Jensen et al., 2005; Miyamoto et al., 2003), and ductal 
genes, such as the transcription factor sex-determining region Y-Box 9 (Sox9), and intermediate 
filament cytokeratin19 (Krt19) (Morris, Cano, Sekine, Wang, & Hebrok, 2010; Zhong et al., 
2004; Zimmermann et al., 2002).  
Successful regeneration has been linked to the resolution of these ADM structures and 
the dampening of the inflammatory response (Fendrich et al., 2008; Figura, Morris, Wright, & 
Hebrok, 2014; Siveke et al., 2008). The resolution of ADM and subsequent regeneration of 
exocrine tissue could be due to the redifferentiation of dedifferentiated acinar cells (Murtaugh & 
Keefe, 2015). This model is supported by lineage tracing experiments demonstrating that the 
majority of newly regenerated acinar cells after injury are produced by pre-existing acinar cells 
rather than neogenesis from a stem cell source (Desai et al., 2007; Strobel et al., 2007). The 
differentiation of ADM structures has been proposed to be regulated by opposing actions of 
prodifferentation factors, such as Nr5a2, Notch1, and Smo, and factors involved in promoting 
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inflammation, acinar cell death, and acinar dedifferentiation, such as Nf-kB (Murtaugh & Keefe, 
2015)Liou:2013dm}. In this model, the balance between these factors dictates whether acute 
pancreatitis is resolved or progresses to chronic pancreatitis (Murtaugh & Keefe, 2015). 
  Chronic pancreatitis is a disease characterized by consistent, low-grade inflammation, 
and fibrosis of the pancreas. Similar to acute pancreatitis, the etiology of chronic pancreatitis is 
not well understood, with multiple risk factors and potential origins of the disease, including duct 
obstruction, genetic factors, or repeated episodes of acute attacks (Majumder & Chari, 2016). 
Regardless of the initial insult, the death of pancreatic exocrine cells results in deposition of 
extracellular matrix (ECM) in the interstitial spaces once occupied by these exocrine cells. This 
expanded fibrosis disrupts the morphology and structural integrity of the pancreas, preventing 
the function of both the exocrine and endocrine compartments. Therefore, individuals with 
chronic pancreatitis suffer from malnutrition due to the failure to secrete enzymes for food 
digestion and diabetes (Brock, 2013). 
The pathogenesis of both acute and chronic pancreatitis highlights the role of a variety of 
different cell types, including acinar, ductal, immune, and pancreatic stellate cells. While much 
emphasis has been placed on understanding the cascade of events within the acinar cell, the 
function of PSCs during disease progression and regeneration has also begun to receive attention. 
As their name implies, PSCs share many characteristics with hepatic stellate cells (HSCs), such 
as the star-shaped morphology (the original German name for HSCs was “sternzellen” or “star 
cells” (Kupffer, 1876)), and the presence of lipid droplets containing vitamin A (Apte, Pirola, & 
Wilson, 2012). These star-shaped, vitamin A storing PSCs are estimated to comprise 4-7% of 
pancreatic cell mass, and are localized at the base of the pancreatic acini as well as near blood 
vessels and pancreatic ducts (Apte et al., 1998; Bachem et al., 1998; Ikejiri, 1990; Watari, Hotta, 
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& Mabuchi, 1982). Transcriptional markers of quiescent PSCs include desmin (Des), vimentin 
(Vim), nestin (Nes), and glial fibrillar acidic protein (Gfap), although not all PSCs express all 
markers. For example, only 20-40% of cultured PSCs were shown to express Des (Bachem et al., 
1998). During homeostasis, PSCs function to maintain ECM turnover (Phillips et al., 2003), and 
facilitate acinar cells’ secretion of digestive enzymes in response to cholecystokinin (CCK) 
(Berna et al., 2010; Phillips et al., 2010).  
During injury, PSCs undergo multiple morphological, transcriptional, and functional 
changes, often referred to as an “activation” process. Upon activation, PSCs no longer contain 
vitamin A lipid droplets, and begin to express genes associated with “myofibroblasts” such as 
alpha smooth muscle actin (Acta2) and ECM proteins, including collagen I, II, and fibronectin 
(Fn1) (Apte et al., 1999; Omary, Lugea, Lowe, & Pandol, 2007). Activated PSCs also increase 
their expression of Nes, an intermediate filament expressed in neural stem cells (Lardon, 
Rooman, & Bouwens, 2002). Acta2 is most commonly used to mark activated PSCs, but this 
marker is also expressed in other cell types, including myofibroblasts, vascular smooth muscle 
cells, and pericytes (Erkan et al., 2011). The expression profiles and functions of these various 
cell types remains poorly defined during homeostasis and disease conditions. PSCs can be 
activated indirectly after injury through the secretion of cytokines from infiltrating immune cells 
(Apte et al., 1999; Mews et al., 2002; E. Schneider et al., 2001) or directly by the insult itself, 
such as alcohol metabolites or oxidative stress (Apte et al., 2000). In particular, transforming 
growth factor beta (Tgf-b), platelet-derived growth factor (Pdgf), and fibroblast growth factor 
(Fgf) ligands have been demonstrated to active PSCs (Apte et al., 1999; Luttenberger et al., 
2000; Satoh, Shimosegawa, Hirota, Koizumi, & Toyota, 1998). 
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Functionally, PSCs increase their proliferation (Mews et al., 2002; E. Schneider et al., 
2001), migration (McCarroll et al., 2004), and secretion of cytokine, chemokines, growth factors, 
and ECM proteins during activation (Andoh et al., 2000; Shek et al., 2002). Increased expression 
of DES was found in human tissue from chronic pancreatitis patients and in a rat model of 
chronic pancreatitis. The authors suggest that this could indicate increased replication of PSCs 
during disease in vivo (Haber et al., 1999), although another possibility is the appearance of a 
different disease-induced cell type that also expresses this protein. Evidence for both autocrine 
and paracrine effects of cytokine secretion have been documented, although most of this work 
has been in vitro. For example, treatment of PSCs with TGF-b1 was shown to regulate 
expression of matrix metalloproteinases (MMPs) and procollagen type 1 (Shek et al., 2002). 
Moreover, PSCs expressed Tgf-b1 and Tgf-b receptors, and inhibition of TGF-b1 in vitro led to 
decreased MMPs and procollagen type 1 expression, suggesting autocrine regulation of PSC 
behavior by TGF-b1(Shek et al., 2002). Another study found ethanol, acetaldehyde, IL-6 and 
TGF-b1 upregulated expression of MMPs and tissue inhibitor of metalloproteinases 2 (Timp2) in 
PSCs, suggesting a role for PSCs in ECM turnover and subsequent fibrosis (Phillips et al., 2003). 
With a lack of markers specific for PSCs, these findings have yet to be verified in vivo. 
Given the important contributions of PSCs to the development of fibrosis during injury, 
the cellular origin of these cells has become a major question in the field. Studies of the origin of 
hepatic stellate cells (HSCs), which share many morphological and transcriptional features with 
PSCs (Erkan et al., 2010), have provided clues for the potential origin of PSCs. Dual expression 
of mesenchymal markers, Des and Vim, and neuronal markers, Nes and Gfap, by HSCs 
suggested potential derivation from mesoderm or neural crest (Roskams, Cassiman, De Vos, & 
Libbrecht, 2004). Lineage tracing with the neural crest marker, Wnt1-Cre, did not support a 
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neural crest origin of HSCs (Cassiman, Barlow, Vander Borght, Libbrecht, & Pachnis, 2006). In 
contrast, lineage tracing with the MesP1-Cre line, which marks early mesoderm cells during 
gastrulation, supported a mesoderm origin of HSCs (Asahina et al., 2008; Saga et al., 1999). 
Whether PSCs are also derived from mesodermal tissues remains to be tested. 
Further studies have focused on the cell types within the mesoderm that give rise to HSCs 
in the liver and myofibroblasts during injury across multiple organs. As mesothelial layers have 
been demonstrated to give rise to mesenchymal cell types during organogenesis (see Chapter 4), 
studies have lineage traced these cells during adult liver homeostasis and disease. Utilizing the 
Wt1-CreER mouse line, Li and colleagues demonstrated that hepatic mesothelial cells underwent 
a mesothelial-to-mesenchymal transition (MMT), and contributed to HSCs and activated HSCs 
in two mouse models of liver fibrosis (Yuchang Li, Wang, & Asahina, 2013). Another study by 
the same group demonstrated that TGF-b signaling within hepatic mesothelial cells promoted 
their migration and differentiation towards an HSC fate (Yuchang Li, Lua, French, & Asahina, 
2016). Similar to the liver, the adult epicardium has been demonstrated to undergo MMT and 
give rise to fibroblasts, myofibroblasts, and vascular smooth muscle cells after myocardial 
infarction (Bin Zhou et al., 2011). These epicardial-derived cell types did not contribute to the 
myocardial cell types of the regenerating heart, but secreted factors that supported the 
regeneration process (Bin Zhou et al., 2011; González-Rosa, Peralta, & Mercader, 2012; J. 
Wang, Karra, Dickson, & Poss, 2013). Finally, studies of human mesothelial cells have provided 
evidence of peritoneal MMT during peritoneal dialysis both in vitro and by in vivo staining of 
human tissue (Yáñez-Mó et al., 2003). Therefore, mesothelial layers may retain their 
differentiation capacity during adult injury conditions to give rise to activated fibroblasts. 
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Studies of the pleural mesothelial layer have also supported a mesothelial origin of 
myofibroblasts during lung injury, although the timing of MMT is debated. Lineage tracing of 
adult pleural mesothelial cells with the Wt1-CreER mouse line showed their MMT, migration 
and differentiation into lung myofibroblasts after TGF-b1-induced injury (Karki et al., 2014). In 
contrast to an adult mesothelial origin, another study found only fetal pleural mesothelial cells 
contributed to myofibroblasts in two models of lung injury (Gise et al., 2016). The different 
conclusions of these studies may result from the short, 4 hour time window after injury examined 
by Karki et al. Von Gise et al. suggest that only the mesenchymal cells derived from fetal 
mesothelial cells make long-term contributions to the activated fibroblasts during injury. 
Therefore, whether adult or fetal mesothelial cells  are the main contributors to myofibroblasts 
may vary across organ systems. 
Evidence from these other organ systems suggest that the pancreatic mesothelium may 
act as a source of PSCs and activated PSCs during pancreatitis. The finding that epicardial-
derived cells secrete factors critical for heart regeneration (Bin Zhou et al., 2011; González-Rosa 
et al., 2012; J. Wang et al., 2013) supports a model of mesothelial-derived activated PSCs, which 
are known to be a source of multiple cytokines, chemokines, and growth factors upon activation 
in vitro. Experiments that lineage trace the adult pancreatic mesothelium can help elucidate the 
derivation of different mesenchymal cell types present during pancreatitis. 
The known importance of activated PSCs in pancreatitis warrants a better understanding 
of their heterogeneity, origin, and function. Similar to the mesenchymal compartment during 
development, very little is known about the heterogeneity of this compartment during adult 
homeostasis. While studies have attempted to differentiate PSCs from other mesenchymal cell 
types, such as fibroblasts, vascular smooth muscle, and pericytes, they have often relied on 
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broadly expressed, poor markers derived from in vitro experiments. It has been difficult to define 
sets of specific markers for each of these cell types in vivo. As different cell types may have 
distinct functions during homeostasis and injury, being able to non-ambiguously define these cell 
types is critical. Once the mesenchymal cell types are defined, the dynamics of these cellular 
populations during disease progression can then be assessed. For example, do new disease-
specific populations arise during pancreatitis? Are there shifts in proportions of cell types during 
different stages of disease progression and recovery? Are there transcriptional changes within 
homeostatic populations upon injury? (Fig. 27). Answers to these questions will uncover how the 
pancreatic mesenchyme changes during pancreatitis and offer new cell types and transcriptional 
targets to prevent or reverse the progression of disease. 
In this work, we utilize single-cell RNA-sequencing to profile the heterogeneity of the 
mesenchymal compartment during adult homeostasis and fibrotic disease. We first establish the 
caerulein model of acute pancreatitis in Swiss Webster mice and verify the induction of 
pancreatitis. Next, we optimize dissociation conditions for adult pancreata, and highlight 
multiple challenges that remain in deriving highly viable, representative single-cell suspensions 
from adult pancreata. Finally, we describe the transcriptional and cellular heterogeneity 
identified by single-cell RNA-sequencing of PBS- and caerulein-treated pancreata at three days 
post-injection, identifying multiple subtypes of mesenchymal and mesothelial populations. 
Shifting populations between PBS and caerulein pancreata reveal potential disease-driven 
transcriptional changes and biases in mesenchymal and mesothelial populations. This work 
begins to define individual mesenchymal cell types in the adult pancreas, and starts to unravel 
the changes induced by fibrosis within this compartment. 
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Results 
Caerulein-induced acute pancreatitis timecourse 
We first set out to establish the caerulein-induced mouse model of acute pancreatitis in our 
laboratory. We injected either 75 ug/kg caerulein or PBS once per hour for 8 hours on two 
consecutive days into the peritoneum of 6-8 week old Swiss Webster adult mice, as previously 
reported (Fukuda, Morris, & Hebrok, 2012; Jensen et al., 2005) (Fig. 28a). Pancreata were 
collected at 24 hr, 48 hr, 72 hr, and 5 days post-injection and stained with hematoxylin and eosin. 
In comparison to PBS injected controls, we found increased pancreatic edema, vacuolization, 
and ADM structures in caerulein injected animals, consistent with a pancreatitis phenotype (Fig. 
28b-c). This was verified by a blinded pathologist at UCSF. Edema was reduced by 48 hrs. post-
injection, and by 5 days post-injection caerulein treated animals displayed reduced vacuolization, 
edema and ADM structures, consistent with regeneration processes. These results demonstrate 
that caerulein injections are able to induce acute pancreatitis in Swiss Webster mice. 
 
Dissociation of adult pancreas  
 Building transcriptional profiles of individual cells requires the dissociation of tissues 
into single cells. The pancreas is an especially challenging organ to dissociate, due to the high 
levels of digestive enzymes produced by the exocrine compartment. Therefore, we tested 
multiple dissociation protocols and measured their yield of viable, single cells by fluorescence-
assisted cell sorting (FACS). Additionally, we measured the percentages of live cells expressing 
epithelial or mesenchymal cellular surface markers, CD326 (EPCAM) and CD140a (PDGFRA), 
respectively, to determine if the dissociation biased the proportions of these compartments. 
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 Prior studies have reported successful dissociation of adult pancreata with an enzymatic  
approach, using Collagenase P (Epshtein, Sakhneny, & Landsman, 2017; Russ et al., 2016).  
Therefore, we first titrated the concentration of Collagenase P in the dissociation of adult 
pancreas using a dissociation buffer comprised of Collagenase P at 0.2, 0.4, or 0.8 mg/mL, 1 
ng/mL DNase1 in PBS, 10% bovine serum albumin (BSA), and 0.2 mg/mL soybean trypsin 
inhibitor (STI) (Figure 29a). BSA is often used as a cellular nutrient and protectant during cell 
culture while STI inhibits the trypsin produced in large amounts by the exocrine compartment of 
the pancreas (Kurup & Bhonde, 2002). After dissociation, single-cells were stained with the 
live/dead dye sytox blue (which enters cells with damaged membranes), CD45 (a marker of 
immune cells), CD326 (an epithelial marker), and CD140a (a mesenchymal marker). We used 
FACS to determine the viability and ratio of epithelial and mesenchymal cells within the single-
cell suspensions. All three concentrations of Collagenase P resulted in similar percentages of live 
cells after dissociation, although the 0.4 mg/mL concentrated was slightly lower than either 0.2 
mg/mL or 0.8 mg/mL (Figure 29a). The percentage of CD45+ and CD140a+ cells was increased 
when dissociation was performed with 0.4 mg/mL, while the percentage of CD326+ cells 
remained consistent across all three concentrations (Figure 29a). Given the increase in CD45+ 
and CD140a+ cells with 0.4 mg/mL Collagenase P, we thought this concentration may better 
facilitate release of single cells from the tissue, with minor effects on cell viability. This result, 
combined with the use of 0.4 mg/mL Collagenase P in prior literature (Epshtein et al., 2017; 
Russ et al., 2016), led us to use 0.4 mg/mL Collagenase P in further downstream experiments.  
 We next tested the inclusion of BSA and STI in the dissociation buffer. Adult pancreata 
were dissociated in three different buffers: 1) 0.4 mg/mL Collagenase P and 1 ng/mL DNase1, 
which we will now term the base buffer, 2) the base buffer plus 0.2 mg/mL STI (Base + STI), or 
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3) the base buffer plus 0.2 mg/mL STI and 10% BSA (Base + STI + BSA) (Figure 29b). We 
found that addition of BSA led to a decrease in the percentage of live cells, from around 47-48% 
in the Base and Base + STI buffers to 19% in the Base + STI + BSA buffer (Figure 29b). 
Therefore, we excluded BSA from further experiments. Between the Base and Base + STI 
buffers, we found a similar percentage of CD140a+ cells and a small increase in CD326+ cells in 
the Base condition (Figure 29b). As STI has been shown to support acinar cell cultivation (Kurup 
& Bhonde, 2002), and lead to relatively similar results as the Base buffer alone, we decided to 
conduct future experiments using the Base + STI buffer. 
  Finally, we tested three dissociation times to optimize the viability and yield of resulting 
single-cell suspensions. We found that a 20 minute dissociation time led to increased viability as 
compared to 10 or 15 minutes and resulted in a 5-7% decrease in CD326+ cells but similar 
percentage of CD140a+ cells (Figure 29c). After dissociation, large pieces of still intact tissue 
were observed in the 10 and 15 minutes dissociation tubes, while these pieces were reduced in 
the 20 minute dissociation. Therefore, in order to avoid biases of dissociating only cells on the 
surface of the tissue we decided to continue with a 20 minute dissociation protocol for future 
experiments. In summary, these optimization experiments led us to dissociate adult pancreata 
with a buffer consisting of 0.4 mg/mL Collagenase P, 1 ng/mL DNase1, and 0.2 mg/mL STI for 
20 minutes for further experiments. 
 
Single-cell RNA-sequencing of adult PBS and caerulein treated pancreata 
 Although mesenchymal cells are critical in disease onset and progression, these cells 
have been challenging to study in vivo due to their poor definition and lack of specific markers. 
To overcome these challenges and begin cataloguing the mesenchymal cell types present during 
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homeostasis and disease, we performed single-cell RNA-sequencing on dissociated pancreata 
from PBS- and caerulein-injected animals utilizing the optimized conditions described above. 
We chose to analyze animals on day 3 after the injection with either PBS or caerulein. This 
timepoint is after a large infiltration of immune cells and death of a large portion of the exocrine 
compartment, but prior to the onset of regeneration (Jensen et al., 2005). Therefore, we 
hypothesized that the exocrine tissue may be primed for regeneration processes. Additionally, the 
mesenchymal compartment is expanded at 3 days post injection (Jensen et al., 2005), allowing 
for identification of heterogeneity of newly formed mesenchymal cells.  
FACS analysis of dissociated pancreata revealed biases in cell type proportions between 
PBS- and caerulein-treated pancreata (Figure 30). First, we found that the percentage of live cells 
varied between PBS- and caerulein-treated pancreata, as measured by the percentage of cells that 
were negative for both sytox blue and propidium iodide (PI) (Figure 30a). Dissociation of 
caerulein-treated pancreata resulted in 56.7% live cells, while PBS-treated single-cell 
suspensions contained only 21.5% live cells. We hypothesize that the digestive enzymes 
produced by acinar cells makes their dissociation particularly difficult, resulting in high amounts 
of cell death. Given that caerulein treatment induces acinar cell death at early stages (day 1) 
(Jensen et al., 2005), it’s possible the higher viability of caerulein-treated pancreata is due to the 
presence of fewer acinar cells during the dissociation and sorting.  
We next measured the percentage of immune cells, marked by CD45+, contained within 
the live fraction. Caerulein-treated pancreata contained more CD45+ cells (33.2%) than PBS-
treated controls (19%), consistent with the infiltration of immune cells during pancreatitis 
(Boggs et al., 2018; Lankisch et al., 2015) (Figure 30b). Within the CD45-negative fraction, we 
found increased representation of mesenchymal cells, marked by CD140a+, in caerulein-treated 
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pancreata (81.8%) compared to PBS-treated pancreata (47.6%) (Figure 30c). This is also 
consistent with increased proliferation of the mesenchymal compartment at this stage (Jensen et 
al., 2005). These experiments suggest a shift in cellular proportions between PBS- and caerulein-
treated pancreata. 
 We next sorted dissociated cells in preparation for single-cell RNA-sequencing. CD45+ 
and CD45-negative fractions of all live cells were sorted into two separate tubes. In order to 
enrich for epithelial and mesenchymal cell types, we combined the sorted tubes in a ratio 
consisting of 15% CD45+ and 85% CD45-negative cells for both the PBS and caerulein samples. 
We then loaded these cellular suspensions onto the 10X Chromium single-cell RNA-sequencing 
platform (10X Genomics) to build transcriptomic profiles of individual cells. Quality control, 
normalization, regression, and clustering led to identification of multiple distinct cellular 
populations in both PBS and caerulein samples (Fig. 31a-b). We first identified the major 
categories of cellular populations present within the samples by plotting the expression of key 
markers for each group: epithelial (Ecad), mesenchymal (Pdgfra), immune (Rac2), and vascular 
(Pecam1) (Fig. 31c-d). Within the PBS sample, we identified one epithelial population, five 
mesenchymal populations, two immune populations, and three endothelial populations. The 
remaining clusters were identified as mesothelial, based on expression of Msln, and proliferating 
cells, based on proliferation genes such as Top2a. One small cluster, named “Ambig” for 
“ambiguous” could not be annotated based on these broad markers (Fig. 31a, c, e). Within the 
Caerulein sample, we did not identify any epithelial populations. Pdgfra identified seven 
mesenchymal clusters, and Msln marked three mesothelial populations. We also found an 
immune, an endothelial, and a proliferating population. Finally, a small “ambiguous” population 
was identified (Fig. 31b, d, f ). 
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To further refine these categories of cell types, we looked for known markers of various 
epithelial and mesenchymal cell types. The PBS epithelial population expressed high levels of 
the ductal markers Spp1, Sox9, and lower levels of Krt19, consistent with a ductal cell identity 
(Fig. 31e). A small percentage of cells also expressed Cpa1, indicating that some acinar cells 
may also be present within this population (Fig. 31e). We did not find expression of any 
hormones expressed by islet cells (Fig. 31e). As we could not detect epithelial cells in the 
caerulein sample, we did not find appreciable levels of Spp1, Sox9, Cpa1, or any hormone (Fig. 
31f). We next probed broad mesenchymal markers, such as Vim, Col3a1, and Col1a1. These 
markers were expressed in all mesenchymal and mesothelial clusters, and immune populations in 
both PBS and caerulein samples (Fig. 31e-f).  Vim was expressed in ductal cells from the PBS 
sample as well, albeit at lower levels. Desmin, another common mesenchymal marker, was 
expressed at low levels in the mesenchymal population and in the PBS sample, and was most 
highly expressed in the third endothelial population (Fig. 31e-f). Mesothelial markers Wt1, 
Upk3b, and Krt19, were highly expressed in all mesothelial populations from both samples (Fig. 
31e-f). Finally, we found low-level expression of Acta2, a vascular smooth muscle and activated 
PSC marker, in the mesothelial populations of both the PBS and caerulein sample (Fig. 31e-f). 
The ambiguous population detected in both samples displayed a similar expression pattern across 
these known markers, with a mixture of ductal- and mesenchymal-type (Fig. 31e-f). Therefore, 
we identified expression of multiple known markers within the epithelial and mesenchymal 
compartments. 
To determine the transcriptional profiles that segregate the subgroups of mesenchymal 
and mesothelial cells, we subclustered the mesenchymal and mesothelial clusters and 
reperformed the analysis for both PBS and caerulein samples. The ambiguous populations were 
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included in both the PBS and caerulein samples, as these cells expressed both epithelial 
intermediate filaments (cytokeratins) and mesenchymal genes (Vim, Col1a1), reminiscent of 
mesothelial layers. In the PBS sample, reanalysis identified six mesenchymal and three 
mesothelial populations, based on expression of Pdgfra and Msln, respectively (Fig. 32a). We 
also found a population expressing both endothelial and mesenchymal markers, which is denoted 
M/Endo, and an ambiguous population with a similar expression pattern to the ambiguous 
population before subclustering (Fig. 32a, c). Two genes with known expression and functional 
roles in adult pancreata homeostasis and injury are Wt1 and Acta2 (Apte et al., 2012; Zang et al., 
2015). WT1 has been reported to be expressed in the adult pancreatic mesothelium and PSCs 
during homeostasis (Chau et al., 2011), while Acta2 is a marker of vascular smooth muscle cells 
and activated PSCs during injury (Apte et al., 2012). In the PBS-treated pancreas, Wt1 was 
highly expressed in the mesothelial, as well as in additional mesenchymal populations, most 
notably M5, matching prior reports (Fig. 32b). Acta2 was only sparsely expressed within the 
mesothelium, perhaps reflecting the homeostatic conditions of the PBS-treated animal and a 
failure to capture vascular smooth muscle cells in this approach (Fig. 32b). 
The ability to selectively study mesothelial cells separately from mesenchymal cells is 
critical for determining their lineage and function. Although numerous mesothelial markers have 
been identified in other organs, their expression patterns in adult pancreas have not been studied. 
Therefore, we grouped all mesenchymal populations and all mesothelial populations and 
determined the differentially-expressed genes between these two larger groups. We found 144 
genes that were more than 2-fold more highly expressed in mesothelial cells, and 172 in 
mesenchymal cells (Fig. 32c). Many known mesothelial markers, such as Upk3b, Gpm6a, Msln, 
Krt18, and Krt19 were identified as pancreatic mesothelial DE genes, consistent with literature in 
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other organs (Kanamori-Katayama et al., 2011; Mutsaers & Wilkosz, 2007; Rinkevich et al., 
2012; Rudat et al., 2014). We also identified markers for the non-mesothelial mesenchymal cells, 
including the known marker Pdgfra, and less well-described markers, such as lipoprotein lipase 
(Lpl) or lumican (Lum) (Fig. 32c). These genes specific to the mesothelium or mesenchyme can 
be used in tool development to further study the function and lineage of these cell types. 
Given the multiple populations of mesenchymal and mesothelial cells, we next assessed 
the transcriptomic signature of each population in contrast to all other populations within the 
subclustered dataset. The mesenchymal clusters, M1-M4, displayed overlapping signatures with 
varying expression levels of two groups of genes (Fig. 32d). M1 and M2 had high expression of 
the ECM-associated glycoproteins, Fbn1 and Mfap5 (Davis et al., 2016; Gibson, Finnis, 
Kumaratilake, & Cleary, 2016). M3 and M4 displayed differential expression of Serpine2, an 
ECM-associated serine protease that promotes the invasion of pancreatic cancer cells by 
remodeling the ECM (Buchholz et al., 2003), and Cxcl14, a chemokine upregulated in the stroma 
of tumors in multiple tissues, including the pancreas (Lu, Chatterjee, Schmid, Beck, & Gawaz, 
2016). The M5 and M6 populations displayed more distinct transcriptomic signatures, with M5 
defined by expression of the ECM-associated glycoprotein, Mfap4 (Pilecki et al., 2016), and 
Cxcl12, a chemokine involved in pancreatic cancer development and progression (Sleightholm et 
al., 2017) (Fig. 32d). While M6 expressed distinct genes, such as Cxcl13 and Gatm, this 
population also shared expression patterns within both the mesenchymal and mesothelial 
populations. For example, Cd74 and Csrp2 were expressed by both M6 and Meso1 while Gsn 
and Col3a1 were expressed by both M6 and M1-M5. M6 also displayed lower levels of 
mesothelial markers, Upk3b and Gpm6a, suggesting that this population may be a transitory state 
between mesothelial and mesenchymal identity.   
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The transcriptomic signatures were weak for the mesothelial populations, with all three 
groups expressing the top markers at varying levels (Fig. 31d). Therefore, we isolated the three 
mesothelial populations and reformed the clustering analysis, which resulted in 5 populations 
(Fig. 32e). One of these populations, cluster 5, was defined by differential expression of acinar 
cell genes, such as Cpa1, Ctrb1, and Try4 (Fig. 32f). Likely, this small cluster represents 
doublets consisting of mesothelial and acinar cells. Similarly, cluster 4 expressed many of the 
mesenchymal-specific gene identified in Fig. 32c, such as Lum, Dpep1, and Ddt, indicating that 
this may be a cluster of doublets of mesenchymal and mesothelial cells (Fig. 32f). However, 
these may also represent real populations that express both sets of markers. The remaining three 
larger populations expressed varying levels of mesothelial markers and distinct transcriptomic 
signatures (Fig. 32e-f). Cluster 1 expressed lower levels of Upk3b, Krt19, and Msln, but the 
highest levels of Wt1, and expressed multiple secreted factors, such as Enpp2, Igfbp3, and 
Igfbp2. This cluster also differentially-expressed Evt1, a transcription factor that regulates 
stromal expansion and metastasis in pancreatic cancer (Heeg et al., 2016). Cluster 2 expressed 
Tnsfrf11b, a secreted decoy TNF receptor that regulates beta cell insulin secretion during 
infection (Kuroda et al., 2016), and lipocalin, Lcn2, which encodes a secreted protein involved in 
the response to injury (Asimakopoulou, Weiskirchen, & Weiskirchen, 2016) (Fig. 32f). Finally, 
cluster 3 was defined by the secreted factor, Sfrp1, an inhibitor of WNT signaling (Jayewickreme 
& Shivdasani, 2015), and the laminin alpha5 receptor, Bcam (Moulson, Li, & Miner, 2001) (Fig. 
32f). These gene expression profiles suggest multiple subtypes of mesothelial cells with 
potentially distinct function roles in regulating cellular processes.  
 Having catalogued the mesenchymal and mesothelial populations in the PBS-treated 
pancreata, we next turned our attention to the caerulein-treated pancreata. We first subclustered 
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the mesenchymal and mesothelial populations (M1-M7, Meso1-Meso3, and Ambig). Pdgfra 
expression identified six mesenchymal populations while Msln marked two mesothelial 
populations (Fig. 33a-b). We found wide-spread expression of the Wt1 gene in the mesenchymal 
and mesothelial populations, in contrast to the more restricted expression pattern in the PBS 
sample (compare Fig. 32a-b with Fig. 33a-b). Although we also expected to see increased 
expression of Acta2 in the caerulein-treated pancreata, we found only sparse expression (Fig. 
33b). The near absence of Acta2 in the dataset could indicate either a failure to capture Acta2+ 
cells or that the transcript is expressed at too low of a level to be captured by the shallow 
transcriptomic coverage of droplet-based approaches. In addition to the large groups of 
mesenchymal and mesothelial populations, we identified one population that expressed both 
Pdgfra and Msln, and therefore, was labeled M/Meso. We also identified two small “ambiguous” 
populations, which did not express either Pdgfra or Msln, but instead displayed distinct 
transcriptomic signatures (Fig. 33c). Expression of both ductal and acinar cell markers, Spp1 and 
Ctrb1, in ambiguous 1 likely indicates a doublet identity for this population. Numerous 
cytokeratins (Krt12, Krt15) and low levels of mesenchymal and mesothelial markers could 
indicate a rare population with all these features, or a small group of mixed doublets. 
 Similar to the PBS sample, the mesenchymal groups in the caerulein sample displayed 
overlapping, but distinct transcriptomic signatures. These groups expressed secreted factors and 
ECM-related proteins that had been identified in the PBS mesenchymal populations, including 
Mfap4, Fbn1, Serpine2, Cxcl12, and Cxcl13. Similar to the PBS populations, we found one 
mesenchymal population, M6, that was closer transcriptionally to the mesothelial populations, 
with a low expression of mesothelial markers (Fig. 33c). The M/Meso population also displayed 
shared mesenchymal and mesothelial characteristics, but in contrast to M6, did not have an 
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additional distinct signature. This could indicate that M/Meso is a doublet population of 
mesenchymal and mesothelial cells, rather than a population of cells with characteristics of both 
cell types. The two mesothelial populations displayed weaker distinct signatures, but differed in 
expression of genes such as Igfbp3, Msln, and Slpi (Fig. 33c). These results suggest an overall 
similar transcriptomic similarity to the PBS sample, but indicates an expansion of Wt1 
expression in the caerulein sample. 
To more directly compare the PBS and caerulein populations, we correlated each cluster 
from the caerulein sample to all the PBS clusters. We found that caerulein clusters M1-M5 
correlate most highly with PBS clusters M1, M2, and M5 (Fig. 33d). Specifically, caerulein 
cluster M4 matched PBS cluster M1, while the M5 clusters from each sample correlated most 
highly. Additionally, the M6 populations from both groups not only correlated most highly to 
each other, but clustered with the mesothelial populations, highlighting their expression of 
mesothelial genes. Two PBS mesenchymal clusters, M3 and M4, did not correlate as highly with 
any caerulein mesenchymal cluster, suggesting perhaps an absence of this particular 
mesenchymal subtype during pancreatitis. The two caerulein mesothelial populations correlated 
most highly with the PBS mesothelial populations, as expected. These results suggest that 
multiple mesenchymal populations in both caerulein (M1-M3) and PBS (M3-M4) samples may 
possess distinct features that do not match in the other sample, resulting in their lower 
correlation. 
As subclustering analysis of the PBS sample resulted in increased resolution of 
mesothelial populations, we next performed the same subclustering on the two identified 
caerulein mesothelial populations. We identified 6 populations and genes that define these 
populations (Fig. 33e, g). Comparisons to the PBS mesothelial populations (Fig. 32e) showed 
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correlation of 5 out of 6 populations to one or more PBS mesothelial populations (Fig. 33f). 
Cluster 6, which did not correlate well, was a small cluster that also expressed mesenchymal 
markers, suggesting that this population may be a small group of mesothelial and mesenchymal 
doublets. Caerulein mesothelial clusters 1 and 2 correlated mostly highly to PBS mesothelial 
cluster 1, while cluster 5 correlated well with PBS mesothelial clusters 2 and 3. Caerulein 
clusters 3 and 4 appeared to be the most distinct mesothelial clusters in comparison to PBS 
mesothelial cells, although these populations still had a spearman correlation coefficient > 0.85. 
Therefore, we find highly similar transcriptional profiles of mesothelial populations between the 
PBS- and caerulein-treated pancreata. 
Although correlation analysis can help uncover major differences between datasets, more 
subtle differences, such as in levels of gene expression within similar populations, require more 
sophisticated analyses. One method of analyzing changes between two datasets is to combine the 
cells into one large dataset that can undergo similar normalization, scaling, and regression 
processes (see Chapter 2 and Chapter 3). Therefore, we combined the PBS and caerulein 
datasets, and utilized two methods of batch correction in order to account for overall technical 
differences between the two datasets. First, we tried linear regression, which was successful in 
our developmental dataset to correct for batch effects (see Chapter 2 and Chapter 3), but found 
very little overlap between PBS and caerulein populations (Fig. 34a). As we had already 
determined that similar populations existed in these datasets (Fig. 31, 32, 33), it was likely this 
separation was due to batch effects. Therefore, we utilized canonical correlation analysis (CCA) 
to merge the two datasets (Fig. 34b-c). We found more overlap between the PBS and caerulein 
samples, although cells from either PBS or caerulein samples aggregated together within 
clusters. Based on the differential gene expression analysis of known markers described above, 
 130 
we identified a ductal, six mesenchymal (M1-M6), two mesothelial (Meso1, Meso2), a mixed 
mesenchymal and mesothelial (M/Meso), two endothelial (Endo 1, Endo 2), two immune (Imm 
1, Imm 2), a proliferating population, and an ambiguous population similar to that described 
before (Fig. 34c-d).  To understand whether similar populations exist during homeostasis and 
pancreatitis, but change in frequency, we calculated the percentage of each population within 
each of the PBS and caerulein samples (Fig. 34e-f).  Within the mesenchymal populations, there 
was a decrease in the frequency of the M1 population and concomitant increase in the M2 
population under caerulein treatment (Fig. 34e). The mesothelial populations displayed a slight 
increase in the M/Meso population and decrease of Meso2 in the caerulein sample (Fig. 34f). 
These shifts suggest that caerulein treatment may favor specific subtypes of mesenchymal or 
mesothelial populations. 
 
Discussion 
 While the mesenchyme is critical for the development, progression, and recovery from 
fibrotic diseases in multiple adult organs, the cellular populations within this compartment and 
their functions in the adult pancreas remain relatively unknown. There is already evidence for 
pancreatic mesenchymal heterogeneity during both homeostasis and disease states. For example, 
Acta2 marks a subset of mesenchymal cells during pancreatitis, the activated PSCs, which are 
critical for turnover of ECM during disease states (Apte et al., 2012). However, it is unclear if all 
PSCs become activated and express Acta2, or only a subset, and whether Acta2-negative PSCs 
also contribute to disease progression. Additionally, knockout of Wt1, a gene expressed in the 
adult pancreatic mesothelium and a subset of PSCs during homeostasis, results in severe atrophy 
of the exocrine pancreas (Chau et al., 2011). Whether this phenotype is due to the loss of this 
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gene in the mesothelium and/or PSCs or in other tissues throughout the body remains unknown. 
Additionally, whether Wt1+ PSCs are functionally distinct from Wt1- PSCs has not been 
determined. An improved understanding of adult mesenchymal heterogeneity would allow for 
the study of cellular interactions and functions that contribute to disease progression.  
 In order to build a catalogue of mesenchymal subtypes, we utilized single-cell RNA-
sequencing on dissociated whole adult pancreata after treatment with caerulein, a pancreatitis-
inducing chemical, or PBS control. A major challenge in executing this technique is the 
dissociation of adult pancreas, a tissue with high production of digestive enzymes. Although we 
optimized multiple conditions of the dissociation, we were still unable to achieve cell-type 
proportions representative of an adult pancreas. While the pancreas is largely composed of 
epithelial exocrine cells, with only 4-7% of the total cellular mass composed of PSCs, our FACS 
analysis showed relatively low percentages (< 30%) of epithelial cells, and much higher 
percentages of mesenchymal cells (ranging from 10% - 50% depending on conditions). The 
results from our single-cell RNA-sequencing show even smaller percentages. Indeed, we were 
only able to capture a small ductal cluster in the PBS sample, while the majority of cells were 
mesenchymal and mesothelial. We hypothesize that this is due to the large amounts of epithelial, 
especially exocrine, cell death upon dissociation of the pancreas. Such a large degree of cell 
death not only results in loss of those particular cells, but likely affects the surrounding, 
surviving cells within the single-cell suspension. Therefore, these datasets must be interpreted 
with caution, and the gene expression profiles validated in vivo before making definitive 
conclusions. 
 Improvements in the protocol for dissociation of adult pancreata would be beneficial for 
the unbiased study of adult cellular heterogeneity. One of the key steps we introduced in our 
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protocol was the lysis of red blood cells (RBCs). The large number of RBCs required a removal 
step to enrich for all other cell types within the pancreas (data not shown). We utilized a common 
RBC lysis buffer that should selectively disrupt RBCs based on the osmolality of the solution. 
However, the specificity of this approach was not verified in our hands, and this lysis step may 
have 1) resulted in non-specific lysis of pancreatic cells or 2) caused indirect effects due to the 
creation of a large amount of cellular debris. We have now tested bead-based approaches, rather 
than lysis, for the removal of RBCs in late stage embryonic pancreata that have resulted in the 
removal of RBCs without major shifts in the pancreatic cellular proportions (data not shown). A 
similar approach could be taken for adult pancreata, in order to minimize  the damage during the 
dissociation and improve the resulting cell type proportions. 
 Another alternative approach would be to perform single-cell RNA-sequencing on 
cellular nuclei, rather than live, intact cells. This methodology would not require maintaining 
digestive enzyme-producing acinar cells through a dissociation, FACS, and single-cell capture, 
which can take multiple hours. Instead, in nuclei sequencing, the cellular membranes are 
disrupted, the nuclei isolated and then loaded for single-cell capture. Therefore, nuclei single-cell 
RNA-sequencing could solve the problem of the high production of digestive enzymes either 
secreted by live acinar cells or released from dying acinar cells during dissociation, and 
potentially improve the quality of the resulting datasets. 
 Besides dissociation, this work highlighted the challenges of merging two independent 
datasets to identify differences between conditions. The separation of real biological differences 
from variation due to technical aspects of the methodology remains a major challenge for the 
entire field of single-cell RNA-sequencing (Yuan et al., 2017). Many batch correction methods, 
including linear regression, were developed for bulk sequencing approaches, and may not be 
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appropriate for single-cell datasets. Batch correction methods for single-cell datasets have 
recently been developed (Buettner et al., 2015; A. Butler et al., 2018), including the canonical 
correlation analysis (CCA) utilized in this study, but these methodologies are still actively being 
tested and an agreed upon gold standard has yet to be decided.  
In our work, we found that the CCA batch correction methodology produced better 
overlap between the PBS and caerulein batches than linear regression. However, there were still 
groupings of batches within the larger mixed clusters, what is sometimes termed a “shadowing” 
effect. The segregation of cells from each sample in this approach may reflect true biological 
differences between the PBS and caerulein control. Indeed, histology and staining have 
demonstrated remarkable differences in pancreatic tissue in vivo. However, this shadowing may 
also be due to unresolved batch effects. The difficulty, therefore, is in determining where the line 
between true differences and technical differences lies, and likely, these differences will be 
intertwined. One way to combat this would be to include another biological replicate to measure 
the effectiveness of the batch correction method. In this case, one can expect complete overlap of 
the biological replicates, and the overlap of the sample representing another condition can 
distinguish true biological commonalities and differences. This approach worked well in our 
developmental datasets (Chapter 2 and Chapter 3) and could be applied to the adult pancreas as 
well. Another option is to multiplex samples in order to pool all cells for single-cell RNA-
sequencing capture and library preparation, which would reduce batch effects associated with the 
single-cell methodology (McGinnis et al., 2018). The improvement of this key aspect of data 
analysis will help facilitate more robust downstream analyses, such as clustering and differential 
gene expression analysis. 
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Although these challenges exist for our current datasets, we were still able to find 
evidence of cellular and transcriptional heterogeneity in the adult pancreas. First, we found 
distinct transcriptomic signatures that segregated all mesothelial populations from all 
mesenchymal cell types. Identification of genes that can specifically mark the mesothelium will 
be critical for future lineage tracing and functional studies. This is especially important for the 
pancreas, where the marker most commonly used to study adult mesothelial layers, Wt1, is 
known to also be expressed in PSCs (Chau et al., 2011), and there have not been studies to 
demonstrate specific expression of other mesothelial markers. We verified specific expression of 
genes such as Upk3b, Krt18, Krt19, Msln, Nkain4, and Gpm6a in the adult pancreatic 
mesothelium, many of which have been described in other mesothelial layers (Kanamori-
Katayama et al., 2011; Yuchang Li et al., 2013). Therefore, the development of tools utilizing 
these gene promoters could facilitate studies of the mesothelium in multiple tissues.   
Within both the mesothelial and mesenchymal groups, we identified multiple 
subpopulations. These populations were segregated by differential expression of a variety of 
secreted factors and ECM-proteins, which implies that these cell types may also have functional 
differences. Given the difficultly of dissociation of the adult pancreas and the potential for gene 
expression patterns to be altered during this process, it is critical that the expression of these 
genes be verified in vivo. Indeed, there are reports of dissociation-induced gene expression 
changes in other systems that can influence single-cell RNA-sequencing results (van den Brink 
et al., 2017). The isolation and culture of PSCs in vitro, for example, is known to cause their 
activation and expression of Acta2 (Apte et al., 1998; Bachem et al., 1998). Validation by 
immunostaining or in situ hybridization will clarify the influence of dissociation effects on these 
gene expression patterns. 
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With the transcriptional and cellular heterogeneity now catalogued in each of the 
homeostatic and diseased samples, we can now focus on understanding the transcriptional and 
cellular differences between PBS- and caerulein-treated pancreata. There may be multiple routes 
for obtaining disease-specific gene expression profiles, including the appearance of new disease-
specific populations, disappearance of homeostatic populations, or shifts in transcription within a 
homeostatic population (Fig. 27). Upon treatment with caerulein, we noticed multiple shifts in 
both transcription and cellular populations. The expression of Wt1, for instance, was expanded in 
the caerulein treated animals. Wt1 has been shown to be important for maintaining homeostasis 
of multiple organs, facilitating EMT processes during development, and regulating transcription 
either as a transcription factor or through the modulation of chromatin (Hastie, 2017), suggesting 
that the upregulation of this gene during pancreatitis may be functionally relevant. 
Understanding the gene expression pattern of Wt1 throughout pancreatitis development, 
progression and recovery will help determine its potential functional role. For example, is Wt1 
expression maintained throughout the recovery process or downregulated once the initial injury 
is cleared? The timing of Wt1 expression may be particularly relevant given that Wt1 regulates 
chromatin switching mechanisms depending on the cellular context (Essafi et al., 2011). The 
latter study demonstrated that Wt1 acts as a repressor of the Wnt4a locus in epicardial cells, but 
activates the same locus in kidney cells, suggesting that Wt1 function can change depending on 
the cellular context.  Therefore, Wt1 may play multiple roles in pancreatic mesothelial and 
mesenchymal cells, and these roles may be dynamic throughout the disease process. Targeted 
transcriptional profiling of Wt1+ populations during disease progression will help identify 
potential downstream functional targets of Wt1. Additionally, future experiments should 
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manipulate Wt1 expression in specific populations at key points during disease progression in 
order to understand the potential various functions of this gene.  
In addition to the transcriptional upregulation of Wt1, we also noticed shifting 
proportions of mesenchymal and mesothelial clusters in the caerulein sample. While the PBS 
sample contained near equal proportions of the M1 and M2 populations, this proportion was 
skewed in the caerulein sample, with the M2 population being the dominant contributor. The M2 
population differentially-expressed the WNT inhibitor, Sfrp4, which is upregulated in mouse 
models of systemic sclerosis (Ssc), and in tissue from Ssc patients (Bayle et al., 2008), and has 
been demonstrated to reduce fibrosis after ischemia in the heart (Matsushima et al., 2010) or 
renal injury (Surendran, 2005). The M2 population also expressed higher levels of the ECM-
glycoproteins Mfap5 and Mfap4. Mfap5 has been shown to increase the stability of procollagen1 
in vitro (R. Lemaire, Korn, Shipley, & Lafyatis, 2005) and Mfap4 was identified as a biomarker 
for hepatic fibrosis (Bracht et al., 2016). This gene expression profile suggests the M2 population 
may be functioning as a caerulein-induced fibrosis-regulating population during pancreatitis.   
In addition to the M2 population, the caerulein sample also contained a higher proportion 
of the M/Meso population. This population shared gene expression patterns of both mesothelial 
and mesenchymal cells, suggestive of an intermediate cell type or an intermediate cell state 
during the differentiation of a mesothelial cell towards a mesenchymal cell fate. This increase in 
M/Meso was concomitant with the decrease in the Meso1 population. The Meso1 population 
expressed the mesothelial markers found in the Meso2 population as well as additional 
mesothelial markers, such as Krt19 and Msln, at higher levels than Meso2. Therefore, Meso1 
may represent a more mature or stable mesothelial population, while Meso2 and M/MEso are 
more plastic or closer transcriptionally to a mesenchymal phenotype.  In this model, caerulein 
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treatment could shift mesothelial cells towards a more plastic state, perhaps to facilitate a MMT 
process and contribute to mesenchymal cell types. Pseudotime ordering methods can be used to 
test these hypotheses in silico. The current challenge to this approach is the input of CCA batch 
corrected data, which is not supported by most pseudotime ordering algorithms, but will likely be 
incorporated soon. In vivo lineage tracing of the M1, M2, and M/Meso populations can also 
directly test this model but will require building additional genetic tools to specifically trace 
these cells. Nevertheless, our findings highlight multiple potential caerulein-shifted populations 
that may be functionally relevant for pancreatitis progression.   
Our current datasets provide a resource for heterogeneity during a specific timepoint of 
caerulein-induced disease. Additional timepoints during caerulein treatment would allow for 
more robust detection of gene expression and cellular population shifts during disease. Earlier 
timepoints may help clarify the populations involved in immune cell recruitment, and the 
activation process of PSCs while later timepoints could target cell types involved in the recovery 
and regeneration process. Understanding how the acute injury is resolved would be especially 
informative for chronic pancreatitis, which may be a result from the failure of the pancreas to 
regenerate (Murtaugh & Keefe, 2015). Applying the approaches taken in this chapter to other 
models of pancreatitis, including those for chronic pancreatitis, will also shed light on key 
processes driving disease onset and progression. This current dataset provides a starting resource 
to add and compare additional timepoints and model systems.  
 138 
 
Figure 27. Acute pancreatitis model and potential alterations in cellular and transcriptional 
heterogeneity. a) Model of acute pancreatitis. Upon exposure to stress or an initiating event, the 
pancreas is characterized by acinar cell death, infiltration of immune cells, and activation of 
resident stellate cells. Activated stellate cells produce and secrete extracellular matrix 
components as part of the wound healing process. Over a few days to one week, the undergoes 
repair and regeneration to result in a histologically normal pancreas. b) Potential cellular shifts 
during disease progression and recovery. There may be expansion (purple population) or 
reduction (green population) of cellular populations present during homeostasis or establishment 
of disease-specific populations (blue population). c) Potential transcriptional shifts during 
disease progression and recovery. Genes may be upregulated during acute injury (blue line), 
disease onset (red line) or disease resolution (purple line). 
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Figure 28. Caerulein injections result in acute pancreatitis in mice. a) Caerulein injection 
scheme. Mice were injected with 75 ug/kg caerulein or PBS once per hour for 8 hours on two 
consecutive days. Pancreata were collected at 24 hr, 48 hr, 72, hr, and 5 days post injections. (b-
c) Hematoxylin and eosin (H&E) staining on pancreata from PBS injected (a) or caerulein 
injected (c) animals. Scale bars represent 200 um. 
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Figure 29. Optimization of adult pancreatic dissociation. a) FACS plots displaying CD140a 
and CD326 expression after dissociation of adult pancreata with varying concentrations of 
Collagenase P. b) FACS plots displaying CD140a and CD326 expression after dissociation of 
adult pancreata with the base dissociation buffer, 0.4 mg/mL Collagenase P and 1 ng/mL 
DNase1 (Base), the base buffer with 0.2 mg/mL soybean trypsin inhibitor (Base + STI), or the 
base buffer with 0.2 mg/mL soybean trypsin inhibitor and 10% bovine serum albumin (Base + 
STI + BSA). c) FACS plots displaying live/dead staining by both sytox blue and propidium 
iodide staining after dissociation for 10, 15, or 20 minutes with the base buffer with 0.2 mg/mL 
soybean trypsin inhibitor. (a-c) Percentages of live, CD326+, and CD140a+ of parent population 
for each condition (rightmost panel). Checkboxes represent conditions used in future 
experiments. 
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Figure 30. Dissociation of pancreata from PBS and caerulein injected animals. (a-c) FACS 
plots comparing (a) sytox blue and propidium iodide, (b) CD45, and (c) CD140a markers 
between dissociated pancreata from PBS (left panels) and caerulein (right panels) injected 
animals. Blue dots represent results from tube 1 of dissociated cells and red dots represent results 
from tube 2 of dissociated cells for each treatment. Percentages of each cell type are noted. In 
(c), cells are derived from the CD45-negative compartment in (b). 
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Fig. 31. Single-cell RNA-sequencing of adult pancreata from PBS- and caerulein-treated 
animals. (n=4 pooled pancreata from individual mice for each sample)(a-b) t-SNE representation 
 143 
of cells from (a) PBS or (b) caerulein samples. (c-d) Expression of markers denoting major 
cellular categories in (c) PBS or (d) caerulein samples. Color indicates level of expression. (e-f) 
Expression of known markers of epithelial and mesenchymal subtypes. Size of the dot represents 
proportion of the population that expresses each specified marker. Color indicates level of 
expression. Mesen. = mesenchymal. Meso = mesothelial. VSM = vascular smooth muscle. 
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Figure 32. Mesenchymal and mesothelial heterogeneity during adult homeostasis. a) t-SNE 
representation of reclustered mesenchymal, mesothelial, and ambigious populations from Fig. 
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30a. b) Expression of known mesenchymal (Pdgfra) and mesothelial (Msln) markers, and 
markers known to be important in the mesenchyme during pancreatic homeostasis or injury, 
(Wt1, Acta2). Color indicates level of expression. c) Comparison of grouped mesenchymal (M1-
M6) and mesothelial (Meso1-Meso3) populations. Green and red dots represent genes that are 
greater than 2-fold differentially-expressed and have an adjusted pvalue < 0.05. Lighter shades of 
green and red dots highlight top differentially-expressed genes. d) Expression of top 
differentially-expressed genes for each cluster. e) t-SNE representation of reclustered mesothelial 
populations from (a) (Meso1-Meso3). f) Expression of differentially-expressed genes in 
mesothelial populations. Bars are colored to match cluster identity in (e). Black bar indicates 
known mesothelial markers. (d, f) Size of the dot represents proportion of the population that 
expresses each specified marker. Color indicates level of expression. 
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Figure 33. Mesenchymal and mesothelial heterogeneity during pancreatitis. a) t-SNE 
representation of reclustered mesenchymal, mesothelial, and ambiguous populations from Fig. 
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30b. b) Expression of known mesenchymal (Pdgfra) and mesothelial (Msln) markers, and 
markers known to be important in the mesenchyme during pancreatic homeostasis or injury, 
(Wt1, Acta2). Color indicates level of expression. c) Expression of top differentially-expressed 
genes for each cluster. d) Correlation of caerulein clusters from (a) with PBS clusters from Fig. 
31a. Color indicates spearman correlation value. e) t-SNE representation of reclustered 
mesothelial populations from (a) (Meso1-Meso2). f) Correlation of caerulein clusters from (e) 
with PBS clusters from Fig. 31e. Color indicates spearman correlation value. g) Expression of 
differentially-expressed genes in mesothelial populations. Bars are colored to match cluster 
identity in (e). Black bar indicates known mesothelial markers. (c, g) Size of the dot represents 
proportion of the population that expresses each specified marker. Color indicates level of 
expression. 
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Figure 34. Merging PBS and caerulein single-cell RNA-sequencing datasets. a-b) t-SNE 
visualization of PBS and caerulein merged dataset with batch corrected by a) linear regression or 
b) canonical correlation analysis (CCA). Colors represent dataset cells are originally derived 
from before merging. c) t-SNE visualization of CCA merged dataset colored by cluster ID. 
t-SNE matches (b). d) Expression of top differentially-expressed genes in clusters shown in (c). 
Size of the dot represents proportion of the population that expresses each specified marker. 
Color indicates level of expression. e-f) Proportion of each (e) mesenchymal or (f) mesothelial 
merged cluster within the PBS and caerulein sample.  
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Chapter 6 
Conclusions and Future Directions 
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In this work, we have identified novel transcriptional and cellular heterogeneity in both 
the epithelial and mesenchymal compartment of the pancreas during development, adult 
homeostasis, and adult fibrotic disease. The identification of a novel epithelial progenitor cell 
population and division of the mesenchyme into distinct subtypes in our developmental studies 
(Chapter 2, 3, and 4) impacts our understanding of endocrine differentiation, the development of 
the pancreatic mesenchyme, and the epithelial-mesenchymal interactions that guide pancreatic 
organogenesis.  In Chapter 5, we provide critical first steps toward defining, cataloguing, and 
comparing the pancreatic mesenchymal cell types in adult homeostasis and disease. These 
findings facilitate future studies that aim to understand the cellular mechanisms regulating 
disease progression and regeneration and identify novel targets for potential therapies. Overall, 
the combination of single-cell RNA-sequencing technology with in vivo immunohistochemistry, 
in situ hybridization, and lineage tracing offers a powerful approach for the study of 
heterogeneity in the cell types that comprise different organs. 
 
The relevance of mouse models to human pancreatic development 
Much of the progress in the study of pancreatic biology has been through the use of 
mouse model systems. While these models offer many advantages, there are known species 
differences that can hinder the translation of findings in mouse models to human therapies. 
Studies have identified key differences during human and mouse pancreatic development (Nair 
& Hebrok, 2015). One major difference in human and mouse endocrine development is the 
expression pattern of Neurogenein3 (Ngn3). In mice, Ngn3 is expressed in two waves, with one 
early wave peaking at E10-E10.5, and a second later wave occurring after E12.5 (Villasenor et 
al., 2008). This expression pattern of Ngn3 correlates with the two waves of endocrine 
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differentiation (Pictet, Clark, Williams, & Rutter, 1972). The majority of endocrine cells 
produced in the first wave of differentiation, from E9.5 – E12.5, are glucagon+ cells, with a 
smaller proportion of polyhormonal cells, which express insulin and an additional hormone 
(glucagon, pancreatic polypeptide, or peptide YY) (Herrera et al., 1991; Upchurch, Aponte, & 
Leiter, 1994). The second wave of differentiation, from E12.5 to E14.5, produces all the single-
hormone endocrine cell types of adult islet. In contrast, during human development NGN3 is 
expressed in a single wave during human pancreatic development, beginning at 8 week post 
conception (wpc) and peaking at 10-12 wpc (Salisbury et al., 2014). Also in contrast to findings 
in mice, beta cells are the earliest produced endocrine cell type in humans, rather than alpha 
cells, and there is an increased proportion of polyhormonal cells (20-30%) during human 
development (Jeon, Correa-Medina, Ricordi, Edlund, & Diez, 2009; K. A. Johansson et al., 
2007; Piper et al., 2004). Finally, differences have been noted for key transcription factors, such 
as Nkx2-2, which marks pancreatic progenitor cells prior to Ngn3 expression and endocrine 
commitment in mice, but is only present after NGN3 expression in humans (Jennings et al., 
2013). These studies suggest that there may be different mechanisms regulating differentiation of 
human endocrine progenitors to the various endocrine cell types of the mature pancreas. 
The Fev+ endocrine progenitors identified in our mouse work were also detected in 
human fetal pancreata at 23 wpc, and in endocrine progenitor stage hESC-derived beta cells in 
vitro. As 23 wpc corresponds to a post-natal timepoint in mouse development (Nair & Hebrok, 
2015), determining the presence of a FEV+ population throughout human pancreatic 
development can give insights into whether all humane endocrine populations are derived from a 
FEV+ progenitor. Additionally, co-expression analysis of FEV and genes that we identified as 
potentially promoting an alpha or beta cell fate in mice, PEG10 and GNG12, should also be 
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analyzed in human tissue. Are FEV+ cells present during the differentiation of the first beta cells 
at 7 wpc in humans, and if so, is GNG12 expressed in these FEV+ cells? Shortly after, when 
alpha cells first appear, is PEG10 upregulated within a subset of FEV+ cells? Answers to these 
questions can provide evidence for the potential function of FEV+ cells during human endocrine 
differentiation. 
Although lineage tracing experiments are not possible in fixed human tissue from 
embryos, the in vitro stem cell differentiations offer a platform for more direct lineage tracing of 
FEV+ cells during human endocrine differentiation. Combining a FEV+ lineage trace with 
knockdown or knockout of PEG10 or GNG12 will determine the function of these genes on cell 
fate decisions in the FEV+ population. Integration of a Fev-Cre into hESCs can trace Fev+ cells 
during a variety of differentiation conditions, including a viral- or CRISPR-mediated knockout 
of PEG10 and GNG12. As differentiation protocols for other endocrine cell types are developed, 
we can also probe for the FEV+ population during differentiation of alpha, epsilon, gamma, and 
delta cells, and help clarify whether a FEV+ progenitor is required for all endocrine subtypes. In 
summary, while we provide evidence for the presence of a FEV+ population in humans, future 
experiment should focus on characterizing the appearance of this population and its function 
during endocrine differentiation in human systems. 
Although recent work in human tissue and in vitro platforms have increased our 
knowledge of human pancreatic epithelial development, there are only a few studies focused on 
the development of the non-epithelial cells of the human pancreas. Differences in the timing of 
pancreatic islet innervation and vascularization have been noted between humans and mice. 
Human pancreatic islets are innervated starting at 12 wpc and fully vascularized by 20 wpc 
(Proshchina, Krivova, Barabanov, & Saveliev, 2014; Roost et al., 2014), while mouse islets are 
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innervated post-natally and fully vascularized at birth (Reinert et al., 2014). As innervation has 
been demonstrated to influence islet cytoarchitecture, these differences may reflect the structural 
differences between mature human and mouse islets (Proshchina et al., 2014).   
Similar to mouse, the remaining loosely packed non-epithelial cell types in the 
developing human pancreas are broadly termed mesenchymal. Very little work has been done to 
understand the development and function of this compartment. One study demonstrated the 
expression of FGF7 and FGF10 in human pancreatic mesenchyme, and further showed that 
these factors could promote pancreatic epithelial progenitor proliferation, mirroring studies in 
mice (Bhushan et al., 2001; Ye, Duvilli, & Scharfmann, 2005). However, the mesenchymal cell 
types present during human pancreatic development remain completely unexplored.  
Both the findings from this study and the approaches utilized can be applied to human 
tissue in order to study the cellular heterogeneity of the human pancreatic mesenchyme. First, a 
directed approach looking for the presence of the mesenchymal populations identified in mice 
can be performed by multiplexed immunohistochemistry and/or in situ hybridization. Second, an 
unbiased single-cell RNA-sequencing approach with human pancreatic tissue can be performed 
in order to more robustly characterize the cellular populations during development. Comparisons 
of these mouse and human datasets would allow for identification of key similarities or 
differences within this compartment.  
 In particular, the development of the human pancreatic mesothelium can be compared to 
our findings in mice. Although the adult human pancreas is known to contain a mesothelial layer, 
little is known regarding its development. Probing human tissue for expression of key 
mesothelial genes identified in our mouse dataset can help determine when and how this tissue 
arises during human development. Additionally, we can correlate the appearance of the human 
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mesothelial layer with the expression of genes expressed in the populations predicted to arise 
from the mouse mesothelial layer during development, such as PITX2 and STMN2. Finally, 
determining the expression pattern of FGF9 and other secreted factors in human pancreas can 
help determine if the human pancreatic mesothelium is likely to function as a source of secreted 
factors. 
 
Giving back to the dish 
 One goal of this study was to inform current efforts to produce hESC-derived beta cells 
for cellular therapy. One component that has traditionally been left out of differentiation 
protocols are the supporting niche cells, including vascular, neuronal, and mesenchymal cells. 
Given the importance of these cell types in pancreatic epithelial development in vivo, both in 
mice and humans, the absence of these cells in vitro may hinder the differentiation process 
towards a beta cell fate. Indeed, co-culture of primary mesenchymal cells with hESC-derived 
definitive endoderm progenitor cells has been demonstrated to support pancreatic progenitor 
proliferation in vitro (Sneddon et al., 2012). The mesenchymal cell lines used for co-culture were 
derived by outgrowth of either human fetal or embryonic mouse pancreata. Therefore, the 
cellular identity of these cells remains unknown, making their mechanistic contribution to the 
differentiation difficult to determine. Additionally, there may be additional mesenchymal 
populations that are critical for beta cell differentiation but are not able to survive or proliferate 
in the outgrowth culture methodology.  
 Co-culture of the mesenchymal subtypes identified in this study with various stages of 
endocrine differentiation in vitro can help elucidate the function of these individual populations 
during development and potentially improve the differentiation efficiency or final product. By 
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testing defined populations, we can compare the differentiation outcome upon addition of 
different mesenchymal populations and correlate this back to the population’s gene expression 
profile to identify mechanistic targets. Additionally, defined ratios and combinations of 
mesenchymal cells types can be tested and matched to the ratios present during developmental 
stages in both mouse and human pancreata. Understanding the impact of these individual 
populations may help improve in vitro differentiation platforms. 
The datasets developed in this study can be probed for cell surface markers that can be 
used to isolate individual mesenchymal populations identified by this study. As the mesenchymal 
populations have highly overlapping transcriptomic signatures and the transcriptomic coverage 
in single-cell RNA-sequencing datasets is only 10-15%, it may be challenging to identify a panel 
of markers capable of separating each population. Deeper sequencing of these populations can be 
obtained by newer versions of commercially available single-cell RNA-sequencing kits (10X 
Genomics, version 2). Additionally, intracellular markers can be identified and used to sort 
mesenchymal populations and then bulk sequencing performed to screen for cellular surface 
molecules specific to that population (Hrvatin, Deng, O'Donnell, Gifford, & Melton, 2014). 
 
Recapitulation of development in disease 
 An emerging theme in the study of disease, wound healing, and regeneration is 
reactivation of processes and pathways that regulate development (Cofre & Abdelhay, 2017; 
Fancy, Chan, Baranzini, Franklin, & Rowitch, 2011; Roxburgh, Murphy, Pollock, & Brazil, 
2006; Shworak, 2004). For example, the progression of renal fibrosis highlights the reemergence 
of epithelial-to-mesenchymal transitions (EMT), and expression of genes that regulate this 
process during development (Roxburgh et al., 2006). Additionally, transcriptomic profiles of 
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various cancers have identified a “developmental” signature, suggesting that cancer cells could 
be considered cells undergoing aberrant or improper developmental processes (Borczuk et al., 
2003; Cofre & Abdelhay, 2017; Kho, 2004). This hypothesis implies that developmental 
mechanisms of cellular differentiation and organization can be used as a guide to probe disease 
progression and may represent critical targets for disease therapies. 
 Within the pancreas, there is evidence for the return of mature pancreatic cells to a more 
“developmental” like state during injury conditions. Pancreatitis is characterized by the 
“dedifferentiation” of acinar cells, as evidenced by the re-expression of genes expressed in acinar 
progenitors during development, such as Pdx1, Notch, and beta-catenin (Jensen et al., 2005). 
After acute injury, these dedifferentiated cells then differentiate into acinar cells in order to 
regenerate the lost exocrine tissue, suggesting that dedifferentiation may be a protective 
mechanism (Jensen et al., 2005). Beta cells have also been shown to undergo dedifferentiation 
during stress conditions, upregulating genes normally expressed in progenitor cells, such as 
Ngn3, Oct4, Nanog, and L-Myc (Talchai, Xuan, Lin, Sussel, & Accili, 2012)}. This process of 
dedifferentiation has been proposed as the major factor leading to reduced beta cell mass in type 
2 diabetes, and similar to acinar cell dedifferentiation, may be a protective mechanism to prevent 
cell death (Accili et al., 2016). 
 The reactivation of developmental programs during injury suggests that the findings from 
our developmental dataset may be relevant for the study of adult disease. Is the Fev+ population 
present during adult homeostasis, or reactivated during a variety of disease conditions, such as 
obesity, diabetes, or fibrosis? The re-expression of Ngn3 and subsequent re-differentiation into 
beta cells in diabetes (Z. Wang, York, Nichols, & Remedi, 2014) could mean that these cells also 
pass through a Fev+ state. If that is true, is the re-differentiation process facilitated by similar 
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mechanisms as those in the development? Are the resulting beta cells equivalent to those 
produced during development, or does this re-differentiation process leave “scars”? Combining 
lineage tracing of these dedifferentiated cells with single-cell RNA-sequencing approaches can 
reveal the trajectory of de- and re-differentiation. Comparison of the gene expression patterns 
with the developmental trajectories in this work can identify the similarities and differences, and 
potentially inform therapeutics for regenerative medicine.  
 Although much emphasis has been placed on the recapitulation of developmental 
programs in the epithelial cells of the regenerating pancreas, it is currently unknown whether 
mesenchymal cells also revert to a developmental phenotype during injury. In the heart, the 
mesothelium has been described as undergoing a “reactivation” process that results in re-
expression of developmental genes and reversion to its developmental function as a 
mesenchymal progenitor cell (Bin Zhou et al., 2011). Pancreatic mesenchymal cells undergo 
dynamic changes during pancreatitis (Apte et al., 2012), but given our lack of understanding of 
the mesenchymal cell types in either development or disease, it has been challenging to study 
these populations. With the datasets derived in this work, we can begin to compare the 
mesenchymal transcriptomic signatures in development and adult homeostasis and disease. 
Evidence of shifting populations in caerulein-treated pancreata suggests that multiple 
mesenchymal and mesothelial populations change transcriptionally during pancreatitis. Do these 
changes reflect reversions to a developmental population? If so, do they share functional roles in 
both development and disease progression or recovery? Future experiments aimed at 
characterizing the mesenchymal populations across the pancreatic timecourse will shed light on 
these questions and help drive progress in identifying new cellular or mechanistic targets for 
therapies. 
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Materials and Methods 
Chapters 2 and 3 
Mice 
All mouse procedures were approved by the University of California, San Francisco 
(UCSF) Institutional Animal Care and Use Committee (IACUC). Mice were housed in a 12-hour 
light-dark cycle in a controlled temperature climate. Noon of the day of vaginal plug was 
considered embryonic day 0.5. 
Timed-pregnant Swiss Webster mice were obtained from Charles River Laboratories. 
Ngn3-Cre(Schonhoff, Giel-Moloney, & Leiter, 2004) (a gift from Dr. Matthias Hebrok), Fev-
Cre(Scott et al., 2005) (The Jackson Laboratory 012712), and ROSA26mTmG(Muzumdar et al., 
2007) (the Jackson Laboratory 007676) mice were maintained in a C57BL/6J background. The 
Cre transgene was genotyped using the following primers: GGGCGGCATGGTGCAAGTT and 
CGGTGCTAACCAGCGTTTTC.  
 
Human tissue procurement and isolation 
Human fetal pancreata were harvested from post-mortem fetuses at 23 weeks of gestation 
with permission from the ethical committee of the University of California, San Francisco 
(UCSF). Tissue was fixed in 4% paraformaldehyde overnight at 4°C. After three washes in 1X 
PBS, tissue was either cryopreserved in 30% sucrose solution at 4°C overnight and embedded in 
OCT, or placed in 40% ethanol then 70% ethanol before paraffin embedding. 8 um sections were 
cut on the cryostat or microtome. In situ hybridization and immunofluorescence were then 
performed as described below.  
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Adult human islets were isolated from cadaveric donor tissue by the UCSF Islet 
Production Core with permission from the UCSF ethical committee. Consented cadaver donor 
pancreata were provided by the nationally-recognized organization UNOS via local organ 
procurement agencies.  The identifiers were maintained at the source only, and the investigators 
received de-identified specimens.   
Informed consent was obtained for all human (fetal and adult) tissue collection, and 
protocols were approved by the Human Research Protection Program Committee on Human 
Research of the University of California, San Francisco (UCSF). 
 
Embryonic stem cell culture and differentiation  
The human embryonic stem cell (hESC) line HUES8 was obtained from Harvard 
University and used for the generation of hESC-derived beta-like cells (BLCs). Pluripotent 
HUES8 cells were maintained as spherical clusters in suspension in mTeSR-1 (StemCell 
Technologies) in 500mL spinner flasks (Corning, VWR) on a magnetic stir plate (Dura-Mag) 
within a 37°C incubator at 5% CO2, 100% humidity, and a rotation rate of 70 rpm. Cells were 
screened for mycoplasma contamination using the MycoProbe Mycoplasma Detection Kit (R&D 
Systems), according to the manufacturer’s instructions. 
hESC-derived endocrine progenitor cells were generated as previously described 
(Pagliuca et al., 2014). In brief, HUES8 cells were seeded into a spinner flask at a concentration 
of 8 x 105 cells/mL in mTeSR-1 media with 10μM Rock inhibitor Y27632 (StemCell 
Technologies) to allow formation of spherical clusters. Differentiation was initiated 72 hours 
later. Differentiation was achieved in a step-wise fashion using the following growth factors 
and/or small molecules: definitive endoderm (Stage 1) (1 day of 100 ng/mL Activin A (R&D 
 160 
Systems) and 14 μg/mL of CHIR99021 (Stemgent); 2 days of 100 ng/mL Activin A); gut tube 
endoderm (Stage 2) (3 days of 50 ng/mL KGF (Peprotech)); early pancreatic progenitors (Stage 
3) (1 day of 200 nM LDN193189 (Fisher Scientific), 50 ng/mL KGF,  0.25 μM Sant-1 (Sigma), 
2 μM Retinoic Acid (Sigma), 500 nM PdbU (EMD Biosciences); 1 day of 50 ng/mL KGF,  0.25 
μM Sant-1, 2 μM Retinoic Acid, 500 nM PdbU); later pancreatic progenitors (Stage 4) (5 days of 
50 ng/mL KGF, 0.25 μM Sant-1, 0.1 μM Retinoic Acid); endocrine progenitors (Stage 5) (4 days 
of 0.25 μM Sant-1, 0.1 μM Retinoic Acid, 1 μM XXI (EMD Millipore), 10 μM Alk5i (Axxora), 
1 μM T3 (EMD Biosciences), 20 ng/mL Betacellulin (Fisher Scientific); 3 days of 25 nM 
Retinoic Acid, 1 μM XXI, 10 μM Alk5i, 1 μM T3, 20 ng/mL Betacellulin); BLCs (Stage 6) (6 
days of 10 μM Alk5i; 1 μM T3). Successful differentiation was assessed at Stages 1, 3, 4, 5, and 
6 via immunofluorescence or FACS for stage-specific marker genes. 
To measure the expression of FEV at various stages of human endocrine differentiation, 
aliquots of clusters were removed from the flask and analyzed at several timepoints: after 5 days 
in Stage 5 (“mid-stage endocrine progenitors”), after 7 days in Stage 5 (“late-stage endocrine 
progenitors”), and after 5 days at the BLC stage.  As a comparator, pluripotent, undifferentiated 
hESCs in mTeSR-1, as well as human adult islets, were also analyzed for FEV expression. 
 
Immunofluorescence 
Embryonic mouse pancreata were dissected in cold 1X PBS and fixed in zinc-buffered 
formalin (Anatech LTD) at room temperature (RT) for 30-90 minutes or overnight at 4°C. After 
three washes in 1X PBS, tissue was processed for either cryopreservation or paraffin embedding. 
Cryopreserved pancreata were placed in 30% sucrose solution at 4°C overnight before 
embedding in OCT. Paraffin-embedded pancreata were placed in 40% ethanol and 70% ethanol 
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before paraffin tissue processing. 8 um sections were cut on the cryostat or microtome. For 
immunofluorescence on paraffin sections, slides were baked at 55°C for 30 minutes, 
deparaffinized in xylene, and rehydrated in decreasing concentrations of ethanol. Heat-mediated 
antigen retrieval was performed using Antigen Retrieval Citra Solution (Biogenex Laboratories). 
Tissue sections were blocked in 5% normal donkey serum (NDS; Rockland Immunochemicals) 
and Mouse-on-Mouse IgG blocking reagent (Vector Laboratories) when appropriate in 0.2% 
Triton X-100 in PBS (PBT) for 1 hour and then stained overnight at 4°C using the following 
primary antibodies: Acta2 (1:200, Abcam ab21027), Cav1 (1:200, Abcam ab2910), 
Chromogranin A (1:100, Abcam ab15160), E-cadherin (1:200, BD Transduction Lab 610182), 
Glucagon (1:100, Abcam ab82270), Insulin (1:50, DAKO A0564), Vimentin (1:200, Abcam 
ab92547), and Wt1 (1:100, Abcam ab89901). All antibodies have been validated by the 
manufacturer. The next day, sections were washed three times in 0.1% Tween 20 in 1X PBS and 
then incubated with species-specific Alexa Fluor 488-, 594-, or 647-conjugated secondary 
antibodies (1:500, Jackson ImmunoResearch) and DAPI in 5% NDS in 0.2% PBT for 1 hour at 
RT. Sections were washed three times in 0.1% Tween 20 in 1X PBS, rinsed in 1X PBS, and then 
mounted in Fluoromount-G mounting medium (SouthernBiotech). Slides were stored at 4°C.  
For immunofluorescence on cryosections, slides were removed from -80°C storage and 
allowed to reach RT. Sections were rinsed in 1X PBS three times and permeabilized in 0.5% 
PBT for 10 minutes at RT. Tissue sections were blocked in 5% NDS and, if needed, Mouse-on-
Mouse IgG blocking reagent in 0.1% PBT for 1 hour and then stained overnight at 4°C using the 
following primary antibodies: CD326 (Epcam) (1:200, BD Transduction Lab 552370), Glucagon 
(1:2000, Millipore 4031-01F), Insulin (1:250, DAKO A0564), Somatostatin (1:500, Santa Cruz 
Biotechnology sc-7819, Ghrelin (1:1500, Santa Cruz Biotechnology sc-10368), Pancreatic 
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Polypeptide (PP; 1:250, Abcam ab77192), and Vimentin (1:200, Abcam ab92547). All 
antibodies have been validated by manufacturer. Sections were washed the next day three times 
in 1X PBS and then incubated with species-specific Alexa Fluor 488-, 555-, 594-, or 647-
conjugated secondary antibodies and DAPI in 5% NDS in 0.1% PBT for 1 hour at RT. Sections 
were washed three times in 1X PBS and mounted in Fluoromount-G mounting medium. Slides 
were stored at 4°C. 
Images were captured on a Zeiss Apotome Widefield microscope with optical sectioning 
capabilities or Leica confocal laser scanning SP8 microscope. Maximum intensity z-projections 
were then prepared using ImageJ, where brightness, contrast, and pseudo-coloring adjustments 
were applied equally across all images in a given series. 
 
In situ hybridization 
 In situ hybridization was performed on 8 um sections using RNAscope technology 
(Advanced Cell Diagnostics)(F. Wang et al., 2012) according to the manufacturer’s instructions. 
In situ probes against mouse Ngn3 (422409-C2), Fev (413241-C3), Isl1 (451931), Ins1 (414661-
C4), Gcg (400601), Sst (404631-C3), Ghrl (415301-C2), Ppy (482701), Peg10 (512921-C4), 
Gng12 (462521-C2), Nnat (432631-C2), Barx1 (414681), Pitx2 (412841-C2), Stmn2 (498391-
C3), Msln (443241) and human NGN3 (505791-C4), FEV (471421-C3), and ISL1 (478591-C2) 
were used in combination with the RNAscope Multiplex Fluorescent Reagent Kit v2 for target 
detection. Following signal amplification of the target probes, sections were washed in 1X PBS 
three times and blocked in 5% NDS in 0.1% PBT for 1 hour at RT. Tissue sections were then 
stained with primary and secondary antibodies as described above in the “immunofluorescence” 
section.  
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For in situ hybridization of hESC-derived clusters, cells were fixed with 4% PFA for 15 
minutes at RT, washed with PBS, and cryoprotected in 30% sucrose overnight. The next day, 
clusters were embedded in a small sphere of 1.5% low-melting temperature agarose; these were 
again cryoprotected in 30% sucrose overnight. The following day, the agarose spheres were 
soaked in OCT and frozen in a dry ice bath. In situ hybridization was then performed on 8 um 
sections using human NGN3, FEV, and ISL1 RNAscope probes.  
 
Quantification of cell proportions 
Quantification of pancreata was performed by manual counting using ImageJ software. 
Cell populations present at less than 1% in Ngn3-lineage traced E14.5 replicates were deemed 
artifact and excluded from further analysis.  
 
Quantitative RT-PCR 
 hESCs from various stages of directed differentiation were collected and RNA extracted 
with the RNeasy Mini Kit (Qiagen). Reverse transcription was performed with the Clontech RT-
PCR kit. RT-PCR was run on a 7900HT Fast Real-Time PCR instrument (Applied Biosystems) 
with Taqman probes for FEV (assay ID: Hs00232733_m1) and GAPDH (assay ID: 
Hs02758991_g1) in triplicate. Data were normalized to GAPDH. Error bars represent standard 
deviation.  
  
Dissociation and FACS of embryonic pancreas  
Embryonic mouse pancreata were dissected and placed in 1X PBS on ice, then 
dissociated into single cells using TrypLE Express dissociation reagent (Thermo Fisher) at 37°C 
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with pipet trituration at 5-minute intervals during incubation. For v1 datasets, E12.5 pancreata 
were dissociated for 10 minutes, E14.5 pancreata for 15 minutes, and E17.5 pancreata for 30 
minutes. For batch 1, we pooled 14 E14.5 pancreata from one litter. For batch 2, which was 
collected on a different day, we pooled tissue from each timepoint separately: 18 E12.5 pancreata 
from two litters, 11 E14.5 pancreata from one litter, and 8 E17.5 pancreata from one litter. 
Dissociations were neutralized with FACS buffer (10% FBS + 2mM EDTA in phenol-red free 
HBSS). Dissociated cells were passed through a 30 um cell strainer and stained with Sytox 
live/dead stain (Thermo Fisher). Stained cells were washed twice in FACS buffer and then sorted 
using a BD FACS Aria II. After size selection to remove doublets, all live cells were collected. 
For version 2 10X datasets, we pooled tissue from each timepoint separately, each 
performed on a different day: 14 E12.5 pancreata from one litter, 13 E14.5 pancreata from one 
litter, and 13 E17.5 pancreata from one litter. For the E14.5 Fev-Cre; ROSA26mTmG 10X sample, 
we pooled 3 pancreata from one litter. Dissociations were performed as described above. Cells 
undergoing a CD140a negative selection were stained with CD140a-APC (1:50; eBiosciences, 
cat. 17-1401-81; validated by manufacturer). Stained cells were washed twice in FACS buffer 
and then sorted using a BD FACS Aria II. After size selection to remove doublets, all live 
CD140a- cells were collected. For the E14.5 Fev-Cre; mTmG pancreata, live GFP+ cells and 
GFP-/TdTomato+ cells were collected. All 4,000 GFP+ (Fev-lineage traced) cells were loaded 
onto the 10X Genomics platform, supplemented with an additional 21,000 TdTomato+/GFP- 
(non-lineage traced). 
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Single-cell capture and sequencing 
To capture individual cells, we utilized the Chromium Single Cell 3’ Reagent Version 1 
Kit (10X Genomics) (Zheng et al., 2017). For batch 1, 12,800 cells from E14.5 pancreata were 
loaded into one well of the 10X chip, while for batch 2, 18,000 cells per timepoint were each 
loaded into their own respective wells to produce Gel Bead-in-Emulsions (GEMs). GEMs 
underwent reverse transcription to barcode RNA before cleanup and cDNA amplification. 
Libraries were prepared with the Chromium Single Cell 3’ Reagent Version 1 Kit. Each sample 
was sequenced on 2 (Batch 1) or 1 (Batch 2) lanes of the HiSeq2500 (Illumina) in Rapid Run 
Mode with paired-end sequencing parameters: Read1, 98 cycles; Index1, 14 cycles; Index2, 8 
cycles; and Read2, 10 cycles.  
The CD140a-depleted E12.5, E14.5, and E17.5 datasets and  Fev-Cre; ROSA26mTmG 
dataset were generated with Chromium Single Cell 3’ Reagent Version 2 kits (10X Genomics). 
27,000 cells were loaded onto their respective wells and underwent the same processing as the 
Version 1 kits, according to manufacturer instructions for Version 2 kits. Libraries were 
sequenced on the NovaSeq (Illumina) with the same sequencing parameters as above. 
 
Single-cell analysis 
For the v1 datasets, we utilized CellRanger v1.1.0 software for v1 datasets and v2.1.0 for 
v2 datasets with default settings for de-multiplexing, aligning reads to the mouse genome (10X 
Genomics pre-built mm10 reference genome) with STAR(Dobin et al., 2012) and counting 
unique molecular identifiers (UMIs) to build transcriptomic profiles of individual cells. For the 
v1 datasets, gene-barcode matrices were analyzed with the R package Seurat v1.4, using the 
online tutorial as a guide (R core team, 2016; Satija et al., 2015). We first performed a filtering 
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step, retaining only the cells that expressed a minimum of 200 genes and only the genes that 
were expressed in at least 3 cells. A large number of cells did not meet this threshold in the 
E17.5 timepoint and were determined to be red blood cells by the high expression of hemoglobin 
genes. Variable genes were determined by mean-variance relationship to identify highly-
expressed and variable genes with the Seurat function MeanVarPlot with default settings.  UMI 
counts were log-normalized, and linear regression was performed with RegressOut to account for 
differences in the number of UMIs between cells. Principal component analysis (PCA) was then 
utilized to determine sources of variability in the dataset with PCAfast. Significant PCs were 
determined based on the Scree plot and utilized for Seurat’s graph-based clustering algorithm 
(function FindClusters) with default parameters, except for the resolution parameter. To vary 
cluster numbers, the resolution parameter in FindClusters was adjusted from 0.6 – 3.0, and 
resulting clusters analyzed as follows. Clusters were visualized with t-distributed stochastic 
neighbor embedding (t-SNE) with Seurat’s RunTSNE function with default settings(Maaten & 
Hinton, 2008). Differentially-expressed genes were determined with the FindAllMarkers 
function, which uses a bimodal likelihood ratio test(McDavid et al., 2012). We confirmed 
differential gene expression analysis with the Wilcoxon rank sum test and MAST(Finak et al., 
2015) utilizing Seurat v2’s FindMarkers function with default settings. These tests calculate 
adjusted p-values for multiple comparisons. To determine the final number of clusters, clusters 
were required to have at least 9 significantly (p <0.05) differentially-expressed genes with a 2-
fold difference in expression in comparison to all other clusters. Clusters were manually curated 
for differential gene expression, and those that did not meet this threshold were manually merged 
with the nearest cluster based on the phylogenetic tree from Seurat’s BuildClusterTree. In some 
cases, clusters met the 9-gene threshold but appeared to have very similar differentially-
 167 
expressed genes to another cluster. This is likely a result of the comparison of individual clusters 
against all other clusters in determining differentially-expressed genes. In these cases, a pairwise 
comparison between the two clusters was performed and the same 9-gene threshold applied. An 
exception to the 9-gene threshold was made to annotate the proliferating population in early 
stages of the cell cycle within the E14.5 mesenchymal analysis (Fig. 4, cluster 8). Additionally, 
cluster 10 in the E14.5 mesenchymal dataset did not meet the 9-gene threshold. Rather, clusters 
1-9 had distinct transcriptomic signatures (with at least 9 differentially expressed genes) that 
distinguished them from cluster 10.  Lists of at least 2-fold differentially-expressed genes for 
individual analyses are provided in Supplementary Data 1.  
For v2 datasets, Seurat v2.2 and v2.3 was utilizing to perform the analysis. Cells with less 
than 200 genes and genes expressed in fewer than 3 cells were removed, as above. UMI counts 
were normalized with NormalizeData using default settings. Variable genes were determined 
with FindVariableGenes, using the following cut-offs suggested by the online tutorial 
(x.low.cutoff = 0.0125, x.high.cutoff = 3, y.cutoff = 0.5). Data was scaled and UMI counts 
regressed out with the ScaleData function. Principal component analysis was performed with 
RunPCA, and significant PCs determined based on the Scree plot. t-SNE analysis and clustering 
was performed as described above for the v1 datasets. For the E12.5 exocrine dataset, the ductal 
population did not meet the 9-gene threshold. All other populations within this dataset could be 
distinguished from the ductal population by at least 9-differentially-expressed genes, therefore 
we still annotated this cluster. Some of the clusters depicted for the Fev-Cre; ROSA26mTmG 
dataset do not meet the 9-gene threshold. We chose to visualize these clusters in order to better 
illustrate their placement along the pseudotime trajectory.  
Custom genome build 
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 The custom genome for alignment of reads to eGFP and TdTomato sequences from the 
mTmG mouse line was created according to instructions provided by 10X Genomics reference 
support (https://support.10xgenomics.com/single-cell-gene-
expression/software/pipelines/latest/advanced/references). eGFP and TdTomato sequences were 
concatenated to the mm10-2.1.0 reference genome (FASTA file) provided by 10X Genomics.  
eGFP and TdTomato annotations were then concatenated to the mm10 annotations  (GTF file) 
provided by 10X Genomics. The cellranger mkref command was then utilized with the genome 
and annotations with eGFP and TdTomato, as described in the above link. 
 
Pathway analysis 
Pathway analysis and calculation of associated p-values were performed using the 
ConsensusPathDB over-representation analysis for pathway-based sets category 
(http://cpdb.molgen.mpg.de) (Kamburov, Wierling, Lehrach, & Herwig, 2008).  
 
Aggregating E17.5 v2 datasets 
E17.5 technical replicates from the v2 dataset were aggregated with Cellranger v2.1, 
utilizing the aggr function with default settings. The aggregated dataset was used for analysis and 
merging with the E12.5 and E14.5 v2 datasets. 
 
Sub-clustering and merging datasets 
Sub-clustering was performed by isolating clusters of interest with the Seurat function 
SubsetData and reanalyzing as described above (identification of variable gene, regression, and 
determination of significant PCs). Cells were classified as epithelial based on the expression of 
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E-cadherin (Cdh1) and other known epithelial population markers. Cells that were Cdh1-, Vim+, 
and collagen3a1 (Col3a1)+ were classified as mesenchymal. Multiple batches were merged with 
the MergeSeurat function. The merged dataset was reanalyzed as above, with batch included as a 
latent variable in the RegressOut function. The v1 E14.5 batch 1 and batch 2 clusters were robust 
to the sampling differences between batches as evidenced by the contribution of cells from both 
batches to each cluster (Supplementary Fig. 2b). We find high correlation of cell type proportion 
between batches in all populations except the exocrine compartment (acinar and ductal) 
(Supplementary Fig. 2c), possibly due to technical challenges of pancreatic dissociation. Within 
each cluster, batch 1 cells correlated most highly with those of batch 2 contained in the same 
cluster, indicating proper cluster calling with the merged datasets (Supplementary Fig. 2d).  
For v2 datasets (E12.5, E14.5 and E17.5), multiple canonical correlation analysis 
(multiCCA) from Seurat v2.3 was utilized to merge the epithelial datasets (A. Butler et al., 
2018). The top 1,000 most highly variable genes that were variable in at least 2 datasets were 
used for the alignment, as recommended in the Seurat tutorial. The shared correlation strength of 
each CC was measured with Seurat’s MetageneBicorPlot, and those before the drop-off were 
used for alignment, analogous to the Scree plot in choosing significant PCs. We then aligned the 
datasets with AlignSubspace and ran an integrated t-SNE and clustering analysis, as outlined in 
the Seurat tutorial. Clusters were required to have 9 significantly differentially-expressed genes 
as described above. Clusters with similar differentially-expressed genes were verified with 
pairwise comparisons to the most related clusters (based on BuildClusterTree) and merged if 
they did not meet the pairwise 9-gene threshold. The Beta 2 cluster in the v2 endocrine merged 
timecourse data met the 9-gene threshold for 2 out of the 3 differential expression tests (Bimodal 
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likelihood ratio and Wilcoxon rank sum tests), but had only 8 differentially-expressed genes for 
the MAST test.  
Doublets were identified based on co-expression of two mutually exclusive genes, such 
as both mesenchymal and epithelial genes, and removed from further analysis. In the v2 datasets, 
rare cells (4 cells in E12.5 and 13 cells in E14.5 endocrine datasets) with high levels of 
hemoglobin gene expression were removed from the analysis. 
 
Downsampling analysis 
 To determine if the sequencing depth was sufficient for calling clusters, downsampling 
analysis was performed for the v1 E14.5 batch 1 dataset. Reads were randomly downsampled 
from the 10x Cellranger bam file output to a specified percentage, then grouped based on UMI to 
generate a count profile for each cell. The number of genes with greater than 0 counts was then 
calculated. UMI downsampling was performed with the SampleUMI function. A new Seurat 
object was created with the downsampled matrix and reanalyzed as above.  
The number of UMIs/cell was downsampled from an average of 4,600 UMIs/cell in the 
full dataset to 200 UMIs/cell, and the median number of genes/cell and clustering robustness was 
then calculated. Clustering robustness was determined as the percentage of cells within the same 
cluster, with clusters required to maintain at least 9 genes with a 2-fold change in expression in 
comparison to all other clusters. Within this dataset, robust clustering was maintained all the way 
down to 500 UMIs/cell, when the percentage of cells in the same cluster began to climb, 
indicating collapsing of individual clusters.  Both of these downsampling analyses indicate that 
sufficient sequencing depth was reached. 
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Pseudotemporal ordering 
We utilized Monocle 2.6.4 (X. Qiu et al., 2017b) to order cells in pseudotime based on 
their transcriptomic similarity. For v1 timecourse datasets, batch-corrected values and variable 
genes from Seurat analysis were used as input, utilizing the gaussianff expressionFamily, and 
clusters were projected onto the minimum spanning tree after ordering.  
For the Fev-lineage traced dataset, UMI counts and variable genes from the Seurat 
analysis were used as input, utilizing the negBinom expressionFamily. To find genes 
differentially-expressed across the branch point in the trajectory, we used monocle’s internal 
BEAM analysis and selected genes with an FDR cutoff of 0.001. Gene expression patterns were 
plotted with plot_genes_branched_heatmap and plot_multiple_branches_pseudotime. 
  
Data and code availability  
The accession number for the raw data files of the single-cell RNA-sequencing analyses reported 
in this paper is GEO: GSE101099. Seurat and monocle R objects used for analysis are available, 
along with scripts, at Figshare, DOI: 10.6084/m9.figshare.c.4158458. Scripts are available at 
https://github.com/sneddonucsf/2018-Developmental-single-cell-RNA-sequencing. 
 
Chapters 4 and 5 
Mice 
All mouse procedures were approved by the University of California, San Francisco 
(UCSF) Institutional Animal Care and Use Committee (IACUC). Wt1-Cre (Bin Zhou et al., 
2008), Wt1-CreER (Bin Zhou et al., 2008) (The Jackson Laboratory 010912), Krt19-CreER 
(Means, Xu, Zhao, Ray, & Gu, 2008) (a gift from Dr. Holger Willenbring), and Krt18-CreER 
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(Van Keymeulen et al., 2009) (a gift from Dr. Ophir Klein), and Fgf9-LacZ (Huh et al., 2015) (a 
gift from Dr. David Ornitz) mice were maintained on mixed backgrounds. Cre alleles were 
genotyped with primers listed in “Mice” for Chapters 2 and 3. Fgf9 mice were genotyped with 
the following primers: WT 3’: CCGCGAATGCTGACCAGGCCCACTGCTAT, WT 5’: 
CATATACATGTACATGCTCACATACACACT, MUT 3’: 
TCTAGAGAATAGGAACTTCGGAATAGGA. WT 3’ and 5’ detected a 500 bp wild type allele 
and MUT 3’ and WT 5’ detected a 141 bp mutant allele. 
 
Immunofluorescence 
Embryonic mouse pancreata were dissected in cold 1X PBS and fixed 4% 
paraformaldehyde in 1X PBS at room temperature (RT) for 30-90 minutes or overnight at 4°C. 
After three washes in 1X PBS, tissue was processed for either cryopreservation or paraffin 
embedding. Cryopreserved pancreata were placed in 30% sucrose solution at 4°C overnight 
before embedding in OCT. 5-8 um sections were cut on a cryostat and immunostaining 
performed as stated in “Immunofluorescence” for Chapters 2 and 3. Additionally antibodies used 
in Chapters 4 and 5 include: WT1 (1:200, Abcam, ab89901), CAV1 (1:200, Abcam ab2910), 
EBP50 (1:200, Abcam, ab3452), CRYAB (1:200, Abcam, ab13496), GFP (1:200, Aves, GFP-
1020), KRT19 (1:200, Abcam, ab133496), CD31 (1:200, BD Biosciences, 553370), CPA1 
(1:200, R&D Systems, AF2765), and SMA (1:200, Abcam, ab21027). 
 
Whole mount immunofluorescence 
 Embryonic mouse pancreata were dissected in cold 1X PBS and fixed with 4% 
PFA for 45 min. at RT. Pancreata were washed three times with 0.2% bovine serum albumin 
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(BSA) in 1X PBS for 10 min. at RT while shaking, and blocked in 2% BSA, 5% normal donkey 
serum (NDS), 0.1% Triton X-100 in 1X PBS for 3 hours at RT. Primary antibodies were diluted 
in the block buffer and pancreata stained overnight at 4°C while shaking. After four washes in 
0.1% Triton X-100 in 1X PBS for 15 minutes each, pancreata were stained with species-specific 
Alexa 488-, 549-, or 647- secondary antibodies diluted in block buffer overnight at 4C while 
shaking. Pancreata were then washed three times with block buffer for 30 minutes each.  
Pancreata were dehydrated in a methanol series: 10 minutes each in 25%, 50%, 75%, and 100% 
methanol and one additional 10 minutes wash in 100% methanol before clearing in 50% benzyl 
alcohol and 50% benzyl benzoate (BABB). Imaging was performed on a Leica confocal laser 
scanning SP8 microscope and three dimensional reconstructions were performed with Imaris 
software. 
Primary antibodies used for whole mount imaging include CD326 (Abcam 552370), 
CRYAB (1:100, Abcam ab13496), and EBP50 (1:100, Abcam, ab3452). 
 
Lineage tracing 
 Wt1-Cre, Wt1-CreER, Krt19-CreER, and Krt18-CreER males were crossed to 
ROSA26mTmG females. Tamoxifen was administered to pregnant dams via interperitoneal 
injection (Krt19-CreER) or oral gavage (Wt1-CreER, Krt18-CreER). ROSA26mTmG crossed to 
Wt1-CreER males received two 2.5 mg doses of tamoxifen 8 hours apart at E12.5, and pancreata 
were collected at either E13.5 or E17.5.  ROSA26mTmG crossed to Krt19-CreER males received 
one 4.5 mg dose of tamoxifen at E12.5 and E13.5, and pancreata were collected at E17.5. 
ROSA26mTmG crossed to Krt18-CreER males received one 3 mg dose of tamoxifen was given at 
E11.5 and E12.5, and pancreata collected at E13.5. 
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Hematoxylin and eosin (H&E) staining 
Adult pancreata from PBS- and caerulein-injected animals were dissected and fixed in 
zinc-buffered formalin (Anatech LTD) overnight at 4C. Pancreata were washed three times in 1X 
PBS over the course of 4 hours, placed in 40% ethanol for 20 minutes at 4C and then stored in 
70% ethanol at 4C until processing for paraffin embedding. 6 um sections were cut on the 
microtome. H&E staining was performed with the following immersion steps: Histoclear twice 
for 4 minutes, 100% ethanol twice for 2 minutes, 95% ethanol for 2 minutes, tap water for 3 
minutes, hematoxylin (ThermoFisher) for 3 minutes, tap water for 3 minutes, 95% ethanol for 1 
min, eosin (ThermoFisher) for 1 minute, 95% ethanol for 1 minute, 100% ethanol twice for 2 
minutes, histoclear twice for 2 minutes. Slides were then mounted with Cytoseal (ThermoFisher) 
and imaged with the Zeiss Brightfield microscope. 
 
Caerulein treatment 
Acute pancreatitis was induced in 6-8 week old Swiss Webster mice. For the timecourse 
experiments, 2 ug Caerulein (Bachem) was injected by i.p hourly for 8 hours on two consecutive 
days in both male and female mice. For the single-cell RNA-sequencing experiments, 75 ug/kg 
caerulein was used per injection and only male mice was used. 
 
Dissociation and FACS of adult pancreas  
 Adult pancreata were dissected in pairs and placed in cold 1X PBS. For the single-cell 
RNA-sequencing experiments, 2 PBS-treated and 4 caerulein-treated animals were dissected. 
Once all dissections were complete pancreata were placed in dissociation buffer (0.4 mg/mL 
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Collagenase P (Roche), 1 ng/mL DNase1 (Roche), 0.2 mg/mL soybean trypsin inhibitor (STI) or 
with modifications as outlined in results) at 37C for 20-25 minutes with pipet trituration at 5-
minute intervals during incubation. Dissociations were neutralized with FACS buffer (10% FBS 
+ 2mM EDTA in phenol-red free HBSS) and passed through a 30 um cell strainer twice. Red 
blood cell lysis buffer (High Yield Lyse, ThermoFisher) was diluted 1:10 in water and added to 
dissociations at a 10:1 ratio for 2 minutes at RT. Cells were stained with various combinations of 
sytox blue (1:2000), propidium iodide (1:1000), CD326-FITC (1:100, eBiosciences 115791), 
CD140a-APC (1:100, eBiosciences 171401), and CD45-PE (1:100, eBiosciences 120451). 
Stained cells were washed twice in FACS buffer and then sorted using a BD FACS Aria II. After 
size selection to remove doublets and live/dead selection of sytox blue and PI negative cells, 
cells were sorted into CD45+ and CD45-negative fractions.  
 
Single-cell capture and sequencing 
The PBS and caerulein datasets were generated with Chromium Single Cell 3’ Reagent 
Version 2 kits (10X Genomics). 27,000 cells total, 15% of which was CD45+ and 85% of which 
was CD45-negative, from each of the PBS and caerulein dissociations were loaded onto separate 
wells of the 10X Chromium machine for single cell capture and libraries prepared according to 
manufacturer instructions for Version 2 kits. Libraries were sequenced on the NovaSeq 
(Illumina) with the same sequencing parameters outlined in “Single-cell capture and sequencing” 
for Chapters 2 and 3. 
 
 176 
Single-cell analysis 
 PBS and caerulein datasets were processed as described in “Single-cell analysis” for 
Chapters 2 and 3. Seurat v2 was utilized for all downstream analysis following the same scripts 
as described for the v2 datasets in Chapters 2 and 3. For clustering, the default resolution of 0.8 
was used without additional merging of clusters. Therefore, we did not apply the 9-gene 
threshold criteria used in Chapters 2 and 3. Differentially-expressed genes were determined 
using the Wilcoxon rank sum test from Seurat’s FindAllMarkers. Subclustering was performed 
as described in “Single-cell analysis” for Chapters 2 and 3, using mesenchymal (Pdgfra) and 
mesothelial (Msln) markers as inclusion or exclusion criteria. 
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